[
    {
        "pmid": "40815785",
        "title": "Willingness to Pay for the COVID-19 Vaccine and Its Correlates in Bangladesh: Cross-Sectional Study.",
        "abstract": "Government Bangladesh offer COVID19 vaccine cost however sustaining free vaccination program large population pose significant challenges Thus assessing willingness pay WTP COVID19 vaccine essential understanding potential pricing strategies subsidy requirements vaccine demand study aimed assess prevalence WTP COVID19 vaccine correlates crosssectional design used collect data 1497 respondent webbased platform facetoface interviews Multivariable logistic regression used analyze correlate WTP result showed 772 1497 516 participant willing pay COVID19 vaccine median 300 BDT IQR 150500 BDT currency exchange rate 1 BDTUS 0008 applicable WTP significantly higher among individual graduate degree adjusted odds ratio aOR 198 95 CI 114345 masters MPhil PhDlevel education aOR 193 95 CI 107348 higher knowledge vaccine aOR 109 95 CI 102115 positive behavioral practice aOR 111 95 CI 106117 stronger subjective norm regarding COVID19 vaccine aOR 125 95 CI 108146 higher anticipated regret getting infected COVID19 aOR 117 95 CI 104132 Conversely WTP lower among participant negative attitude toward vaccine aOR 091 95 CI 088095 high perceived behavioral control regarding COVID19 vaccination aOR 086 95 CI 076096 P006 nearly half respondent unwilling pay study highlight need improve vaccinerelated knowledge enhance incomebased affordability increase WTP Health promotion effort focus disseminating knowledge vaccine addressing negative perceptions Additionally subsidized program lowincome group help mitigate financial barrier promote equitable access vaccines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815785/"
    },
    {
        "pmid": "40813708",
        "title": "One Health investigation of the first human rabies death linked to a clinically suspected rabid bull calf in Bangladesh.",
        "abstract": "Rabies fatal neglected zoonotic disease remains endemic Bangladesh human case result dog bites uncommon livestock bitten dogs report present first known clinically diagnosed human rabies case Bangladesh associated exposure infected livestock case involved 65yearold male farmer rural Bangladesh died clinically diagnosed rabies minor unrecognized exposure bull calf suspected rabies man suffered little hand injury feeding calf showing progressive neurological symptom consistent rabies Despite medical advice receive postexposure prophylaxis PEP largely due negligence Thirtyfour day exposure man began exhibit early symptom rabies including limb weakness neck back pain anxiety early sign hydrophobia illness quickly progressed classic feature furious rabies severe hydrophobia aerophobia confusion agitation died 41 day initial exposure case triggered fear panic local community reflecting broader lack awareness rabies particularly transmission nontraditional host like livestock incident highlight severe consequence inadequate awareness delayed missed PEP following potential rabies exposure emphasizes urgent need raise public awareness possible transmission routes ensure timely access PEP human animals stray dog vaccination strengthen publicveterinary health collaboration Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813708/"
    },
    {
        "pmid": "40791273",
        "title": "Childhood diarrhoeal disease in South Asian countries: a population-based analysis.",
        "abstract": "Despite advancement water sanitation vaccination childhood diarrhoeal disease CDDs continue pose significant public health challenges especially South Asia study aim estimate pooled prevalence CDDs South Asia identify key factor contributing persistence providing crucial insight future policy intervention strategies study utilised data recent Demographic Health Surveys conducted 2015 2022 Afghanistan Bangladesh India Nepal Maldives Pakistan focusing child 5 year old Descriptive statistic used measure prevalence CDDs multivariable logistic regression performed identify significant factors p value 005 considered level significance overall pooled prevalence CDDs 1013 95 CI 983 1045 Afghanistan highest rate childhood diarrhoea South Asian region prevalence 2915 95 CI 2801 3031 Maldives lowest prevalence 417 95 CI 320 542 Higher odds CDDs associated younger children male sex younger mothers mother little education larger households unimproved drinking water type toilet facilities lack access antimicrobial agent handwashing limited electronic medium access However factor varied country country study highlight persistently high prevalence childhood diarrhoea South Asia Countryspecific finding underscore urgency focused interventions particularly Afghanistan Pakistan effectively reduce CDDs region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791273/"
    },
    {
        "pmid": "40790080",
        "title": "Genetic diversity analysis of IVM resistant Haemonchus contortus in sheep in inner Mongolia of China.",
        "abstract": "Haemonchus contortus widely distributed world seriously harmful small ruminant serious resistance common anthelmintics time prevalence intensity host infection parasite gradually increased necessary study phylogenetic genetic change single anthelmintic resistant strains study first analyze genetic diversity population structure IVMresistant Hcontortus L3egg adult n  30  Inner Mongolia China Hcontortus identified IVM resistance cultured fecal egg count reduction test larval development inhibition test larval locomotor behaviour test complete sequence ITS2  second internal transcribed spacer  partial sequence nad4  nicotinamide dehydrogenase subunit 4 gene  L3 adult egg amplified time compared ITS2 nad4 partial sequence Hcontortus reported NCBI database carry phylogenetic analysis haplotype determination study variation population genetic diversity IVMRR samples sample identified Hcontortus resistant IVM Phylogenetic analysis ITS2 IVMRR Hcontortus showed branch genetic relationship close intraspecific relatively conserved significant correlation AR significant difference different stage development samples addition 30 nad4 gene sequence IVMRR sample obtained 13 haplotypes 169th base site 70 nad4 gene mutated nucleotide diversity 000623 haplotype diversity 0926 IVMRR compared five countries Hcontortus nad4 found genetic differentiation level IVMRR population relatively low China Pakistan populations Fixation index Fst 010957 017262 respectively genetic differentiation level Bangladesh Greece France population higher Fst value 046978061825 098101 Perhaps population structure differentiation correlated regional localization anthelmintic frequency treatment report analyzed genetic diversity population differentiation IVM resistant Hcontortus different developmental stages obtained resistant samples haplotypes hoping provide new direction study AR vaccine research",
        "mesh_terms": [
            "Animals",
            "Haemonchus",
            "Genetic Variation",
            "Sheep",
            "China",
            "Phylogeny",
            "Drug Resistance",
            "Haemonchiasis",
            "Anthelmintics",
            "Haplotypes",
            "Sheep Diseases",
            "Ivermectin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790080/"
    },
    {
        "pmid": "40784902",
        "title": "Dengue fever in Bangladesh: rising trends, contributing factors, and public health implications.",
        "abstract": "Dengue fever emerged major public health crisis Bangladesh unprecedented surge case fatality recent years paper analyzed epidemiological trends contributing factors public health implication rising dengue burden country Surveillance data revealed staggering 203406 dengue case 989 death January September 2023 marking 19fold increase compared entire year 2019 capital bear brunt outbreak account half case deaths Climatic factors rapid urbanization population density insecticide resistance lack public awareness created perfect storm dengue transmission overburdened healthcare system struggle cope influx patients leading compromised quality care economic strain Vulnerable population heightened risk developing severe complication mortality paper highlight urgent need multipronged approach encompassing surveillance case management vector control risk communication community engagement combat dengue epidemic Bangladesh Sustained political commitment adequate resources strong multisectoral collaboration imperative reduce disease burden safeguard public health face escalating threat",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784902/"
    },
    {
        "pmid": "40784108",
        "title": "Community willingness to participate in a Nipah vaccine trial in Bangladesh.",
        "abstract": "Nipah virus NiV deadly zoonotic disease pandemic potential prioritized World Health Organization research vaccine development Since Bangladesh faced annual NiV outbreak repeated spillover since 2001 likely site Phase II vaccine trial study explored peoples knowledge NiV willingness participate NiV vaccine trial Bangladesh conducted mixed method study collecting qualitative quantitative data Mirpur township Dhaka NiVaffected Faridpur District December 2021 November 2022 team interviewed adult male female respondent responsible household treatment vaccination decisions team conducted 66 indepth interview 978 survey interviews Many indepth interviewee aware NiV and asked would participate NiV vaccine trial responded one three options willing unwilling would decide later concerned vaccine safety side effect making decision participation survey respondent Mirpur township Dhaka heard disease transmitted bat people 57  272478 vs 52  262500 willing participate vaccine trial 45  217478 vs 22  111500 Faridpur high number expressed willingness take investigational NiV vaccine outbreak Dhaka 75  205272 vs Faridpur 81  398491 Faridpur find association knowledge NiV willingness participate NiV vaccine trial Many respondent expressed willingness participate NiV vaccine trial especially outbreak suggesting trial may feasible Bangladesh Given concern safety side effects clear communication issue may support informed participation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784108/"
    },
    {
        "pmid": "40783163",
        "title": "Epidemiology, clinical characteristics and genetic diversity of Nipah virus strains from Bangladesh: 2016 to 2023.",
        "abstract": "Nipah virus NiV cause deadly outbreak Bangladesh fatality rate 71 Two sublineages NiVBD 1 NiVBD 2 identified study aimed characterize epidemiological clinical diversity study analyzed 21 new 20162023 17 previously 20122015 reported NiV genome sequence compared sublineages using descriptive bivariate analysis Median age sequenced case 17 year IQR 930 66 male Raw date palm sap consumption main transmission pathway 92 NiVBD 2 showed broader geographic distribution including southern region sublineages differ significantly age sex transmission modes sublineages presented fever altered mental status unconsciousness Respiratory distress frequent NiVBD 2 2329 cases hospitalization longer NiVBD 1 median 3 days IQR 123 Overall mortality 84 significant difference sublineages Phylogenetic analysis demonstrated NiVBD 1 NiVBD 2 formed distinct cluster 98729925 nucleotide 99989999 amino acid identity structural nucleoprotein N matrix M protein remained conserved across sublineages study highlight genetic spatiotemporal clinical variation sublineages emphasizing continuous genomic surveillance inform future vaccine therapeutic strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783163/"
    },
    {
        "pmid": "40781305",
        "title": "How did health service utilization and delivery change during the COVID-19 pandemic? Frontline healthcare workers' perceptions from the Central African Republic, the Democratic Republic of Congo, and Bangladesh.",
        "abstract": "country experienced disruption essential health service since beginning COVID19 pandemic risk prioritization COVID19 leading diversion resource health staff Disruptions particularly concerning humanitarian fragile setting due preexisting vulnerabilities investigated healthcare worker HCW perceived change health service provision whether programmatic adaptation introduced three humanitarian settings Key informant interview conducted 29 39 54 frontline HCWs Central African Republic Democratic Republic Congo Bangladesh respectively interview coded two author using deductive inductive coding Data organized framework thematic analysis conducted identify similarity discrepancy across respondent study sites Data collected March July 2021 country HCWs perception varied across service countries HCWs reported decreased consultation maternal newborn health sexual reproductive health communicable diseases communitybased activities mixed perception across country vaccinations nutrition noncommunicable diseases referrals Reasons reduced healthcare utilization included fear contracting COVID19 receiving COVID19 vaccine compliance movement restrictions financial barriers medication stockouts Factors specific humanitarian setting included insecurity population displacement presence technical partner lack medical equipment staff shortages Infection prevention control measure ie patient triage maskwearing physical distance hand washing introduced countries service adaptation included spaced consultations reduced group size extended drug prescriptions change nutrition protocols telemedicine shift COVID19 focus awareness activities first year COVID19 pandemic HCWs reported varying healthcare utilization according different service context three humanitarian settings Program adaptation address COVID19 risk introduced Although guidance existed global level contextual factor insecurity displacement preexisting capacity affected healthcare utilization health service delivery COVID19 pandemic especially DRC CAR number reported COVID19 case remained low several months",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Democratic Republic of the Congo",
            "Bangladesh",
            "Female",
            "Health Personnel",
            "Male",
            "Adult",
            "Central African Republic",
            "SARS-CoV-2",
            "Delivery of Health Care",
            "Attitude of Health Personnel",
            "Patient Acceptance of Health Care",
            "Middle Aged",
            "Interviews as Topic",
            "Qualitative Research",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781305/"
    },
    {
        "pmid": "40779535",
        "title": "The role of financial stress, food insecurity, and COVID-19-related illness concerns shaping mental health in five South Asian countries during the pandemic (2020-2022): A secondary analysis of the online COVID-19 Trends and Impact Survey (CTIS) data.",
        "abstract": "COVID19 pandemic substantially impacted mental health worldwide yet little attention given acute longterm effect mental health low middleincome country LMICs study investigates triad pandemicrelated worriesfinancial stress food insecurity COVID19related illness concernsare associated depression anxiety across five South Asian LMICs Bangladesh India Nepal Pakistan Sri Lanka Using data COVID19 Trends Impact Survey CTIS analyzed response 36 million participant collected June 27 2020 June 25 2022 employed surveyweighted logistic regression model based complete case N  1062786 adjusting demographic calendar time Due substantial change survey design May 20 2021 analysis divided two distinct periods Period 1 prechange Period 2 postchange main finding reveal three type pandemicrelated worry significantly associated increased level depression anxiety across studied countries Period 1 randomeffects metaanalysis showed financial stress highest pooled adjusted odds ratio OR depression 241 95 confidence interval CI 226 258 followed COVID19related illness concern 158 95 CI 143 175 food insecurity 152 95 CI 140 167 Period 2 pooled adjusted depression increased 274 95 CI 238 312 financial stress food insecurity showed notable rise 242 95 CI 223 262 Heterogeneity across country substantial Formula see text ranged 6033 8668 except association food insecurity depression Period 2 Countryspecific analysis confirmed results Additionally calendar time vaccination status gender education ruralurban residential status modified associations result underscore need targeted intervention address socioeconomic stressor improve mental health resilience LMICs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779535/"
    },
    {
        "pmid": "40766357",
        "title": "Typhi Mykrobe: fast and accurate lineage identification and antimicrobial resistance genotyping directly from sequence reads for the typhoid fever agent <i>Salmonella</i> Typhi.",
        "abstract": "Typhoid fever result systemic infection iSalmonella entericai serovar Typhi Typhi cause 10 million illness annually Disease control relies prevention water sanitation hygiene intervention vaccination effective antimicrobial treatment Antimicrobial resistant AMR Typhi lineage emerged become established many part world Knowledge local pathogen population informed genomic surveillance including lineage defined GenoTyphi scheme AMR determinants increasingly used inform local treatment guideline inform vaccination strategy Current tool genotyping Typhi require multiple read alignment assembly step validated analysis data generated Oxford Nanopore Technologies ONT longread sequencing devices Here introduce Typhi Mykrobe command line software tool rapid genotyping Typhi lineages AMR determinants plasmid replicons direct sequencing reads validated Typhi Mykrobe lineage genotyping comparison current standard read mappingbased approach demonstrated 998 concordance across nearly 13000 genome sequenced Illumina platforms isolates discordant calls show Typhi Mykrobe result better supported evidence raw sequence read data result generated using mappingbased approach also demonstrate 999 concordance detection AMR determinant compared current standard assemblybased approach similar result plasmid marker detection Typhi Mykrobe predicts clinical resistance categorisation SIR eight drug classes show strong agreement phenotypic categorisation generated reference laboratory minimum inhibitory concentration MIC data n1572 Illuminasequenced isolates 99 agreement within one doubling dilution show strong concordance 96 genotype 98 AMR plasmid call made ONT read made Illumina read isolates sequenced platform n 93 genomes Typhi Mykrobe take less minute per sample available httpsgithubcomtyphoidgenomicsgenotyphi Typhi Mykrobe provides rapid sensitive genotyping Typhi genome direct Illumina ONT reads although lower accuracy observed R9 ONT data demonstrated accurate assignment GenoTyphi lineage detection AMR determinant prediction corresponding AMR phenotypes identification plasmid replicons",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766357/"
    },
    {
        "pmid": "40763727",
        "title": "An O-Specific Polysaccharide Shigella flexneri 3a Conjugate Vaccine is Immunogenic and Protective against Virulent Keratoconjunctival Challenge in Guinea Pigs.",
        "abstract": "Shigella infection major cause diarrhea cognitive physical stunting death young child resourcelimited settings vaccine protective shigellosis needed Immune response target Ospecific polysaccharide OSP Shigella spp protective shigellosis previously reported development evaluation conjugate vaccine targeting Shigella flexneri S flexneri 3a mice Here report evaluation vaccine Shigella conjugate vaccine S flexneri 3a OSP conjugated 52 kiloDalton recombinant fragment tetanus toxin heavy chain SCVSf3a OSPrTTHc second animal model guinea pig vaccine induced prominent OSP lipopolysaccharide rTTHcspecific Immunoglobulin IgG IgA IgM response serum vaccinated animals Shigella conjugate vaccine S flexneri 3a also induced serum bactericidal functional antibody responses vaccinated guinea pig protected virulent strain keratoconjunctival challenge standard Shigella Sereny assay result support development SCVSf3a OSPrTTHc",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763727/"
    },
    {
        "pmid": "40756454",
        "title": "Global Burden of Human Metapneumovirus: Bridging Gaps in Prevention, Diagnostics and Treatment.",
        "abstract": "Human metapneumovirus hMPV respiratory virus significant impact particularly paediatric population yet remains underrecognized contributor respiratory infection globally Recent epidemic China India Europe underscore clinical burden severe case linked bronchiolitis pneumonia exacerbation chronic conditions Despite impact hMPV remains underdiagnosed due limited access molecular diagnostics routine surveillance particularly low middleincome countries absence antiviral vaccine exacerbates public health challenge Advances multiplex diagnostics vaccine development offer hope require sustained global investment Addressing gap prevention diagnostics treatment critical mitigating hMPVs growing threat ensuring equitable healthcare outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756454/"
    },
    {
        "pmid": "40756412",
        "title": "Barriers and drivers to childhood vaccinations in Forcibly Displaced Myanmar Nationals (FDMN)/Rohingya refugees in Cox's Bazar, Bangladesh: a scoping review.",
        "abstract": "one million Forcibly Displaced Myanmar Nationals FDMNRohingya refugee live refugee camp Coxs Bazar experiencing recurring vaccinepreventable disease outbreak despite established vaccination programs scoping review focused evidence individual context barriers drivers intervention childhood vaccination uptake FDMNRohingya refugee Coxs Bazar Four database grey literature systematically searched Theoretical framework used organize findings 4014 record screened 21 article included literature heterogenous Barriers driver FDMNRohingya refugee receiving vaccination focused motivation relating trust belief fear 19 barrier driver 11 articles accessibility information availability 19 barrier driver 11 articles well knowledge ability eight barrier driver nine articles sociocultural genderrelated norm social support seven barrier driver eight articles health service provider facilitating vaccinations context factors availability vaccine staff frequently identified 13 barrier driver 12 articles Interventions mostly related vaccination campaign informationeducation often lacked detail formal evaluations Future research intervention childhood vaccination consider barrier driver health service providers diversity camp population explore role communityreligious leader genderrelated social norms Additionally reporting evaluation intervention strengthened httpsdoiorg1017605OSFION6D3URL httpsosfion6d3z",
        "mesh_terms": [
            "Humans",
            "Refugees",
            "Myanmar",
            "Vaccination",
            "Bangladesh",
            "Health Services Accessibility",
            "Child",
            "Male",
            "Female",
            "Health Knowledge, Attitudes, Practice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756412/"
    },
    {
        "pmid": "40754580",
        "title": "A cost-benefit analysis of using wastewater monitoring to guide typhoid vaccine campaigns.",
        "abstract": "Enteric disease leading cause mortality developing countries yet highly preventable Typhoid vaccine remain underutilized diagnostic capacity constraint impede treatment prevention Wastewater monitoring could provide accurate picture disease burden detection quantification Salmonella Typhi wastewater advanced motivate country invest improve wastewater testing methods conducted costbenefit analysis quantifying value approach could yield estimated benefit could accrue wastewater data informed early launch theoretical typhoid vaccine campaign Coxs Bazar Bangladesh empirically estimating leadtime advantage wastewater data clinical data flag case upticks simulated change case count 1 14day early campaign launch using ordinary differential equation modeling quantified benefit resulting averted case from preserved caregiver time school days wages hospitalization from saving public funds death using value statistical life calculated cumulative benefits costs ratio two varied campaign launch timing scenario fiveyear period Wastewater concentration Salmonella Typhi upticked 13 day case counts Cumulative benefit varied year launch timing 13day early launch every 100 spent wastewater monitoring could yield 295 societal benefit year 5 Cumulative benefit roughly equaled cumulative cost 5day early launch outweighed cost campaign launched even earlier wastewater data advanced reliably provide early warning new typhoid outbreaks government could reap large benefit justify spending program implementation finding could generalize highaid country that like Bangladesh experience routine enteric disease outbreak strong operational networks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40754580/"
    },
    {
        "pmid": "40750539",
        "title": "Exosome: The hidden messengers in cancer detection and immunotherapy.",
        "abstract": "Cancer continues pose significant global health challenge driving need innovative approach early detection treatment management Exosomes small extracellular vesicle secreted various cell types play pivotal role intercellular communication transferring molecular cargo donor recipient cells emerged key player cancer progression therapy Exosomes contribute tumor growth mediating immune suppression drug resistance metastasis Yet distinctive property also present valuable tool cancer diagnosis Tumorderived exosomes abundant body fluids promising candidate liquid biopsies offering noninvasive biomarkers aid cancer detection prognosis realtime monitoring disease progression Beyond diagnostics exosomes forefront cancer immunotherapy particularly developing exosomebased vaccine targeted therapies capacity deliver molecular cargo directly cancer immune cell allows personalized highly effective cancer treatments review explores current understanding exosomes cancer biology underscore emerging diagnostic potential examines transformative role advancing future cancer immunotherapy strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750539/"
    },
    {
        "pmid": "40744673",
        "title": "Association of women's empowerment with childhood immunisation coverage in South and Southeast Asia: meta-analysis of Demographic and Health Surveys data from 11 countries.",
        "abstract": "Child health gender inequality significant global public health issue demand immediate action particularly South Southeast Asian SSEA country challenge prevalent study examines association womens empowerment child vaccination coverage 11 SSEA low middleincome countries Using populationlevel crosssectional data Demographic Health Surveys across 11 SSEA countries developed IndividualLevel Womens Empowerment Index ILWEI based three dimension womens empowerment decisionmaking autonomy attitude towards intimate partner violence social independence threestage mixedeffect individual participant data metaanalysis employed assess association ILWEI childhood immunisation coverage India 8128 woman reported participation three four decisionmaking areas followed 6207 Bangladesh Full immunisation coverage ranged 3243 Afghanistan 6330 Bangladesh association womens empowerment vaccination coverage varied across South Southeast Asia strongest positive association observed Pakistan However mixed negative association found country India TimorLeste finding indicate several SSEA countries including Pakistan Cambodia Philippines Afghanistan higher level individual womens empowerment positively associated increased likelihood childhood immunisation coverage However country India Myanmar TimorLeste higher womens empowerment associated lower odds childhood immunisation highlighting potential contextual systemic barrier may hinder vaccination uptake underscore critical role womens empowerment enhancing childhood vaccination intake also emphasising need targeted intervention address countryspecific challenges Coordinated multifaceted strategy essential empower woman thereby support immunisation child across regions",
        "mesh_terms": [
            "Humans",
            "Female",
            "Vaccination Coverage",
            "Asia, Southeastern",
            "Empowerment",
            "Cross-Sectional Studies",
            "Health Surveys",
            "Adult",
            "Child",
            "Adolescent",
            "Middle Aged",
            "Decision Making"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40744673/"
    },
    {
        "pmid": "40742520",
        "title": "Genetically Modified Lactic Acid Bacteria: a Promising Mucosal Delivery Vector for Vaccines.",
        "abstract": "advent mucosal vaccine target primary entry point many pathogen revolutionized field immunology Genetically modified lactic acid bacteria gmLAB include genus Lactobacillus Bifidobacterium emerged promising vector delivering antigen mucosal surfaces grampositive nonpathogenic microorganism exhibit inherent probiotic properties survive gastrointestinal tract efficiently interact host immune system Advances genetic engineering enabled expression wide range antigen gmLAB promote systemic mucosal immunity Studies demonstrated gmLABbased mucosal vaccine elicit mucosal systemic immune responses providing protective immunity specific pathogenic infections addition gmLAB vector offer good safety profiles stability costeffective production compared traditional vaccine platforms Recent study demonstrated potential LAB vaccine preventing infection caused viral bacterial parasitic pathogen immunotherapy treating allergy cancers review highlight mechanism underlying gmLABbased mucosal vaccine delivery current advancements challenges prospect recombinant mucosal vaccines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40742520/"
    },
    {
        "pmid": "40733731",
        "title": "Innate Immune Response to Powassan Virus Infection: Progress Toward Infection Control.",
        "abstract": "Powassan virus emerging tickborne flavivirus pose significant threat human health outcome Powassan virus infection shaped viral factor host immune response review aimed examine innate immune response particularly tolllike receptormediated immune response Powassan virus data specific immune response Powassan virus remain scarce Therefore focused tolllike receptor response related flavivirus infer possible mechanism host response Insights vivo vitro study critical guiding development effective therapeutic preventive strategies Currently clinically approved treatment vaccine Powassan virus highlighting urgent need development also highlight recent progress POWV vaccine development emphasis potential use tolllike receptor agonist adjuvant enhance immunogenicity improve vaccine efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733731/"
    },
    {
        "pmid": "40733730",
        "title": "Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines.",
        "abstract": "bBackgroundb effective vaccine Nipah virus NiV crucial due high fatality rate recurrent outbreak South Southeast Asia Vaccine development challenged lack validated accessible neutralization assays virus culture requires BSL4 facilities restricting implementation resourcelimited settings address this standardized validated pseudotyped virus neutralization assay PNA assessing NiVneutralizing antibody BSL2 laboratories bMethodsb NiVPNA validated following international regulatory standards using replicationdefective recombinant Vesicular stomatitis virus rVSV backbone dependent pseudotyped virus Assessments included sensitivity specificity dilutional linearity relative accuracy precision robustness assay calibrated using International Standard antiNiV antibody characterized reference serum ensure reliable performance bFindingsb Preliminary evaluation developed NiVPNA showed 100 sensitivity specificity across 10 serum sample 5 positive 5 negative positive correlation calibrated reference assay Rsup2sup  08461 Dilutional linearity Rsup2sup  09940 accuracy 9818 confirmed across analytical titer range 111728 IUmL assay also exhibited high precision intraassay intermediate precision geometric coefficient variation 666 1563 respectively Robustness testing demonstrated minimal variation across different pseudotyped virus lots incubation times cell counts bConclusionsb validated NiVPNA reproducible scalable assay platform quantifying NiV neutralizing antibodies offering safer alternative virus culture validation integration CEPI Centralized Laboratory Network enhance global capacity vaccine evaluation outbreak preparedness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733730/"
    },
    {
        "pmid": "40733519",
        "title": "Cellular and Humoral Immune Profiles After Hepatitis E Vaccination and Infection.",
        "abstract": "Hepatitis E virus HEV cause significant morbidity mortality globally particularly affecting vulnerable population pregnant women HEV239 Hecolinsup®sup recombinant vaccine containing immunodominant protruding E2 domain HEV capsid protein demonstrated effectiveness yet detailed human cellular immune response remain understudied study characterized humoral cellular immune response following vaccination HEV239 natural HEV infection healthy Bangladeshi woman aged 1639 years Using dual IFNγ IL4 ELISpot assays found robust predominantly Th1mediated cellular response 30 day third vaccine dose comparable response acute infection Longitudinal antibody assessment confirmed sustained antibody production primarily E2 domain genotype 1 3 persisting two year postvaccination Despite limitation related sample size assay sensitivity finding underscore immunogenic potential HEV239 support broader use HEVendemic regions",
        "mesh_terms": [
            "Humans",
            "Hepatitis E",
            "Female",
            "Hepatitis E virus",
            "Adult",
            "Adolescent",
            "Immunity, Humoral",
            "Young Adult",
            "Immunity, Cellular",
            "Vaccination",
            "Viral Hepatitis Vaccines",
            "Bangladesh",
            "Hepatitis Antibodies",
            "Antibodies, Viral",
            "Vaccines, Synthetic",
            "Capsid Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733519/"
    },
    {
        "pmid": "40721546",
        "title": "Factors associated with common prevalent diseases in the Sonali chicken farms of the different regions of Bangladesh: a retrospective study.",
        "abstract": "study aimed determine factor associated common disease prevalence Sonali chicken farm different region Bangladesh total 243 farm randomly selected four Bangladesh district collect retrospective data study found prevalent disease Newcastle Disease 7654 Infectious Bursal Disease 5144 Avian Influenza 2963 Colibacillosis 2263 Coccidiosis 6955 Brooder Pneumonia 3498 Ascariasis 2016 secondary group education level farmer 849 visitor allowance farm 819 farm dead bird buried 913 significantly P ≤ 005 higher prevalence ND potential flocklevel protective factor ND prevalence visitor allowed farm OR  050 95 CI 028092 P  0024 dead chicken disposal buried OR  021 95 CI 008056 P  0000 Farmers used deep well 569 clean feeder drinker every 3 day 722 higher prevalence P ≤ 005 IBD risk factor IBD Sonali chicken farmer idea vaccine transportation maintain temperature OR  177 95 CI 101313 P  0048 Rangpur district 448 farm used cefalexin 511 farm brooding period farm farmer idea chick grade higher prevalence P ≤ 005 AI farm whose farmer bought chick hatchery 367 noticeably P ≤ 005 higher prevalence colibacillosis Mymensingh district 800 male farmers farm 747 largescale farm 875 farm wood shaving used litter 778 higher prevalence P ≤ 005 coccidiosis Rangpur district 492 farm farmer practicing handwashing 415 maintain routine cleaning feeder drinker 436 use antibiotic brooding period 681 higher prevalence brooder pneumonia Kishoreganj district 300 male farmer 221 farmer primary education level 307 Largescale farm 25015200 birds 251 farm using wood shaving litter material 356 farm sourcing chick hatchery 230 farm used florfenicol 308 antibiotic brooding period significant P ≤ 005 higher prevalence Ascariasis Poor biosecurity improper waste management inexperience chick quality  antibiotic used missing regular vaccination make farm likely experience disease outbreaks",
        "mesh_terms": [
            "Animals",
            "Chickens",
            "Bangladesh",
            "Retrospective Studies",
            "Poultry Diseases",
            "Prevalence",
            "Risk Factors",
            "Animal Husbandry",
            "Farmers",
            "Farms",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40721546/"
    },
    {
        "pmid": "40716798",
        "title": "Is rotavirus aetiology in young children with acute diarrhoea associated with sociodemographic and clinical factors, including rotavirus vaccination status? A secondary cross-sectional analysis of the ABCD trial.",
        "abstract": "One leading cause global child mortality continues diarrhoea rotavirus contributed 24 death among diarrhoeal deaths mostly lowincome middleincome countries Rotavirus vaccination programme contributed reduction mortality 24 19 rotavirus infection among hospitalised children burden rotaviral diarrhoea remains high especially setting undernutrition aimed determine association rotaviral diarrhoea aetiology prior vaccination socioeconomic status clinical factor child see utility clinical settings analysed secondary data multicentre clinical trial antibiotic impact child diarrhoea increased risk mortality used stored stool sample 6697 child aged 223 month old presenting health facility diarrhoea increased risk mortality determined rotavirus aetiology prevalence using quantitative PCR qPCR looked association patients rotaviral vaccination status clinical symptom sociodemographic characteristics Prevalence ratio PR calculated logbinomial regression models converge logPoisson model used Rotavirus prevalence 211 observed weak statistically nonsignificant inverse association rotavirus vaccination rotaviral diarrhoea aetiology adjusted PR 071 95 CI 049 103 five tested clinical symptoms shorter diarrhoea duration associated rotaviral aetiology PR 265 95 CI 129 545 seven tested socioeconomic characteristics maternal paternal secondary education compared formal education associated rotaviral aetiology PR 086 95 CI 074 100 PR 087 95 CI 075 100 respectively Rotaviral diarrhoea aetiology cannot accurately determined prior receipt rotavirus vaccination among child presenting facility diarrhoea increased risk mortality Short diarrhoea duration parental secondary education associated increased prevalence rotaviral aetiology however utility clinical care remains unclear",
        "mesh_terms": [
            "Humans",
            "Rotavirus Infections",
            "Infant",
            "Male",
            "Female",
            "Rotavirus Vaccines",
            "Cross-Sectional Studies",
            "Diarrhea",
            "Vaccination",
            "Prevalence",
            "Rotavirus",
            "Socioeconomic Factors",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40716798/"
    },
    {
        "pmid": "40718465",
        "title": "Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.",
        "abstract": "Cervical cancer fourth common cancer among woman worldwide 660000 new case 350000 death reported 2022 disease mainly affect woman low lowermiddleincome country LMICs 90 case occur study explored LMICs responding World Health Organizations WHO call eliminate cervical cancer looked cervical cancer rates use human papillomavirus HPV vaccines suggested strategy fight disease study analyzed rate cervical cancer death LMICs effectiveness HPV vaccination programs well screening effort working compare data across countries used agestandardized incidence rate ASIRs agestandardized mortality rate ASMRs per 100000 woman per year 2022 ASIR 254 lower income country 169 lowermiddleincome countries ASMR also higher lower income country 185 compared lowermiddleincome country 103 HPV vaccine coverage remains low many LMICs significant difference rate first final dos completed 2050 number new cervical cancer case expected rise Although aim eliminate cervical cancer achieving 90 HPV vaccination age 15 70 screening coverage 90 access treatment many challenge remain LMICs include weak healthcare systems poor infrastructure lack health education Overcoming challenge better vaccine distribution improved screening programs stronger healthcare system essential eliminate cervical cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718465/"
    },
    {
        "pmid": "40702012",
        "title": "Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.",
        "abstract": "Nipah virus NiV cause severe neurological disease humans first NiV outbreak Malaysia involved pigtohuman transmission resulted significant economic loss local pig industry Despite risk NiV pose pigdense regions licensed vaccine exist study therefore assessed three NiV vaccine candidate pigs 1 adjuvanted soluble NiV sG protein 2 adjuvanted prefusion stabilised NiV mcsF protein 3 adenoviral vectored NiV G ChAdOx1 NiV G NiV sG induced strongest neutralising antibody response NiV mcsF induced antibody best able neutralise cellcell fusion whereas ChAdOx1 NiV G elicited CD8supsup Tcell responses Despite difference immunogenicity primeboost immunisation candidate conferred high degree protection NiV infection Followup study demonstrated longevity immune response broadly comparable immune response Bangladeshi pig field conditions study provide platform developing NiV vaccine pigs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40702012/"
    },
    {
        "pmid": "40701374",
        "title": "Childhood diarrheal infections among the multi hazard disaster risk zones in Bangladesh: A household level analysis.",
        "abstract": "Bangladeshs geographic climatic condition make highly disasterprone increasing vulnerability underfive child diarrheal infections study analyzed MICS Bangladesh 2019 dataset using multivariable logistic regression model assess diarrhea prevalence low moderate high multihazard risk zones focusing floods tornadoes cyclones earthquakes Diarrhea prevalence highest highrisk zone 771  followed moderate 598  lowrisk zone 467  Socioeconomic factor male gender urban residence extreme poverty lack handwashing facility associated higher risk diarrhea highrisk zones though link weaker moderate lowrisk zones Public health official aid organization must mitigate increased diarrheal disease risk following extreme events Interventions prioritize highrisk area awareness campaigns early warning systems improved water sanitation hygiene moderate highrisk zones vaccination particularly impoverished household disasterprone regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40701374/"
    },
    {
        "pmid": "40696437",
        "title": "Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model.",
        "abstract": "Typhoid fever systemic infection caused Salmonella enterica serovar Typhi S Typhi invasion gut lumen Transmission people occurs ingestion contaminated food water particularly setting poor water sanitation infrastructure resulting 10 million illness annually pathogen invades via gastrointestinal tract plausible gut microbiome may influence outcome S Typhi exposure evidence bacteria producing shortchain fatty acid SCFAs may create environment unfavourable invasive Salmonella data human limited investigate association gut microbiome typhoid fever analysed sample collected three allage cohort enrolled prospective surveillance study conducted across three setting typhoid fever endemic Dhaka Bangladesh Blantyre Malawi Kathmandu Nepal Cohorts consisted acute typhoid fever patient n  92 asymptomatic household contact typhoid fever patient representing individual likely exposed S Typhi develop disease n  97 asymptomatic serosurvey participant high Vi antibody titre representing individual exposed S Typhi may carriers n  69 stool microbiomes cohort characterised using shotgun metagenomics bacterial diversity composition function compared identified 4 bacterial specie significantly lower abundance typhoid fever patient compared household contact ie probably exposed two three participant population Bangladesh Malawi bacteria may represent taxon provide protection development clinical infection upon exposure S Typhi include inflammationassociated specie Prevotella copri clade Haemophilus parainfluenzae functional analysis identified 28 specific metabolic gene cluster MGCs negatively associated typhoid fever Bangladesh Malawi including seven MGCs involved SCFA metabolism putative protection provided microbiome SCFA metabolism supported data controlled human infection model conducted UK population participant develop typhoid fever following ingestion S Typhi higher abundance putative SCFAmetabolising MGC qvalue  022 study identified protective association taxonomic functional microbiota characteristic nonsusceptibility typhoid fever across multiple human populations Future research explore potential functional role SCFAs inflammationassociated bacteria resistance S Typhi enteric infections Video Abstract",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Gastrointestinal Microbiome",
            "Salmonella typhi",
            "Prospective Studies",
            "Male",
            "Female",
            "Malawi",
            "Adult",
            "Bangladesh",
            "Nepal",
            "Adolescent",
            "Child",
            "Feces",
            "Young Adult",
            "Endemic Diseases",
            "Fatty Acids, Volatile",
            "Middle Aged",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40696437/"
    },
    {
        "pmid": "40689249",
        "title": "Epidemiological and Clinical Features of Enterotoxigenic <i>Escherichia coli</i> (ETEC) Diarrhea in an Urban Slum in Dhaka, Bangladesh.",
        "abstract": "Enterotoxigenic iEscherichia colii ETEC major cause diarrheal illness populationbased data incidence clinically significant ETEC diarrhea developing country limited provide insight ETEC epidemiology followed populationbased cohort vaccine trial analyzed data clusterrandomized controlled trial oral cholera vaccine conducted urban slum Dhaka Bangladesh study cover 90 geographical cluster average population 2988 householdscluster baseline population 268 896 Two cohort analysis conducted 1 dynamic cohort included subject vaccination inmigrants birth 4 year closed cohort included individual present baseline evaluated individual placed treatment centerbased diarrheal surveillance 2011 2015 dynamic cohort ETEC incidence 150100 000 personyears PY 95 CI 141159 seasonal peak warmer months closed cohort incidence 153100 000 PY 95 CI 140 166 highest rate seen child aged 1 year 2007 95 CI 16642402 aged 14 year 314 95 CI 252386 rate rose aged 45 year 219100 000 PY 95 CI 177267 rate severe ETEC ≤35100 000 PY person aged ≤45 year 95 CI 2744 rose 82 adult aged 45 year 95 CI 58113 ETEC diarrhea major health problem young child older adults prevention vaccination improved water sanitation hygiene target age groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689249/"
    },
    {
        "pmid": "40687549",
        "title": "Comparative Analysis of Preferences and Willingness to Pay for COVID-19 Vaccine Among Individuals With and Without Chronic Diseases: A Discrete Choice Experiment Approach.",
        "abstract": "rapid development deployment COVID19 vaccine pivotal global battle pandemic However vaccine acceptance remains critical determinant effectiveness numerous study explored factor influencing vaccine acceptance notable dearth research regarding preference willingness pay WTP among individual chronic disease ChD heightened risk severe COVID19 outcomes study address gap investigating COVID19 vaccine preference WTP among individual without chronic diseases Employing discrete choice experiment DCE approach interviewed 843 participant assess preference COVID19 vaccine attribute origin efficacy level protection duration provider used mixed logit model analyze DCE data estimated WTP taking negative ratio preference price parameters Furthermore performed stratified analysis according household heads ChD status expected vaccine higher efficacy longer protection preferred Interestingly research show preference European American vaccine Chinese vaccines Additionally study reveals preference private facility government facility vaccination among vaccine seekers Patients ChD exhibit higher WTP without conditions demonstrating groups urgency becoming vaccinated Vaccine procurement administration decision health authority evidencebased reflect public preference regarding acceptance WTP Health authority prioritize high efficacy longlasting protection vaccine procurement ensuring neither compromised approach address top concern groupsvaccine effectiveness ChD group extended immunity NChD group study also informs policy decision regarding vaccine origin suggests incorporating private facility vaccine administration point reduce pressure government facilities",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40687549/"
    },
    {
        "pmid": "40678119",
        "title": "Epigallocatechin-3-gallate: a multi-target bioactive molecule derived from green tea against Oropouche virus-a computational approach to host-pathogen network modulation.",
        "abstract": "Oropouche virus OROV emerging arbovirus transmitted arthropods caused significant outbreak South Central America half million reported cases Despite public health threat approved vaccine antiviral treatment exist Oropouche fever OF study explores potential epigallocatechin3gallate EGCG bioactive polyphenol green tea antiviral agent OROV using computational approaches Due lack experimentally resolved OROV protein structures employed AlphaFold2 predict 3D model key viral proteins including RNAdependent RNA polymerase RdRp envelopment polyprotein nucleoprotein glycoprotein Gc Molecular docking revealed strong binding affinity EGCG targets particularly high interaction RNA polymerase 71 kcalmol envelopment polyprotein 87 kcalmol suggesting inhibition viral replication entry Proteinprotein interaction PPI network analysis identified critical human host gene eg FCGR3A IRF7 IFNAR1 involved immune responses Gene Ontology GO Kyoto Encyclopedia Genes Genomes KEGG pathway analysis highlighted enriched antiviral inflammatory pathways ADMET profiling indicated challenge EGCGs bioavailability including poor gastrointestinal absorption bloodbrain barrier permeability low toxicity natural origin support potential lead compound finding suggest EGCG may disrupt OROV infection multitarget mechanisms warranting experimental validation study provides foundation developing EGCGbased therapeutic OROV underscore utility computational method antiviral drug discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678119/"
    },
    {
        "pmid": "40672517",
        "title": "National burden and optimal vaccine policy for Japanese encephalitis virus in Bangladesh.",
        "abstract": "Bangladesh first reported Japanese encephalitis virus JEV 1977 seen regular case since however JEV vaccination program currently exists barrier use JEV vaccine limited understanding underlying burden conducted nationally representative serological community study 70 community individual age N2938 October 2015January 2016 Serum sample tested IgG antibody JEV developed spatially explicit serocatalytic model estimate underlying force infection across country used mathematical model estimate annual JE disease burden currently different vaccination strategies overall JEV seroprevalence Bangladesh 34 95CI 2841 range 028 across communities annual probability infection 0005 95CI 00030009 risk greatest near border regions estimated annually 157 clinical case 95CI 89253 31 death 95CI 1852 vaccination strategy 10 affected district 60 115 year old would require 5 million dos avert 1 case per 100000 dos five year compared 35 million dos 05 case averted nationwide campaign vaccination scenario costeffective willingnesstopay threetimes gross domestic product spatially targeted vaccine campaign would effective reducing JEV burden however would still meet standard cost effectiveness targets CDC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40672517/"
    },
    {
        "pmid": "40650256",
        "title": "Potent Inhibition of Chikungunya Virus Entry by a Pyrazole-Benzene Derivative: A Computational Study Targeting the E1-E2 Glycoprotein Complex.",
        "abstract": "Chikungunya virus CHIKV continues pose significant global health challenge due absence effective antiviral treatment limited vaccine availability study employed comprehensive silico workflow incorporating highthroughput virtual screening binding freeenergy calculations ADMET absorption distribution metabolism excretion toxicity analysis 200 n molecular dynamic MD simulations identify new inhibitor targeting E1E2 glycoprotein complex crucial CHIKV entry membrane fusion Four promising candidate identified library 20000 compounds CID 136801451 showing potent binding docking score 10227 ΔGbind 5153 kcalmol top four compound exhibited favorable ADMET profiles meeting nearly criteria MD simulation confirmed stable binding strong interaction CID 136801451 E1E2 complex evidenced consistently low RMSD values finding highlight CID 136801451 promising CHIKV entry inhibitor warranting vitro vivo evaluation advance development effective antiCHIKV therapeutics",
        "mesh_terms": [
            "Chikungunya virus",
            "Antiviral Agents",
            "Virus Internalization",
            "Viral Envelope Proteins",
            "Molecular Dynamics Simulation",
            "Molecular Docking Simulation",
            "Pyrazoles",
            "Humans",
            "Protein Binding",
            "Chikungunya Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40650256/"
    },
    {
        "pmid": "40644485",
        "title": "Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group.",
        "abstract": "Coronavirus disease 2019 COVID19 highly contagious infectious disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 responsible million death substantial morbidity worldwide Several study report 50 individual recover acute SARSCoV2 infection experience plethora longCOVID symptom may persist weeks months even year Abnormal pulmonary function one critical manifestation longCOVID even recovering COVID19 Understanding longterm pulmonary consequence immune response among individual recovering COVID19 experienced disease severity ranging mild severe crucial comprehensive postrecovery care vaccination strategies prospective casecontrol study included 29 individual recovered COVID19 history mild severe symptom 64 controls Assessments pulmonary functional measures FVC FEV1 FEV1FVC ratio FEF MEF PEF carried following recovery COVID19 Additionally IgG antibody response examined ELISA six month multiple followup following two dos vaccination additional followup 30 day booster dose third dose Pulmonary functional abnormality prevalent recovered group previously exhibited varying symptom severity 53 mild 66 moderate 50 severe compared control group 23 Higher IgG antibody titer observed among recovered group significantly elevated titer severe moderate case following vaccination vaccination recovered group showed significantly higher titer day 14 particularly severe 1418 IUmL moderate 1390 IUmL groups compared control group 968 IUmL p  0005 Notably antibody titer negatively correlated pulmonary function test PFT parameter Forced Vital Capacity FVC Forced Expiratory Volume 1 second FEV1 group experienced significant p  0005 decrease antibody titer within 90120 day receiving two dos vaccination five six months antibody titer returned baseline levels highlighting importance vaccination additional booster dos regardless previous infection history Overall study underscore significance pulmonary function assessment postCOVID19 recovery longterm respiratory health emphasizes importance vaccination regardless infection history assess impact longCOVID respiratory health study underscore importance evaluating pulmonary function individuals whether symptomatic asymptomatic COVID19 Furthermore finding immune response analysis highlight critical role vaccination regardless infection history key strategy pandemic preparedness",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Male",
            "Female",
            "SARS-CoV-2",
            "Immunoglobulin G",
            "Middle Aged",
            "Case-Control Studies",
            "Antibodies, Viral",
            "Prospective Studies",
            "Adult",
            "Respiratory Function Tests",
            "Aged",
            "Lung",
            "Pandemics",
            "Betacoronavirus",
            "Spike Glycoprotein, Coronavirus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40644485/"
    },
    {
        "pmid": "40644440",
        "title": "Herd immunity and prevention in HPV transmission with exogenous reinfection.",
        "abstract": "Cervical cancer major global health concern primarily caused human papillomavirus HPV spread unsafe sexual contact Natural immunity often fails provide full protection permitting exogenous reinfection play key role persistence transmission HPV paper present analyzes deterministic mathematical model HPV transmission incorporating exogenous reinfection utilized VIA test result data 2019 2023 Bangladesh estimate key parameter values finding validated numerical simulation using MATLAB analytical result demonstrated strong consistency numerical outputs critical insight presence reinfectioninduced backward bifurcation indicating targeting primary infection alone insufficient eradication highlighting need address exogenous reinfection effective control propose optimal control strategy tailored resourcelimited setting like Bangladesh limited vaccine access present significant challenges communitydriven education safe sexual practice crucial continuously evolving result emphasize effective approach combine targeted prevention widespread community education precision intervention implementation essential prevent reinfection surge could prolong disease persistence undermine control efforts insight provide strong foundation refining intervention strategy offer valuable guidance controlling HPV transmission nonpharmaceutical interventions particularly resourceconstrained settings",
        "mesh_terms": [
            "Humans",
            "Papillomavirus Infections",
            "Female",
            "Immunity, Herd",
            "Uterine Cervical Neoplasms",
            "Bangladesh",
            "Reinfection",
            "Papillomavirus Vaccines",
            "Models, Theoretical",
            "Papillomaviridae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40644440/"
    },
    {
        "pmid": "40641013",
        "title": "Designing of Peptide Vaccine by Investigating Monkeypox Virus Membrane Glycoprotein: An Integrated In Silico and Immunoinformatics Approach.",
        "abstract": "2022 World Health Organisation WHO announced new case developing Monkeypox Virus MPXV zoonotic orthopoxvirus viral infection mimic smallpox signs Despite ongoing infection proper medication available completely overcome infection study aim construct multiepitope vaccine targeting Monkeypox Virus MPXV membrane glycoprotein provoke robust immune responses construct potential immunodominant epitope vaccine combat MPXV target sequence sourced UAEtoIndia travel case analyzed identify potential Bcell Tcell epitope MHCI MHCII Immunodominant epitope selected fused βdefensinI PADRE increase immunogenicity vaccine modeled docked TLR3 subjected 500 n molecular dynamic simulation stability analysis Immune response bacterial expression also evaluated vaccine comprising 230 amino acids demonstrated antigenicity 06620 nonallergenicity broad population coverage Selected epitope included 3 Bcells 4 MHCI 2 MHCII ensuring potent immunodominant profile Docking TLR3 revealed binding affinity 172 kcalmol simulation confirmed stability Cloning pET28a  immune response analysis showed strong immunogenic profile including elevated IgG1 IgM antigen levels supported Codon Adaptation Index CAI 10 proposed multiepitope vaccine show promise MPXV However vivo vitro investigation essential confirm immune efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40641013/"
    },
    {
        "pmid": "40638524",
        "title": "Clinical Epidemiology and Molecular Investigation of Protoparvovirus carnivoran1 Infection in Naturally Infected Domestic Cats in Bangladesh.",
        "abstract": "infection cat Protoparvovirus carnivoran1 global concern due likelihood infection multiple genetically similar viruses present study undertaken investigate clinicomolecular epidemiology Protoparvovirus carnivoran1 infection naturally infected domestic cat Bangladesh Rectal swab N  100 collected cat manifesting clinical sign screened presence Protoparvovirus carnivoran1 using polymerase chain reaction PCR Selected positive sample n  38 partially sequenced molecular analysis structured questionnaire developed estimate potential risk factor Protoparvovirus carnivoran1 infection clinical therapeutic outcome overall association among variables Data analysed using descriptive univariable multivariable statistical techniques overall PCR detection rate targeted Protoparvovirus carnivoran1 virus 99 99100 Young nonvaccinated animal mostly infected p  005 mortality case fatality infected cat 10 45 respectively clinical outcome vary animal receiving different therapeutic group p  019 phylogenetic analysis suggests Protoparvovirus carnivoran1 isolates share common ancestor isolates different global regions finding indicate Protoparvovirus carnivoran1 circulating Bangladesh clinicoepidemiological evolutionary outcome used guide future preventive control measure parvovirus infection locally internationally",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Cats",
            "Cat Diseases",
            "Parvoviridae Infections",
            "Male",
            "Female",
            "Phylogeny",
            "Polymerase Chain Reaction",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40638524/"
    },
    {
        "pmid": "40636082",
        "title": "Comprehensive immunoinformatics guided design and in silico assessment of a multi-epitope vaccine to elicit immunity against Mayaro virus.",
        "abstract": "Mayaro virus MAYV emerging arbovirus Alphavirus genus family Togaviridae share clinical epidemiological feature arbovirus Chikungunya Dengue Zika cause Mayaro fever humans characterized febrile illness prolonged arthralgia often leading misdiagnosis Given absence licensed vaccine antiviral therapy presence competent vector endemic regions MAYV pose significant threat epidemic particularly rural South America research computational immunological method employed construct polypeptide vaccine focus structural polyprotein Mayaro virus series rigorous computational assessment used predict potent B lymphocyte epitope vaccine candidate vaccine exhibited favorable physicochemical properties stable secondary tertiary structures high solubility Molecular dynamic simulation demonstrated structural stability docking study indicated robust interaction TLR2 TLR4 receptors essential initiating immune responses Codon optimization along silico cloning demonstrated efficient expression vaccine candidate iE colii system Finally immune simulation indicated vaccine candidate could induce robust longlasting immune response online version contains supplementary material available 101007s40203025003875",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40636082/"
    },
    {
        "pmid": "40635997",
        "title": "<i>In-silico</i> molecular analysis and blocking of the viral G protein of Nipah virus interacting with ephrin B2 and B3 receptor by using peptide mass fingerprinting.",
        "abstract": "Nipah virus NiV zoonotic paramyxovirus closely related Hendra virus pose significant global health threat due high mortality rate zoonotic nature recurring outbreak primarily Malaysia Bangladesh India Infection NiV lead severe encephalitis carry case fatality rate ranging 40 75 lack vaccine limited understanding NiV pathogenesis underscore urgent need effective therapeutics study focus identifying viral peptide Nipah virus using peptide mass fingerprinting technique approach identified antiviral peptide acting potent inhibitors targeting viral Gproteins interaction cellular ephrinB2 B3 receptors receptor crucial viral entry host cell subsequent pathogenesis Identifying NiV viral peptide enhances understanding viruss structural functional property also open avenue developing novel therapeutic strategies blocking interaction viral Gprotein host receptors antiviral peptide offer promising prospect drug development NiV Twentyone peptide identified using peptide mass fingerprinting peptide subjected docking analysis two antiviral peptide ephrin B2 receptor monoclonal antibody demonstrating robust stability binding affinity predicted peptide contribute broader field virology elucidating key aspect NiV biology paving way development targeted antiviral therapies Future study may explore therapeutic potential peptide application combating viral infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40635997/"
    },
    {
        "pmid": "40634976",
        "title": "Integrated Immuno and bioinformatics assisted novel epitope vaccine against HIV infection: a study based on complete genome.",
        "abstract": "HIVbased complication still going high infection mortality rate requires novel strategy combat infection due unavailability proper therapeutic Therefore utilize integrated immuno bioinformatics approach study design peptide vaccine HIV infection targeting complete genome complete genome sequence analyzed potential B cell predicted Among predicted epitopes promising one selected used adjuvant linker formulate vaccine candidate vaccine modeled activity stability towards TLRs analyzed via docking dynamic 500ns vaccinegenerated immune activity expression via iiniisilicoi cloning also evaluated total 6 B cells 7 CTL 6 HTL identified immunodominant epitope used vaccine formulation epitope fused together via linkers efficiency constancy enhanced Adjuvant PADRE epitope Histag Further formulated vaccine show high population coverage stable feature based 2D 3D assessments docking investigation demonstrated strong activity vaccine towards TLR2 TLR3 binding affinity − 108 kcalmol1 − 158 kcalmol1 also disclosed remarkable constancy based 500ns simulation period vaccineassisted immune simulation expression level vector revealed robust immune response towards host based vaccination significant expression level Based integrated approach validation steps overall finding suggests formulated vaccine may strongly immunodominant property could combat infection online version contains supplementary material available 101186s12985025027640",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40634976/"
    },
    {
        "pmid": "40622505",
        "title": "Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes.",
        "abstract": "batborne Nipah virus known causing high mortality rate humans reported India Megaderma spasma Bangladesh Pteropus medius Malaysia Pteropus vampyrus different bat specie serving reservoirs virus also infects various animals often act intermediate host transmission humans Due high fatality rate associated Nipah virus outbreaks World Health Organization flagged significant public health concern prompting extensive research development antiviral therapeutic vaccines However effective vaccine therapeutic agent yet established context propose miRNAbased approach identify key human cellular miRNAs capable binding potentially cleaving degrading Nipah virus gene implicated human infections study revealed substantial number miRNA binding site across various viral genes suggesting potential mechanism gene silencing Furthermore calculated free energy value  4 kcalmol three regions downstream upstream target indicate thermodynamically favorable binding could facilitate effective miRNAmediated repression viral gene expression Additionally translational efficiency COSM value suggested swift miRNAmediated cleavage degradation viral genes Moreover analysis miRNAmRNA duplex free energy secondary structures predicted RNAFold indicated interaction human miRNAs Nipah virus gene thermodynamically stable stable duplex formation support potential efficient binding leading effective gene silencing cleavage degradation mechanisms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40622505/"
    },
    {
        "pmid": "40619274",
        "title": "From Bench to Bedside in Emerging Therapies for Gynecological Malignancies: A Narrative Review.",
        "abstract": "Gynecological malignancies including cervical endometrial ovarian cancers pose significant global health challenge due increasing incidence limitation conventional treatments Current therapeutic approaches surgery chemotherapy radiation often face obstacle like multidrug resistance tumor recurrence adverse side effects response emerging therapiesincluding targeted therapy immunotherapy gene therapyare reshaping treatment paradigms Precision medicine leveraging Poly ADPribose Polymerase PARP Vascular Endothelial Growth Factor VEGF inhibitors enhances therapeutic efficacy immune checkpoint inhibitor vaccinebased therapy offer promising immunotherapeutic strategies Additionally advancement nanotechnology gene therapy including Clustered Regularly Interspaced Short Palindromic Repeats CRISPR based approach nanoparticlemediated drug delivery provide novel treatment modalities Despite innovations translational challenge persist necessitating research clinical application personalized treatment strategies review highlight latest advancement emerging therapy gynecological malignancies emphasizing potential improve patient outcome address existing treatment limitations",
        "mesh_terms": [
            "Humans",
            "Female",
            "Genital Neoplasms, Female",
            "Genetic Therapy",
            "Immunotherapy",
            "Precision Medicine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619274/"
    },
    {
        "pmid": "40601639",
        "title": "Development of a potential vaccine against Capripox virus implementing reverse vaccinology and pan-genomic immunoinformatics.",
        "abstract": "CPXV responsible animal disease affecting cattle Lumpy Skin Disease sheep Sheeppox goat Goatpox outbreaks disease huge socioeconomic effects Now vaccination effective sheeppox goatpox lumpy skin disease available work used immunoinformatic methodology discover possible target vaccination CPXV 122 CPXV protein obtained Vipr database several investigation proteins virulence antigenicity toxicity solubility IFNg activity carried out Three outer membrane extracellular protein selected predict Bcell Tcell epitope based certain distinctive features epitope exhibit conservation across three species namely Sheeppox virus SPPV Goatpox virus GTPV Lumpy skin disease virus LSDV CPXV provide comprehensive immunity diverse virus strain worldwide Nine MHCI MHCII Bcell epitope selected generate multiepitope vaccine constructions construct linked using AAY GPGPG KK linkers 50S ribosomal protein L7L12 adjuvant enhance immunogenicity vaccines Molecular modeling structural validation enabled production vaccine construct highquality 3D structures CPXV Protein A35 Protein Resolve A22 Scaffold Protein selected analysis varied immunological physiochemical property Number Amino Acids Molecular Weight Daltons Theoretical pI Aliphatic index Grand average hydropathicity GRAVY Instability index GC content CAI value docking scores bacterial expression system showed notable gene expression CPXVV5 vaccine shown computational cloning analysis Molecular dynamic MD simulation revealed structural stability longterm epitope visibility implying strong immune response delivery result suggest developed vaccine might quite safe effective practical settings offer solid foundation experimental verification",
        "mesh_terms": [
            "Capripoxvirus",
            "Animals",
            "Viral Vaccines",
            "Epitopes, T-Lymphocyte",
            "Epitopes, B-Lymphocyte",
            "Vaccinology",
            "Computational Biology",
            "Poxviridae Infections",
            "Vaccine Development",
            "Sheep",
            "Goats",
            "Viral Proteins",
            "Immunoinformatics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40601639/"
    },
    {
        "pmid": "40600140",
        "title": "Benchmarking pangenome dynamics and horizontal gene transfer in <i>Mycobacterium marinum</i> evolution.",
        "abstract": "Horizontal gene transfer HGT key driver microbial evolution promoting genetic diversity contributing emergence antibiotic resistance study explores pangenome dynamic HGT iMycobacterium marinumi iM marinumi close relative iMycobacterium tuberculosisi Multiple pangenome datasets analyzed quantify gene gain loss pangenome openness utilizing Panstripe Generalized Linear Model GLM framework assess gene presenceabsence across strains Additionally comparative benchmarking analysis gene ontology GO annotation conducted using eggNOG InterProScan evaluate functional annotation accuracy finding demonstrated significant difference gene gain loss rates suggesting variation annotation accuracy presence mobile genetic element MGE Single nucleotide polymorphism SNPs also identified highlighting genetic variability may impact strainspecific trait pathogenicity antibiotic resistance Pangenome iM marinumi characterized highly open substantial variability gene content reflecting ongoing genetic exchange adaptability Functional annotation benchmarking demonstrated eggNOG InterProScan provided complementary insights tool excelling distinct strength gene function identification Overall finding highlight complex interplay HGT pangenome evolution antibiotic resistance iM marinumi analytical framework presented provides robust approach future study aiming inform therapeutic intervention vaccine development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600140/"
    },
    {
        "pmid": "40599414",
        "title": "Mental Health Consequences of COVID-19 Vaccine Side Effects: Findings From a Cross-Sectional Analysis.",
        "abstract": "COVID19 pandemic intensified preexisting mental health issue Bangladesh yet study specifically examined factor related COVID19 vaccination influence mental health within context study aimed examine relationship mental health symptoms including depression anxiety stress COVID19 vaccination status related factor among adult Bangladeshi population crosssectional study convenience sampling technique employed gather data sample size response rate 1085 9368 mean age participant 3430 SD 1279 553 female Descriptive inferential statistic carried out reliability instruments measured Cronbachs alpha was depression 078 anxiety 082 stress 083 overall DASS 092 average number COVID19 vaccine dos taken 233 additional dose COVID19 vaccine significantly reduces stress score 061 Additionally prevaccination concern side effect significantly increase anxiety score 063 Furthermore experiencing pressure get vaccinated associated significant increase depression score 078 Moreover experiencing negative outcome vaccine significantly decrease score across three mental health metrics depression 091 anxiety 087 stress 135 study reveals broad psychological consequence COVID19 vaccination Bangladesh underscore importance effective communication supportive strategies alongside targeted psychological intervention vaccination sites",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40599414/"
    },
    {
        "pmid": "40598764",
        "title": "Attitudes and acceptance of mRNA-based vaccine for neglected tropical diseases: A multi-country study in Asia.",
        "abstract": "study seek investigate willingness receive vaccination NTDs using mRNAbased vaccine various Asian countries including China June December 2023 anonymous crosssectional survey carried five countries survey assessed knowledge attitude regarding mRNA vaccine potential impact vaccination acceptance majority indicated somewhat willing 449 193 expressed extreme willingness High knowledge score adjusted odds ratio aOR  261 95 confidence interval CI 231296 associated higher willingness receive mRNAbased NTD vaccines Participants Bangladesh recorded highest proportion expressed willingness 514 followed China 159 Vietnam 154 Malaysia 148 Pakistan 110 India 113 recorded lowest proportion willingness Understanding mechanism mRNA vaccine awareness difference mRNA vaccine conventional one knowledge item significantly predict acceptance Concerns regarding potential unknown side effect associated mRNAbased approaches perception traditional vaccine development method safer negatively correlate willingness Conversely belief advantage mRNAbased approaches rapid development heightened potency reduced cost positively correlate willingness High overall knowledge attitude score associated higher willingness receive vaccines younger age group female demonstrated greater vaccination acceptance Overall study highlight opportunity challenge promoting uptake mRNAbased vaccine NTDs Asia countries study provides insight enhancing knowledge fostering positive attitude toward mRNAbased vaccines",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Adult",
            "Cross-Sectional Studies",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged",
            "Young Adult",
            "Neglected Diseases",
            "Patient Acceptance of Health Care",
            "Asia",
            "Vaccination",
            "Surveys and Questionnaires",
            "Adolescent",
            "mRNA Vaccines",
            "Vaccines, Synthetic",
            "RNA, Messenger"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40598764/"
    },
    {
        "pmid": "40598372",
        "title": "Effects of serial passaging of field isolates of Bangladeshi PPR virus in Vero cells on the fusion protein.",
        "abstract": "Fusion F protein crucial facilitating viral entry host cell contributes virulence Morbilliviruses Serial passaging Peste Des Petits Ruminants virus PPRV nonnative host lead mutation potentially reduce pathogenicity Hence study aimed investigate effect serial passaging Bangladeshi strain PPR virus Vero cell Fusion protein pathogenicity MATERIALS METHODS PPR virus initially isolated natural PPR outbreaks confirmed reverse transcriptase polymerase chain reaction RT‒PCR passaged 9th passage Vero cells sequenced preserved previous study 9th passage virus repository utilized viral inoculant passaging Vero cells 60th passage completed presence PPR viral RNA confirmed tissue culture fluid TCF RT‒PCR different passage numbers TCF 60th passage sequenced used immunogenicity study via live animal experiments subsequent immunity measured via cELISA Comparative analysis sequence 9th 60th passages along sequences revealed substitution 14 nucleotide nts 4 amino acid aa within leucine zipper structure fusion protein Notably live animal experiment demonstrated occurrence protective immunity study suggests amino acid substitution genetic divergence may positively affect viral virulence highlighting importance development potent vaccine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40598372/"
    },
    {
        "pmid": "40592849",
        "title": "Personalized azithromycin treatment rules for children with watery diarrhea using machine learning.",
        "abstract": "use machine learning identify innovative strategy target azithromycin child watery diarrhea likely benefit Using data randomized trial azithromycin watery diarrhea NCT03130114 develop personalized treatment rule given set diagnostic child clinical characteristics employing robust ensemble machine learningbased procedure procedure estimate childlevel expected benefit given set covariates combining prediction library statistical models rule estimate proportion treated rule average benefit treatment Among 6692 children treatment comprehensive rule recommended average one third children risk diarrhea day 3 101 lower 95 CI 54 149 azithromycin compared placebo among child recommended treatment NNT 10 day 90 rehospitalization death risk 24 lower 95 CI 06 41 NNT 42 pathogen diagnostics strong determinant azithromycin effect diarrhea duration host characteristic may better predict benefit rehospitalization death suggests targeting antibiotic treatment severe outcome among child watery diarrhea may possible without access pathogen diagnostics",
        "mesh_terms": [
            "Humans",
            "Azithromycin",
            "Machine Learning",
            "Diarrhea",
            "Anti-Bacterial Agents",
            "Child, Preschool",
            "Female",
            "Male",
            "Infant",
            "Child",
            "Precision Medicine",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40592849/"
    },
    {
        "pmid": "40585639",
        "title": "Comparative Analysis of Anti-receptor Binding Domain (RBD) IgG Responses to Homologous and Heterologous SARS-CoV-2 Vaccine Regimens: A Study From Bangladesh.",
        "abstract": "COVID19 pandemic necessitated robust vaccination strategies including booster dos sustain immunity SARSCoV2 comparative immunogenicity homologous same vaccine type versus heterologous different vaccine types booster regimen remains understudied particularly diverse settings study assesses antireceptor binding domain RBD IgG antibody response regimen Bangladesh prospective quasiexperimental study conducted Bangabandhu Sheikh Mujib Medical University Dhaka Bangladesh March 2022 February 2023 Seventythree participants selected via convenience sampling grouped homologous n40 heterologous n33 vaccine regimen based primary booster vaccine types AntiRBD IgG level measured prebooster three week postbooster using SARSCoV2 IgG II Quant Reagent Kit Abbott Ireland Demographic clinical factor age sex BMI diabetes blood pressure evaluated MannWhitney U KruskalWallis test used p≤005 indicating significance Participants mean age 3551 years 795 male showed higher prebooster median 449965 vs 18637 AUmL p0001 postbooster median 1383515 vs 104233 AUmL p0014 antiRBD IgG level homologous group compared heterologous group However heterologous group exhibited greater fold increase median 46 vs 365 p0024 antiRBD IgG levels higher proportion participant homologous regimen achieved high postbooster IgG level 20000 AUmL p0016 Diabetes significantly reduced antibody response heterologous group p0006 Hypertensive participant significantly reduced antibody response p0005 p0001 booster heterologous group p0033 booster homologous group Age sex BMI significant effect results Homologous regimen yield higher antiRBD IgG levels heterologous regimen produce greater fold increase antiRBD IgG levels indicating robust recall Diabetes hypertension impair responses particularly heterologous regimens finding support need tailored vaccination strategy enhance immune protection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40585639/"
    },
    {
        "pmid": "40585162",
        "title": "Evaluating the accuracy of <i>Salmonella</i> Typhi Hemolysin E and lipopolysaccharide IgA to discriminate enteric fever from other febrile illnesses in South Asia.",
        "abstract": "Existing method identify patient infected Salmonella enterica Typhi S Typhi Paratyphi inadequately accurate affordable efficient evaluated discriminatory power antibody S Typhi hemolysin E HlyE lipopolysaccharide LPS Bangladesh Nepal Pakistan Plasma concentration antiHlyE LPS IgA measured blood cultureconfirmed enteric fever case febrile control laboratoryconfirmed alternative etiology Receiver operating characteristic analysis showed combining antiLPS HlyE IgA distinguished enteric fever case febrile illness area curve AUC 093 AntiLPS IgA alone performed nearly well AUC 092 child 5 combination outperformed individual biomarkers AUC 096 vs 094 HlyE 093 LPS accurate Bangladesh Pakistan compared Nepal finding support antiHlyE LPS IgA ELISA accurate method identify enteric fever endemic settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40585162/"
    },
    {
        "pmid": "40583904",
        "title": "A robust comprehensive immunoinformatics approach for designing a potential multi-epitope based vaccine against a reiterated monkeypox virus.",
        "abstract": "Mpox viral disease caused monkeypox virus MPXV public health emergency international concern since 2024 absence mpoxspecific treatment vaccine along emergence new variant like Clade Ib underscore urgent need targeted vaccine development address challenge study employed reverse vaccinology immunoinformatics approach design multiepitope vaccine MPXV vaccine construct includes four Linear B lymphocyte LBL nine Cytotoxic lymphocyte CTL seven Helper lymphocyte HTL epitopes LBL epitope selected six membrane glycoprotein virus Tcell epitope selected experimentally validated conserved epitope similar orthopoxviruses epitope combined appropriate linkers adjuvant enhance structural flexibility immunogenicity potency engineered vaccine underwent rigorous evaluation considering physicochemical properties structural integrity population coverage immune system response simulation 3D structure vaccine predicted optimized docking analysis revealed robust interaction human Tolllike receptor 2 4 TLR2 TLR4 supported highly negative HADDOCK score low RMSD values stability vaccine construct stable interaction TLR2 TLR4 confirmed molecular dynamic MD simulation Additionally immune simulation result showed vaccination significantly increased IgM level primary response IgG subtypes well combined IgM IgG level nearly doubled secondary tertiary responses iIn silicoi expression iEscherichia colii iE colii confirmed potential production Overall study present highly immunogenic promising vaccine candidate MPXV demand experimental validation clinical application",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583904/"
    },
    {
        "pmid": "40580988",
        "title": "Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis.",
        "abstract": "Killed wholecell oral cholera vaccine kOCVs standard prevention control measure choleraendemic area outbreak humanitarian emergencies New evidence emerged way vaccine used changed aimed provide updated synthesis evidence protection conferred kOCV systematic review metaanalysis used search procedure previous systematic review identify randomised clinical trial RCTs observational study reported estimate protection conferred kOCVs medically attended confirmed cholera Eligible study English French Spanish Chinese published March 8 2024 including identified previous review included Data efficacy effectiveness extracted number doses duration followup age group Efficacy effectiveness estimate summarised separately using randomeffect model estimate protection time since vaccination metaregression model used estimate protection dose function time since vaccination updated study registered along original review PROSPERO CRD42016048232 identified 8205 record published online March 8 2024 including 6224 article previous review 1981 article new search after Jan 1 2016 these 53 eligible fulltext review Five RCTs ten observational study 23 publication included Average twodose efficacy 12 month vaccination 55 95 CI 4662 declining 44 2559 48 month vaccination Average twodose effectiveness 69 5878 12 month vaccination declining 47 970 48 month vaccination one RCT assessed onedose efficacy found sustained protection 24 month 57 4269 among 5 year older significant protection younger children Average onedose effectiveness 12 month vaccination 60 5168 24 month 47 3458 Using age groupspecific metaanalysis found average twodose efficacy child younger 5 year half older individuals Two dos kOCV provide protection medically attended cholera least 4 year vaccination One dose kOCV provides protection least 2 year vaccination wane faster two doses Children younger 5 year less protected kOCVs aged 5 year older regardless number dos received Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Cholera Vaccines",
            "Cholera",
            "Vaccines, Inactivated",
            "Child"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580988/"
    },
    {
        "pmid": "40580979",
        "title": "Killed whole-cell cholera vaccines: is the evidence sufficient for their widespread use?",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580979/"
    },
    {
        "pmid": "40580038",
        "title": "Evaluating the effectiveness of COVID-19 vaccines during a period of Omicron variant predominance among Bangladeshi population: A test-negative design measurement.",
        "abstract": "study conducted estimate protective effectiveness PE complete primary booster dose regimen COVID19 vaccine deployed Bangladesh study conducted four hospital Dhaka December 30 2021 August 31 2022 following testnegative design Patients aged ≥18 year attended COVIDlike symptom enrolled tested RTPCR Testnegative control matched confirmed case 11 ratio considering site date age groups Conditional logistic regression used estimate PE considering association receipt complete primary without booster regimen development COVID19 disease symptoms Whole genome sequencing WGS carried confirm variants RTPCR positive 847 case matched 847 controls WGS strain revealed 6 Delta variant 94 Omicron variant PE conferred receipt complete primary regimen without booster dose vaccine revealed significant protection 15 95 CI 11 36 ipi  23 COVID19 disease severe disease 14 95CI 23 39 ipi  42 However protective association receipt complete primary regimen without booster dose one mRNA vaccine PfizerBioNTech COVID19 disease 88 95 CI 26 98 ipi  023 first 90 days analysis suggested little vaccine effectiveness Omicron surge possible exception one mRNAvaccine 90 day dosing",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "COVID-19",
            "SARS-CoV-2",
            "COVID-19 Vaccines",
            "Male",
            "Female",
            "Adult",
            "Vaccine Efficacy",
            "Middle Aged",
            "Immunization, Secondary",
            "Young Adult",
            "Adolescent",
            "Whole Genome Sequencing",
            "Aged",
            "Case-Control Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580038/"
    },
    {
        "pmid": "40568491",
        "title": "Genomic features and pathogenic potential of <i>Streptococcus agalactiae</i> isolated from bovine clinical mastitis.",
        "abstract": "goal study describe genome iStreptococcus agalactiaei found clinical mastitis cattle Bangladesh work show strong bacteria important public health Whole genome sequencing WGS performed using Illumina MiSeq platform followed comprehensive analysis various bioinformatic tool identify key genomic features WGS revealed isolates closely related belonging sequence type ST4 rare type previously identified human animal hosts isolates possess 44 virulencerelated gene linked adherence capsule biogenesis enzyme production immunoreactive antigens protease cytolysin production also carry two pilus island PIs PI1 PI2b often associated invasive diseases PI2b protein key target vaccine development Group B Streptococcus GBS isolates belong serotype Ia carry gbs20182 variant indicating adaptability wide range hosts including human animals virulence factor critical understanding iS agalactiaeis pathogenicity developing vaccine infections Additionally isolates harbor antimicrobial resistance gene conferring resistance glycopeptides ivanTi ivanYi macrolides imreAi peptide imprFi penicillin iβilactams ipbpi aminoglycosides Source tracking via BacWGSTdb website identified isolates closely related human pathogens indicating zoonotic potential result suggest iS agalactiaei could zoonotic pathogen highlight need ongoing genomic surveillance fully understand cause disease come effective way control it",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40568491/"
    },
    {
        "pmid": "40563126",
        "title": "Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024.",
        "abstract": "report outbreak ceftriaxoneresistant Salmonella enterica serovar Typhi Bangladesh 47 case identified AprilSeptember 2024 Isolates belonged genotype 4312 harbored blasubCTXM15sub gene pCROB1 plasmid genotypeplasmid lineage represents recent introduction calling strengthened surveillance antimicrobial stewardship vaccination strategies",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Salmonella typhi",
            "Ceftriaxone",
            "Typhoid Fever",
            "Disease Outbreaks",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Drug Resistance, Bacterial",
            "Male",
            "Female",
            "Adult",
            "Child, Preschool",
            "Child",
            "Adolescent",
            "Middle Aged",
            "Young Adult",
            "Genotype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40563126/"
    },
    {
        "pmid": "40561131",
        "title": "Use of minimally invasive tissue sampling to determine the contribution of diarrheal diseases to under-five mortality and associated co-morbidities and co-infections in children with fatal diarrheal diseases in Africa and Bangladesh.",
        "abstract": "Achieving Sustainable Development Goal reducing child mortality 25 death per 1000 live birth 2030 requires strategy prevent diarrheal diseaserelated morbidity mortality Accurate etiological diagnosis essential study used postmortem diagnostics investigate contribution diarrhea under5 mortality examine comorbidities coinfections Africa South Asia Child Health Mortality Prevention Surveillance CHAMPS generates data child death minimally invasive tissue sampling clinical record review verbal autopsies Multidisciplinary panel assign causes death using International Classification Diseases analysis included death among child aged 159 month enrolled 18 December 201631 December 2023 across six African site Ethiopia Mali Kenya Sierra Leone Mozambique South Africa Bangladesh 1517 death assessed diarrhea causal pathway 240 158 proportion diarrhearelated death highest Ethiopia 410 3483 followed Bangladesh 300 310 Mozambique 217 56258 Mali 175 18103 Kenya 139 51366 Sierra Leone 128 46358 South Africa 94 32339 Diarrhea underlying cause 442 106240 case immediateantecedent cause 583 140240 death involving multiple role causal chain diarrhea underlying cause sepsis 330 lower respiratory infection 255 common downstream conditions antecedentimmediate cause leading underlying cause malnutrition 643 HIV 136 pathogen identified 496 119240 diarrhearelated deaths among these diarrhea underlying cause 429 Among 121 pathogenattributed deaths frequent EAEC 347 typical EPEC 157 ShigellaEIEC 140 STETEC 124 rotavirus 264 adenovirus non4041 190 4041 50 pathogen frequently identified coinfections Diarrheal disease accounted substantial share child death across CHAMPS sites Reducing mortality require preventing diarrhea addressing key contributor malnutrition HIV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40561131/"
    },
    {
        "pmid": "40555405",
        "title": "Evaluation of Interventions to Improve Vaccination Coverage Among Children Aged 12-23 Months in Urban Slum Areas of Bangladesh Using the WHO Interactive Evidence to Decision (iEtD) Framework: A Stakeholder Perspective.",
        "abstract": "Childhood vaccination costeffective public health intervention however coverage slumlike area remains significant challenge unique socioeconomic disparity logistical barriers aimed evaluate intervention literature improving vaccination coverage among child aged 1223 month slum area using iEtD framework TOPSISEntropy method decisionmaking Bangladesh identify stakeholder rank felt need intervention across study slums crosssectional study conducted six slum two city corporation area Dhaka Bangladesh involving 67 demandside 35 supplyside stakeholders Rating score ranged 0 1 indicating priority interventions study highlight demandside stakeholder favour incentive interventions whereas supplyside stakeholder support multicomponent strategies stakeholders educational intervention ranked highest score 0745 followed multicomponent intervention score 0666 incentive score 0651 reminderrecall scoring score 0305 Educational intervention identified shared priority common ground addressing felt need demand supplyside stakeholders finding support tailored contextspecific approach enhance vaccination coverage child health vulnerable communities",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40555405/"
    },
    {
        "pmid": "40532465",
        "title": "Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia.",
        "abstract": "Newborns infected Hepatitis B Virus HBV risk chronic liver disease hepatocellular carcinoma study investigated prevalence HBV infection among pregnant woman cord blood Hepatitis B surface antigen HBsAg positivity newborn Bangladesh Bhutan India Ethiopia Mozambique Kenya Nigeria Mali South Africa Randomly selected paired maternal cord blood sample n  101 site taken delivery tested HBsAg Hepatitis B extractable antigen HBeAg woman using chemiluminescent microparticle immunoassay Similarly cord blood sample newborn assessed HBsAg reactivity HBV DNA quantified using Xpert® HBV viral load assay followed genotyping overall prevalence maternal HBsAg positivity 55  95 CI 04 71  n  50909 HBsAg positivity higher African country 73  95 CI 54 96  n  44606 compared South Asian country 20  95 CI 08 43  n  6303 p  0002 Relative South Africa higher odds HBsAg seropositivity woman Mozambique aOR 77 95 CI 16 378  Mali aOR 57 95 CI 11 297  rate HBsAg positivity cord blood baby born HBsAg positive woman 280  95 CI 171 423  n  1450 including 318  95 CI 195474  n  1444 African countries cord blood HBsAg positivity observed South Asia Genotypic analysis revealed HBV genotype 417  E 583  predominant high rate cord blood positivity 280  HBsAg underscore urgency enhancing HBV prevention strategy meet World Health Organizations target 90  reduction new HBV infection 2030",
        "mesh_terms": [
            "Humans",
            "Female",
            "Hepatitis B Surface Antigens",
            "Pregnancy",
            "Fetal Blood",
            "Prevalence",
            "Infant, Newborn",
            "Hepatitis B",
            "Adult",
            "Hepatitis B virus",
            "Pregnancy Complications, Infectious",
            "Young Adult",
            "DNA, Viral",
            "Africa South of the Sahara",
            "Asia",
            "Genotype",
            "Viral Load",
            "Infectious Disease Transmission, Vertical",
            "Adolescent",
            "Hepatitis B e Antigens",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40532465/"
    },
    {
        "pmid": "40526624",
        "title": "Determinants of incomplete immunization and factors for missed opportunities in urban Dhaka: A cross-sectional study.",
        "abstract": "vaccination immunization schedule need two dos elicit protective immune response Therefore completion dos crucial achieving best possible immunity objective study investigate factor influencing missed opportunity polio vaccination child age 13 year urban Dhaka 2018 according immunization card record history parentsguardians sorted13yearold child area Dhaka South City Corporation fully immunized Immunization record obtained Expanded Program Immunization EPI card maternal recall Reasons nonvaccination documented total 501 child tracked determine cause incomplete polio doses Determinants incomplete immunization factor missed opportunity assessed using bivariate multivariable logistic regression model household child received recommended vaccine considerably lower monthly income 18000 BDT p  0001 complete partial vaccination groups average family size five people average child age 28 months Education level household head adjustment AOR odds event occurring decrease 25 primary education 95 CI 066 085 pvalue  0001 Occupation household head rickshawvancart puller AOR odds increase even more event 315 time likely occupation 95 CI 195 508 statistical significance pvalue  005 Again daily wager AOR 216 time higher daily wager 95 CI 135 345 statistical significance pvalue 0001 study identifies sociodemographic factor influence incomplete childhood immunization urban area Dhaka order improve coverage identified factor need mitigated policymakers focus enhancing community engagement combating misinformation increasing accessibility vaccination services",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Child, Preschool",
            "Cross-Sectional Studies",
            "Male",
            "Infant",
            "Vaccination",
            "Urban Population",
            "Immunization Schedule",
            "Poliomyelitis",
            "Immunization",
            "Immunization Programs"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40526624/"
    },
    {
        "pmid": "40505670",
        "title": "Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.",
        "abstract": "Replacing oral polio vaccine inactivated polio vaccine IPVs necessary stop potential transmission vaccinederived polio viruses aimed compare safety immunogenicity dosesparing IPV dsIPV fulldose IPV infant Bangladesh doubleblind randomised controlled phase 3 study done two field site Bangladesh Kamlapur Matlab Eligible participant healthy infant aged 68 weeks parent intended reside area study period Participants randomly assigned 1111 receive either dsIPV one three lot lot A B C Serum Institute India Pune India IPV Serum Institute India Three intramuscular dos 0·5 mL administered age 6 10 14 week addition standard vaccines study staff involved safety evaluation study procedures parent participants laboratory personnel masked treatment allocations primary endpoint seroconversion poliovirus type 1 2 3 28 day third dose assessed perprotocol full analysis populations Solicited adverse event collected 4 day vaccine dose unsolicited adverse event serious adverse event collected 28 day third dose study registered ClinicalTrialsgov NCT05163561 complete Jan 9 2022 April 29 2023 1072 eligible participant randomly assigned receive dsIPV n801 IPV n267 1052 completed study 755 96 95 CI 94 97 786 participant dsIPV group versus 256 97 94 98 265 participant IPV group seroconversion poliovirus type 1 difference 0·55 95 CI 3·05 1·95 744 95 93 96 786 participant dsIPV group versus 261 98 96 100 265 participant IPV group seroconversion poliovirus type 2 difference 3·83 6·48 1·19 765 97 96 98 786 participant dsIPV group versus 260 98 96 99 265 participant IPV group seroconversion poliovirus type 3 difference 0·78 2·73 1·16 Solicited event observed 446 56 801 participant dsIPV group 143 54 267 participant IPV group Unsolicited event observed 746 93 801 participant dsIPV group 250 94 267 participant IPV group Serious adverse event observed 23 3 801 participant dsIPV group five 2 267 participant IPV group common serious adverse event pneumonia n10 dsIPV group n3 IPV group bronchiolitis n3 dsIPV group n1 IPV group diarrhoea n3 dsIPV group n1 IPV group None unsolicited event serious adverse event causally related study vaccines Delivery three intramuscular dos novel dsIPV vaccine safe immunologically noninferior delivery three intramuscular dos IPV dose sparing formulation might therefore become attractive option national immunisation programme due lower expected vaccine costs Serum Institute India",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40505670/"
    },
    {
        "pmid": "40496144",
        "title": "Addressing influenza in Bangladesh: closing evidence and policy gaps with strategic interventions.",
        "abstract": "Since establishment National Influenza Surveillance Program 2007 Bangladesh significantly progressed monitoring influenza national international collaboration However collaboration translated actionable control policies coupled low vaccination coverage impose substantial health economic burden Bangladesh Critical gap remain understanding influenza burden among highrisk population barrier influencing vaccine uptake gap hinder development evidencebased strategy prevention control consequently leaving country vulnerable potentially catastrophic influenza epidemic challenge require multifaceted approach including continuous local data collection disease burden vaccine barriers vaccine costeffectiveness analyses design contextspecific interventions Leveraging existing infrastructure offer opportunity develop tailored strategy highrisk populations robust national influenza policy imperative mitigate burden reduce future pandemic threats",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40496144/"
    },
    {
        "pmid": "40493576",
        "title": "Awareness about cervical cancer and its socio-economic determinants among adults in Bangladesh: Results from a nationwide cross-sectional study.",
        "abstract": "Cervical cancer major global health issue second leading cancer among woman Bangladesh caused primarily Human papillomavirus HPV Despite effective vaccination screening methods awareness access preventive method limited developing regions nationwide study aim explore socioeconomic cultural factor affecting cervical cancer awareness Bangladesh generate evidencebased recommendation tailoring suitable health promotion strategy country crosssectional study conducted Bangladesh evaluate cervical cancer awareness among adult aged 18 year above semistructured questionnaire designed research keeping mind local sociocultural contexts Facetoface interview conducted getting participants consent making sure understood questions checking data quality consistency response 2151 participant finally retained collected data analyzed using STATA Version 17 statistical software majority 8015 participant aware cervical cancer healthcare worker primary source information Higher awareness rate noted among married individual 8088 urban dweller 8324 education average 1196 ± 436 years individual higher income 8817 belonging nuclear family 8286 Healthcare professional significantly greater awareness 9891 compared occupations Participants undergoing regular health checkup informed association statistically significant 8703 p  0001 Univariate multiple logistic regression model revealed additional year education increased probability aware 1620 Men significantly lower odds aware compared woman Adjusted Odds Ratio AOR  041 β  0895 95 CI 023 070 p  0001 multiple logistic regression analysis Similarly respondent cohabitating spouse less aware living partner AOR  047 β  0750 95 CI 028 081 p  0006 Income level conversely influenced awareness level participant highest income group earning 3500150000 BDT 47 lower odds AOR  053 β  0629 95 CI 036 080 p  0002 awareness compared lowest income group earning ≤20000 BDT Despite widespread awareness cervical cancer among Bangladeshi adults remains notable gap particularly among certain demographics Since study identified healthcare workers social media mass medium major source information targeted educational campaign medium channel outreach activity healthcare worker might effectively enhance nationwide awareness cervical cancer",
        "mesh_terms": [
            "Humans",
            "Female",
            "Uterine Cervical Neoplasms",
            "Bangladesh",
            "Adult",
            "Cross-Sectional Studies",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged",
            "Socioeconomic Factors",
            "Young Adult",
            "Surveys and Questionnaires",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40493576/"
    },
    {
        "pmid": "40489552",
        "title": "Demographic, temporal, and spatial analysis of human animal bite cases in Mymensingh District, Bangladesh.",
        "abstract": "study aimed analyze demographic temporal spatial characteristic animal bite AB case human across 12 Upazilas within Mymensingh district Bangladesh Retrospective hospitalbased data individual AB case 2022 2023 collected SK Hospital dataset included information victim demographics bite details vaccination information Rabies Immune Globulin RIG administration Additionally monthly case count 2016 2024 sourced analyzed identify trends Descriptive statistic time series analysis using seasonal decomposition technique conducted Risk map animal bite 2022 2023 generated using standardized incidence ratio SIR approach almost twofold increase proportion category 3 bite receiving RIG 36 2022 65 2023 noted 97 2022 169 2023 bite victim received PEP day exposure whereas 765 2022 846 2023 received PEP within 24 hours Moreover significant seasonal pattern annual increasing trend AB case observed Males child 14 year old higher risk bitten Dogs 482 2022 cat 526 2023 identified primary animal responsible bites Notably leg body part frequently bitten bite risk map identified four high risk Upazilas Despite improvement PEP coverage achieved within 24 hours critical gap remains sameday PEP coverage years study result also suggest potential improvement healthcare practice treatment protocols need veterinary surveillance system Increasing AB case highlight need enhance surveillance control measures Targeted awareness campaign tailored highrisk group male child 14 year age along preventive program focused dog imperative Coordinated One Health effort among healthcare professionals veterinarians policymakers community stakeholder crucial effectively mitigate incidence AB cases safeguarding public health eliminate dog mediated rabies 2030 region",
        "mesh_terms": [
            "Humans",
            "Bites and Stings",
            "Bangladesh",
            "Male",
            "Animals",
            "Child",
            "Adolescent",
            "Female",
            "Rabies",
            "Child, Preschool",
            "Retrospective Studies",
            "Adult",
            "Young Adult",
            "Infant",
            "Middle Aged",
            "Spatio-Temporal Analysis",
            "Incidence",
            "Dogs",
            "Seasons",
            "Post-Exposure Prophylaxis",
            "Rabies Vaccines",
            "Aged",
            "Cats"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40489552/"
    },
    {
        "pmid": "40463970",
        "title": "In-hospital mortality among hospitalized COVID-19 patients in a tertiary care hospital in Dhaka City: a retrospective cohort study.",
        "abstract": "Inhospital mortality COVID19 treatment crucial metric used assess severity disease effectiveness medical interventions identifying mortality risk factors aim inform policy decisions optimize resource allocation improve preparedness future pandemics retrospective cohort study conducted tertiary hospital Dhaka City Bangladesh Data gathered hospitals electronic medical record July 2021 September 2021 applying specific inclusion exclusion criteria 218 patient complete medical record selected analysis independent variable examined included demographic characteristics comorbidities clinical features assess inhospital mortality relative risk RR 95 confidence interval calculated using multivariable logistic regression analysis employing Delta method study included 218 hospitalized COVID19 patients primarily male 514 average age 564 year standard deviation 15 years overall inhospital mortality rate 183 Older age ≥60 RR310 95 CI 116829 longstanding hypertension ≥5 years RR278 95 CI154502 chronic kidney disease CKD RR443 95 CI293670 significant risk factor mortality Patients diabetes ≥3 years moderately increased risk RR168 95 CI 101283 Notably shorter hospital stay ≤7 days associated higher mortality potentially due delayed treatment initiation Moreover Vaccinated patient significantly lower risk death RR 007 compared unvaccinated patients highlighting protective effect vaccination Greater lung involvement especially lower lobes higher Total Severity Scores TSS ≥ 14 strongly predict COVID19 mortality nonsurvivors exhibiting significantly worse radiographic damage Age particularly combined chronic condition like hypertension chronic kidney disease key predictor inhospital COVID19 mortality gender independent risk factor male tend higher mortality rates Delayed treatment reflected shorter hospital stays also increase risk Vaccination markedly lower mortality resourcelimited settings lower lobe involvement 50 TSS ≥ 14 serve early triage marker guide ICU admission intensified care indicator inform risk assessment tools resource allocation targeted intervention reduce pandemicrelated mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463970/"
    },
    {
        "pmid": "40463439",
        "title": "Azithromycin treatment response as a probe to attribute bacterial etiologies of diarrhea using molecular diagnostics: a reanalysis of the Antibiotics for Children with Severe Diarrhea (ABCD) trial.",
        "abstract": "Multipathogen molecular diagnostics enhance understanding pathogenspecific burden diarrhea However attributing etiology remains challenging highburden setting coinfections common Antibiotics Children severe Diarrhea ABCD trial provides unique opportunity leverage azithromycin treatment response identify bacterial diarrhea analyzed data 6692 child watery diarrhea enrolled ABCD 2017 2019 randomized receive azithromycin placebo modelled heterogeneity azithromycin treatment response enteric pathogen quantity detected quantitative PCR using logbinomial regression Azithromycin treatment response varied pathogen quantity strongest effect observed iShigellai log₁₀ increase iShigellai quantity associated 13 reduction 95 CI 323 diarrhea risk day 3 azithromycin group compared placebo observed similar though nonsignificant trend iVibrio choleraei STETEC tEPEC contrast association found pathogen quantity azithromycin response iCampylobacteri LTETEC EAEC pattern remained consistent evaluating hospitalization death risk within 90 days observed association azithromycin treatment response pathogen quantity iShigellai iVibrio choleraei STETEC tEPEC support prior evidence pathogen likely cause diarrhea present high quantities Conversely absence similar response pattern iCampylobacteri LTETEC EAEC consistent largescale study showing limited association quantity diarrhea",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463439/"
    },
    {
        "pmid": "40463364",
        "title": "An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: a study based on HIV subtype C.",
        "abstract": "Currently HIV human immunodeficiency virus infection one leading complication public health cause acquired immunodeficiency syndrome AIDS especially African region specific vaccine available combat this multistrain variability one hurdles investigation employed variability epitope HIV subtype C target introduce mutation construct epitopebased vaccine Four target examined predict B cell major histocompatibility complex class II Among predicted epitopes immunodominant epitope selected mapped identified variable amino acid incorporate mutation selected mutated epitope used nonmutated mutated vaccine construction considering linker fusion adjuvant improve activity vaccines structure modeled examined validate structural quality high population coverage also found docking investigation nonmutated mutated vaccine Tolllike receptor 3 show remarkable activity followed strong binding affinity simulation 100 n revealed constancy complex system immune response revealed strong effectiveness generating multiple immunoglobulin followed time step infection further iin silicoi cloning demonstrated high expression iEscherichia colii based favorable Codon Adaptation Index GC value integrated approach investigation help plan potent immunodominant vaccine work multiple strain HIV infection",
        "mesh_terms": [
            "Humans",
            "HIV-1",
            "HIV Infections",
            "Mutation",
            "AIDS Vaccines",
            "Computational Biology",
            "Epitopes, T-Lymphocyte",
            "Immunodominant Epitopes",
            "Molecular Docking Simulation",
            "Epitopes, B-Lymphocyte"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463364/"
    },
    {
        "pmid": "40460588",
        "title": "Post-mortem study of endemic human coronaviruses (HCoV-NL63, OC43, 229E and HKU-1) in deaths of children under five in low- and middle-income countries: Findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) study.",
        "abstract": "Endemic human coronaviruses HCoV229E HKU1 NL63 OC43 common cause mild asymptomatic respiratory infection child considered rare cause death evaluated pediatric death January 2017 December 2022 panel expert determined cause death CoD reviewing available data including pathological molecular finding minimally invasive tissue sampling lung tissues blood CSF nasopharyngeal swabs clinical records verbal autopsies Endemic HCoV detected respiratory sample 3  n  863357 enrolled decedents 1  n  122043 neonates 5  n  35681 infant 6  n  39633 child deaths However HCoVs attributed CoD two case  involving young infant underlying birth defect severe wasting succumbed polymicrobial hospitalacquired infection involving HCoVOC43 Klebsiella pneumoniae Acinetobacter baumannii Amongst remaining 84 decedent HCoV detected 82  n  6984 median Ct 2534 range 15283617 death attributed infections including 54  n  3269 median Ct 2386 range 1528352 lower respiratory infection determined CoD bulk death 96  n  6669 attributed pathogen  Plasmodium falciparum 27  n  1969 K pneumoniae 23  n  1669 Streptococcus pneumoniae 20  n  1469 Escherichia coli 16  n  1169 Cytomegalovirus 10  n  769 Although endemic HCoV identified child died respiratory infections rarely attributed CoD Nevertheless research warranted explore potential role HCoVs LRTI pathogenesis impact facilitating pathogenic infections",
        "mesh_terms": [
            "Humans",
            "Infant",
            "Coronavirus Infections",
            "Child, Preschool",
            "Infant, Newborn",
            "Male",
            "Female",
            "Autopsy",
            "Respiratory Tract Infections",
            "Coronavirus",
            "Cause of Death",
            "Developing Countries",
            "Coronavirus OC43, Human",
            "Coronavirus NL63, Human",
            "Coronavirus 229E, Human"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40460588/"
    },
    {
        "pmid": "40449873",
        "title": "Global dengue epidemic worsens with record 14 million cases and 9000 deaths reported in 2024.",
        "abstract": "Dengue caused dengue virus DENV fastestgrowing mosquitoborne disease worldwide utilised monthly data dengue case death reported World Health Organisations WHO global surveillance system period 1supstsup January 31supstsup December 2024 performed generalised linear regression model understand countrylevel determinant denguerelated mortality 2024 141 million dengue case reported globally surpassing historic milestone 7 million observed 2023 figure represents twofold increase compared 2023 12fold rise compared 2014 n1206644 2024 9508 denguerelated death recorded resulting global casefatality rate 007 regression analysis country Southern hemisphere incidence rate ratio IRR 595 95 CI 419846 aged population IRR 104 CI 101107 mean annual temperature IRR 121 CI 116126 significantly associated higher denguerelated mortality per million population ongoing dengue outbreak underscore urgent need global investment DENV research vaccine development vector control therapeutic strategies urge inclusion DENV WHOs Research Development Priority Disease list address growing global health threat",
        "mesh_terms": [
            "Humans",
            "Dengue",
            "Global Health",
            "Dengue Virus",
            "Epidemics",
            "Adolescent",
            "Incidence",
            "Adult",
            "Child",
            "Middle Aged",
            "Child, Preschool",
            "Female",
            "Male",
            "Young Adult",
            "Infant",
            "Aged",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40449873/"
    },
    {
        "pmid": "40437297",
        "title": "A One Health approach to understanding and managing Nipah virus outbreaks.",
        "abstract": "Nipah virus NiV zoonotic paramyxovirus belonging genus Henipavirus infects Pteropus bat specie Southeast South Asia Since discovery late 1990s Malaysia NiV caused outbreak human Singapore Bangladesh India Philippines spillover pathway recent NiV outbreak 2023 Kerala India remains speculative NiV cause serious disease infected humans mean casefatality rate 70 approved treatment vaccine exist Humans infected directly bat shared food infected bridging hosts including pig horses although spillover pathway may exist Here review pathway NiV spillover transmission highlighting area needing research emphasize importance collaborative multidisciplinary effort laboratory field implementation One Health strategy prevent future epidemics",
        "mesh_terms": [
            "Henipavirus Infections",
            "Nipah Virus",
            "Animals",
            "Humans",
            "Disease Outbreaks",
            "Chiroptera",
            "One Health",
            "Zoonoses",
            "Swine",
            "Viral Zoonoses",
            "Horses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40437297/"
    },
    {
        "pmid": "40432708",
        "title": "Environmental Health Risk Evaluation and Potential to Cause Disease X as a Global Pandemic: A Call for Global Preparedness.",
        "abstract": "Emerging infectious disease pose constant threat global health economy Among them concept disease X emerged owing uncertainty identity pathogen may cause next pandemic Disease X gained significant attention due potential cause public health emergency future study aimed investigate disease X identify key risk factor leading emergence spread propose strategy prevent future global pandemics performed comprehensive literature review identified relevant information study Pandemic public health emergency infectious disease used keywords literature search study indicates disease X could lifethreatening global pandemic Among various risk factors climate change increased animalhuman contact emergence antibiotic resistance risk factor may lead pandemic help transmission zoonotic infections Here discussed potential pathogens including bacteria viruses fungi capable causing disease X Finally indicated necessary measure required prevention management future global pandemic Disease X already posed substantial threat global health system warranting urgent attention action Comprehensive preparedness measures including robust surveillance systems early detection vaccine development essential mitigating risk posed disease X Collaboration among healthcare organizations research communities government body essential resilience future pandemics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40432708/"
    },
    {
        "pmid": "40432698",
        "title": "Risk Evaluation and Mitigation Strategies for Newly Detected Mysterious Dinga Dinga Virus Infection in Africa: A Narrative Review.",
        "abstract": "Dinga Dinga Virus DDV emerged mysterious disease gripping woman Uganda raising alarm due unusual distressing dancing like symptoms symptoms characterized involuntary movement resembling dance suggest possible neurological involvement though exact pathogen remains unidentified causative agent DDV still unknown hypothesized possible microorganism could virus bacteria vectorborne origin Therefore comprehensive research urgently needed confirm cause performed comprehensive literature search Scopus Web Science related different outbreak viruses collected relevant information appropriate article review unique representation disease spreading rapidly localized area potential escalate broader public health crisis Preventive measure focused symptom monitoring public awareness isolation suspected case limit transmission Authorities emphasize hygiene practices using personal protective equipment PPE early reporting manage outbreak effectively Simultaneously global health organization called collaborate diagnostic development therapeutic interventions vaccine research disproportionate impact woman brought social cultural dynamic spotlight stigma misinformation exacerbate outbreaks challenges Immediate longterm strategy must address aspect strengthening healthcare infrastructure enhancing disease surveillance systems world recovers COVID19 pandemic DDV stark reminder ongoing threat emerging infectious diseases Proactive sciencedriven effort critical understanding mitigating enigmatic disease ensuring escalate another global health crisis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40432698/"
    },
    {
        "pmid": "40430433",
        "title": "Systems Biology-Driven Discovery of Host-Targeted Therapeutics for Oropouche Virus: Integrating Network Pharmacology, Molecular Docking, and Drug Repurposing.",
        "abstract": "bBackgroundb Oropouche virus OROV part Peribunyaviridae family emerging pathogen causing Oropouche fever febrile illness endemic South Central America Transmitted primarily midge bite iCulicoides paraensisi OROV specific antiviral treatment vaccine study aim identify hosttargeted therapeutic OROV using computational approaches offering potential strategy sustainable antiviral drug discovery bMethodsb Virusassociated host target identified using OMIM GeneCards databases Enrichr DSigDB platform used drug prediction filtering compound based Lipinskis rule drug likeness proteinprotein interaction PPI network analysis conducted using STRING database Cytoscape 3103 software Four key host targetsIL10 FASLG PTPRC FCGR3Awere prioritized based role immune modulation OROV pathogenesis Molecular docking simulation performed using PyRx software evaluate binding affinity selected smallmolecule inhibitorsAcetohexamide Deptropine Methotrexate Retinoic Acid 3Azido3deoxythymidineagainst identified targets bResultsb PPI network analysis highlighted immunemediated pathway Fcgamma receptor signaling cytokine control Tcell receptor signaling critical intervention points Molecular docking revealed strong binding affinity selected compound prioritized targets suggesting potential efficacy hosttargeting antiviral candidates Acetohexamide Deptropine showed strong binding multiple targets indicating broadspectrum antiviral potential vitro vivo validation needed confirm finding translate clinically relevant treatments bConclusionsb study highlight potential using computational approach identify hosttargeted therapeutic Oropouche virus OROV targeting key host protein involved immune modulationIL10 FASLG PTPRC FCGR3Athe selected compounds Acetohexamide Deptropine demonstrate strong binding affinities suggesting potential broadspectrum antiviral candidates experimental validation needed confirm efficacy potential clinical application offering promising strategy sustainable antiviral drug discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40430433/"
    },
    {
        "pmid": "40424392",
        "title": "\"Everything had stopped, no meeting, no gathering\": Social interactions during the COVID-19 pandemic in the Central African Republic, the Democratic Republic of Congo, and Bangladesh.",
        "abstract": "Understanding spread COVID19 humanitarian fragile setting challenging many reasons including lack data social dynamic preventive behavior epidemic investigate social interaction three setting  Democratic Republic Congo DRC Central African Republic CAR Coxs Bazar CXB Bangladesh  changed first year pandemic comparative mixedmethods study us representative household survey focus group discussion key informant interview site Descriptive weighted analysis survey response conducted multivariate logistic regression identified factor associated change social interactions Thematic analysis conducted qualitative data Nearly participant social interaction day survey although average number daily interaction low Interactions primarily occurred indoors home without masks saw discrepancy knowledge practice preventive behaviors respondent reported interacting less often 773 CXB 867 CAR 588 DRC shorter meeting 80 CXB 778 CAR 478 DRC Reluctance towards COVID19 vaccine risk factor noncompliant behavior CAR OR increased frequency  351 95CI  141875 increased duration  247 95CI  115529 DRC OR increased duration  306 95CI  171549 likely pointing distrust towards institutional policies Respondents IDP community DRC less likely reduce frequency interaction likely living condition facilitate physical distancing Increased knowledge CXB associated compliant behavior for 1ptincrease increased frequency  047 95CI  032068 increased duration  046 95CI  031069 Understanding social dynamic fundamental predict infectious disease spread particularly humanitarian settings evidence needed understand behavior influencing disease dynamic driver behaviors including trust authorities social economic factors Peace community engagement reduction misinformation remain critical epidemic response humanitarian settings",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Democratic Republic of the Congo",
            "Female",
            "Male",
            "Bangladesh",
            "Adult",
            "Middle Aged",
            "Pandemics",
            "Social Interaction",
            "SARS-CoV-2",
            "Young Adult",
            "Surveys and Questionnaires",
            "Adolescent",
            "Focus Groups"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40424392/"
    },
    {
        "pmid": "40421764",
        "title": "Poxvirus pathology and pathogenesis in agriculturally important species.",
        "abstract": "Zoonotic poxviruses including monkeypox virus MPV causative agent Mpox disease gained significant medium scientific attention due recent outbreak human population across globe increase human case poxvirus infection unexpected routine vaccination smallpox a disease caused poxvirus variola virus cross protects orthopoxviruses discontinued 1980s eradication Large number vertebrate invertebrate specie susceptible infection iPoxviridaei Clinical sign histologic lesion caused genetically different poxvirus strikingly similar notable exception eg poxviral infection fish purpose article review poxvirus pathology pathogenesis observed specie agricultural significance including poultry cattle goats sheep camels swine rabbits horses salmon carp",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40421764/"
    },
    {
        "pmid": "40419097",
        "title": "Foot-and-mouth disease virus O/ME-SA/SA-2018: A new emerging threat posed by viruses circulating in Asia?",
        "abstract": "2018 novel lineage footandmouth disease virus FMDV termed OMESASA2018 identified India subsequently spread neighbouring country Nepal Bangladesh Sri Lanka Since then incursion lineage occurred Middle East beyond usual epidemiological distribution Using sequence data derived field cases paper reconstructs evolutionary history OMESASA2018 lineage present vaccine matching data six commercially available FMD vaccines describes novel lineagespecific RTPCR assay used help detect field case due emerging lineage surveillance study warranted understand distribution virus Asian countries",
        "mesh_terms": [
            "Foot-and-Mouth Disease Virus",
            "Foot-and-Mouth Disease",
            "Animals",
            "Asia",
            "Phylogeny",
            "Communicable Diseases, Emerging",
            "Viral Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40419097/"
    },
    {
        "pmid": "40412396",
        "title": "Health-care burden related to respiratory syncytial virus in a resource-constrained setting: a prospective observational study.",
        "abstract": "Respiratory syncytial virus RSV leading cause paediatric hospital admission worldwide straining health systems lack data burden RSV infection impact health system resourcelimited setting hinders evidencebased policy decisions Here aimed assess RSVs burden health system Bangladesh January December 2019 conducted prospective study Bangladeshs largest paediatric hospital among child aged 059 month admitted possible respiratory infection guided RSV hospitalbased surveillance case definition Outcomes RSVpositive child younger 5 year analysed also followed outcome child denied hospitalisation due bed shortages Adjusted hazard ratio child denied admission versus admitted estimated using survival analysis Monte Carlo simulation queueing model used estimate effect RSV prefusion F maternal vaccine nirsevimab admission denial mortality 40 664 child admitted 31 692 younger 5 years 19 940 study wards Among 7191 admitted possible respiratory infections 6149 85·5 nasopharyngeal swab taken 1261 20·5 testing RSVpositive median age child tested positive RSV 3·0 month IQR 1·08·0 median hospital stay 5 day IQR 48 24 1·9 1261 died hospital 8274 5·5 151 110 bed day child positive RSV Additionally 9169 child denied admission outcome tracked 3928 compared 2845 admitted hazard ratio death 1·56 95 CI 1·34 1·81 child denied versus admitted highest neonate 2·27 1·87 2·75 RSV prefusion F maternal vaccine nirsevimab could reduced denial 677 95 prediction interval 63 1347 1289 684 1865 respectively potentially preventing 130 60 322 258 32 469 deaths RSV strain health care Bangladesh increasing mortality risks Preventive intervention could lessen impact boosting healthcare capacity child health resourcelimited settings Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Respiratory Syncytial Virus Infections",
            "Prospective Studies",
            "Infant",
            "Child, Preschool",
            "Female",
            "Bangladesh",
            "Male",
            "Infant, Newborn",
            "Hospitalization",
            "Cost of Illness",
            "Health Resources"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40412396/"
    },
    {
        "pmid": "40380137",
        "title": "Science tikkun: a bioscience pandemic framework in a Hebrew tradition of global repair.",
        "abstract": "past decade seen steady increase dangerous pandemic threats include two major Ebola epidemic cholera Africa dengue Zika yellow fever Americas COVID19 pandemic H5N1 Texas happening confluence modern force including urbanization deforestation climate change Yet pandemic emerge crowded warming planet antiscience disinformation antisemitism impede response Science tikkun overarching framework repair redress honor legacy Maimonides Teilhard de Chardin others sought reconciliation science religion",
        "mesh_terms": [
            "Humans",
            "Pandemics",
            "COVID-19",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40380137/"
    },
    {
        "pmid": "40377940",
        "title": "Adherence to Perinatal Asphyxia or Sepsis Management Guidelines in Low- and Middle-Income Countries.",
        "abstract": "23 million annual neonatal death occur subSaharan Africa South Asia perinatal asphyxia neonatal sepsis leading cause neonatal mortality neonatal death considered preventable highquality clinical care includes adherence clinical care guidelines assess adherence World Health Organization clinical care guideline management perinatal asphyxia neonatal sepsis identify patientlevel factor adherence among neonate died conditions crosssectional study obtained data December 2015 October 2023 Child Health Mortality Prevention Surveillance CHAMPS catchment area 7 low middleincome country subSaharan Africa Ethiopia Kenya Mali Mozambique Sierra Leone South Africa South Asia Bangladesh Participants neonate born alive aged 0 28 day time death either perinatal asphyxia neonatal sepsis Medical record neonate died perinatal asphyxia neonatal sepsis determined postmortem diagnostics main outcome proportion deceased neonate received guidelineadherent treatment died Mixedeffect multivariable logistic regression analysis performed identify factor associated administration least bagvalvemask BVM ventilation perinatal asphyxia 1194 neonate median IQR age time death 2 16 days 692 male 580 died enrolled CHAMPS available clinical data 476 399 died perinatal asphyxia 562 470 died neonatal sepsis 156 131 conditions neonate median IQR birth weight 2130 12662988 g case perinatal asphyxia guideline adherence ranged 122 n  77 adrenaline administration 854 540 supplemental oxygen administration 44 neonate 28 perinatal asphyxia received recommended treatments Among case neonatal sepsis antibiotic administered 868 623 although recommended treatment administered 610 438 multivariable analyses neonate clinician accurately identified perinatal asphyxia likely receive BVM ventilation received discordant antemortem postmortem diagnosis adjusted odds ratio 200 95 CI 129312 crosssectional study clinical care guideline adherence suboptimal among neonate died perinatal asphyxia neonatal sepsis finding underscore critical need increase adherence region high rate neonatal mortality may inform strategy strengthening health system support compliance clinical care guidelines",
        "mesh_terms": [
            "Humans",
            "Infant, Newborn",
            "Asphyxia Neonatorum",
            "Guideline Adherence",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Developing Countries",
            "Neonatal Sepsis",
            "Sepsis",
            "Africa South of the Sahara",
            "Practice Guidelines as Topic",
            "Infant Mortality",
            "Infant"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40377940/"
    },
    {
        "pmid": "40355819",
        "title": "Bioinformatics-guided decoding of the Ancylostoma duodenale genome for the identification of potential vaccine targets.",
        "abstract": "Ancylostoma duodenale parasitic nematode worm found involved various infections including intestinal blood loss protein malnutrition anemia Antimicrobial resistance available therapeutic prompted search new drug vaccine target A duodenale Despite significant advance vaccine development A duodenale commercial FDAapproved vaccine exists safeguard human infection caused pathogen investigation stringent bioinformatics analysis identified 36 unique essential hostinteracting proteins Based subcellular localization 6 protein located extracellular space outer membrane categorized vaccine targets remaining protein predicted act potential drug candidates vaccine candidate assessed antigenicity allergenicity physicochemical analysis determine suitability designing multiepitope vaccine Two candidate protein chosen optimal target development vaccine design identified T Bcell epitope protein combined appropriate linkers adjuvant design chimeric vaccine construct aimed inducing cellular humoral immune responses Molecular docking molecular dynamic simulations PCA analysis DCCM analysis binding free energy calculation proved stable interaction designed vaccine human immune cell receptors Within bacterial cloning system vaccine construct demonstrated ability cloned expressed immunological stimulation elicited significant immunological response proposed vaccine investigation identified new therapeutic target developed peptidebased multiepitope vaccine A duodenale infection Additional experimental verification open new therapeutic alternative emerging resistant pathogen",
        "mesh_terms": [
            "Computational Biology",
            "Ancylostoma",
            "Animals",
            "Molecular Docking Simulation",
            "Vaccines",
            "Humans",
            "Epitopes, T-Lymphocyte",
            "Helminth Proteins",
            "Epitopes, B-Lymphocyte",
            "Molecular Dynamics Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40355819/"
    },
    {
        "pmid": "40335470",
        "title": "Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.",
        "abstract": "Chronic care manages longterm progressive conditions acute care address shortterm conditions Chronic condition increasingly strain health systems often unprepared demands study examines burden condition requiring acute versus chronic care including sequelae Conditions sequela Global Burden Diseases Study 2019 classified acute chronic care categories Data analysed age sex sociodemographic index presenting total number contribution burden metric DisabilityAdjusted Life Years DALYs Years Lived Disability YLD Years Life Lost YLL Approximately 68 DALYs attributed chronic care 27 due acute care Chronic care need increased age representing 86 YLDs 71 YLLs accounting 93 YLDs sequelae finding highlight chronic care need far exceed acute care need globally necessitating health system adapt accordingly",
        "mesh_terms": [
            "Humans",
            "Chronic Disease",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Middle Aged",
            "Aged",
            "Adult",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Aged, 80 and over",
            "Health Services Needs and Demand",
            "Adolescent",
            "Acute Disease",
            "Persons with Disabilities",
            "Child",
            "Child, Preschool",
            "Infant",
            "Cost of Illness"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40335470/"
    },
    {
        "pmid": "40333874",
        "title": "Immunization status of children with cerebral palsy: A cross-sectional hospital-based study in Vietnam.",
        "abstract": "describe immunization status child CP Vietnam identify factor associated vaccine nonuptake group conducted active prospective case ascertainment child cerebral palsy CP attending National Childrens Hospital Hanoi June November 2017 following model proposed Paediatric Active Enhanced Disease Surveillance system Australia child assessed trained paediatrician hospital immunization history recorded Data collected 765 child CP median age  17 years IQR  27 years children 827 fully immunized age compared 964 general child population according Vietnamese Expanded Programme Immunization EPI schedule BCG vaccination scar present 940 child CP 959 eligible child received measlesrubella vaccine part national campaign compared 960 982 general population respectively Incomplete vaccination according EPI associated younger age living earthsand house homebirth lowlevel maternal education diagnosed CP age three bilateral CP associated impairment ie epilepsy intellectual visual speech level IVV Gross Motor Function Classification System undernutrition first study document immunization status child CP Vietnam large proportion received measlesrubella vaccine 173 fully immunized increase vaccination coverage intervention strategy required ensure child CP equitable access early diagnosis immunization health education programs outreach programs frequent followup Early diagnosis focused intervention early life could improve vaccination coverage child CP",
        "mesh_terms": [
            "Humans",
            "Cerebral Palsy",
            "Vietnam",
            "Female",
            "Male",
            "Child, Preschool",
            "Infant",
            "Cross-Sectional Studies",
            "Child",
            "Vaccination",
            "Prospective Studies",
            "Immunization Programs",
            "Immunization",
            "Hospitals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40333874/"
    },
    {
        "pmid": "40322786",
        "title": "Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh.",
        "abstract": "Digital platform like social medium increasingly used promote vaccine uptake low middleincome country LMICs yet limited evidence exists economic value study estimate costeffectiveness behavioral insightsinformed social medium campaign designed increase HPV vaccine uptake among adolescent girl age 914 Bangladesh static costeffectiveness analysis conducted health system perspective Inputs included campaign delivery costs vaccine procurement distribution treatment cost averted cervical cancer prevention Disabilityadjusted life year DALYs averted per vaccinated girl modeled using global burdenofdisease parameters Effectiveness estimate drawn quasiexperimental evaluation campaign reported 95 percentagepoint increase vaccine uptake one study arm 53 percentagepoint increase another relative control group finding preceded posttest study Dhaka Division showed strong association campaign exposure vaccination behavior incremental cost per vaccinated girl 602 cost per DALY averted  ie Incremental CostEffectiveness Ratio ICER  3957 fall well established costeffectiveness thresholds including 40 GDP per capita commonly applied LMICs finding suggest digital campaign guided behavioral insight represent highly costeffective approach addressing persistent immunization coverage gaps result support integration strategy national immunization programs particularly context traditional outreach method may face financial constraints",
        "mesh_terms": [
            "Humans",
            "Female",
            "Cost-Benefit Analysis",
            "Bangladesh",
            "Adolescent",
            "Papillomavirus Vaccines",
            "Papillomavirus Infections",
            "Uterine Cervical Neoplasms",
            "Child",
            "Vaccination",
            "Social Media",
            "Health Promotion",
            "Immunization Programs",
            "Disability-Adjusted Life Years"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40322786/"
    },
    {
        "pmid": "40322557",
        "title": "Evaluation of Immunostimulatory Effects of Bacterial Lysate Proteins on THP-1 Macrophages: Pro-inflammatory Cytokine Response and Proteomic Profiling.",
        "abstract": "Bacterial lysate protein BLPs serve potential immunostimulants recognized pattern recognition receptor PRRs immune cells eliciting robust immune response study THP1 macrophage treated varying dos BLPs derived iStreptococcus pyogenesi SP iStreptococcus agalactiaei SA iSerratia marcescensi SM result showed significant increase ipi  005 proinflammatory cytokine TNFiαi IL1iβi IL6 IL12 granulocyte macrophagecolony stimulating factor GMCSF eotaxin macrophage inflammatory protein MIP1iαi except 5 µg BLPs TNFiαi eotaxin 5 µg SP IL12 production significant difference found corresponding dos SP SA SP SM except GMCSF doses SA SM showed difference 5 µg dose GMCSF Furthermore significant difference 10 20 µg dos BLPs indicating dos higher 10 µg significantly enhance proinflammatory response Combination dos SP  SM SA  SM show significant differences except IL1iβi suggesting synergistic effect Cytotoxicity observed increase higher BLP concentration dosedependent manner combination SP  SM SA  SM exhibiting greater cytotoxicity individual BLPs Proteomic analysis BLPs identified immunostimulatory proteins including heat shock protein HSPs ClpB DnaK GroEL metabolic enzyme glyceraldehyde 3phosphate dehydrogenase GAPDH enolase arginine deiminase ADI surface secreted protein ESAT6like protein CRISPRassociated endonuclease Cas9 OmpA porin OmpC serralysin involved immune modulation bacterial clearance immune evasion study underscore potential bacterial protein vaccine adjuvant supplementary therapies however research essential find balance immune activation inflammation reduction develop safer effective immunostimulants",
        "mesh_terms": [
            "Humans",
            "Macrophages",
            "Cytokines",
            "Proteomics",
            "Bacterial Proteins",
            "THP-1 Cells",
            "Streptococcus pyogenes",
            "Adjuvants, Immunologic",
            "Inflammation Mediators",
            "Streptococcus agalactiae",
            "Proteome",
            "Bacterial Lysates"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40322557/"
    },
    {
        "pmid": "40318346",
        "title": "Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.",
        "abstract": "Enteric fever caused Salmonella enterica serovars Typhi Paratyphi and lesser extent S Paratyphi B C remains significant cause mortality morbidity resourceconstrained settings Typhoid conjugate vaccine TCVs protect S Typhi vaccine date protects paratyphoid fever several bivalent S TyphiParatyphi product development however low incidence paratyphoid fever many setting limit feasibility phase 3 efficacy studies Two bivalent vaccine adding S Paratyphi Aspecific O2 lipopolysaccharide conjugated protein carrier TCV construct successfully completed phase 1 study progress rapidly development WHOs Product Development Vaccines Advisory Committee PDVAC endorsed regulatory pathway bivalent S TyphiParatyphi vaccine contemplates demonstrating protective efficacy S Paratyphi infection controlled human infection model CHIM Since use CHIM data lieu phase 3 efficacy study identify marker immune protection yet widely accepted regulatory bodies organized consultation vaccine developers manufacturers regulators purpose meeting discus feasibility consideration licensure bivalent S TyphiParatyphi vaccine aim consultation gain alignment among key stakeholder facilitate pathway licensure endemic countries",
        "mesh_terms": [
            "Typhoid-Paratyphoid Vaccines",
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Salmonella paratyphi A",
            "Paratyphoid Fever",
            "World Health Organization",
            "Endemic Diseases",
            "Vaccine Development",
            "Advisory Committees",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40318346/"
    },
    {
        "pmid": "40316604",
        "title": "Computational analysis of lupenone derivatives as potential inhibitor of human papillomavirus oncoprotein E6 associated cervical cancer.",
        "abstract": "Cervical cancer remains major global health challenge largely driven persistent infection highrisk human papillomavirus HPV Although preventive vaccine reduced cervical cancer incidence settings effective therapeutic strategy established HPVassociated malignancy remain limited Highrisk HPV type particularly 16 18 utilize E6 oncoprotein promote ubiquitinmediated degradation tumor suppressor p53 thereby facilitating uncontrolled cell proliferation immune evasion Targeting E6 thus emerged key strategy counteract HPVdriven carcinogenesis work employed comprehensive silico frameworkencompassing density functional theory DFT ADMET absorption distribution metabolism excretion toxicity profiling molecular docking including refinement validation molecular dynamic MD simulationsto evaluate series chemically modified lupenone derivative potential HPV oncoprotein inhibitors Initially lupenone modified different functional groups derivative screened druglikeness via ADMET analysis confirm pharmacological viability Concurrently pharmacophore mapping highlighted key alignment ligand functional group pharmacophoric sites DFT calculation elucidated compounds electronic structure conformational stability chemical reactivity Subsequent docking assessment E6 oncoprotein molecular dynamic simulation confirmed structural robustness several topperforming compounds indicating minimal conformational fluctuation time finding demonstrate potential lupenone derivative promising scaffold antiHPV therapy However vitro vivo investigation necessary confirm efficacy toxicity profiles clinical relevance mitigating HPVrelated cervical cancer",
        "mesh_terms": [
            "Humans",
            "Uterine Cervical Neoplasms",
            "Female",
            "Oncogene Proteins, Viral",
            "Molecular Docking Simulation",
            "Molecular Dynamics Simulation",
            "Papillomavirus Infections",
            "Repressor Proteins",
            "Human papillomavirus 16",
            "Human Papillomavirus Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40316604/"
    },
    {
        "pmid": "40309315",
        "title": "Human papillomavirus in Bangladesh: Challenges and opportunities for prevention.",
        "abstract": "•Cervical cancer second leading cause cancerrelated death among female Bangladesh•Despite progress vaccination HPVrelated health challenge persist due limited vaccine access low public awareness emerging viral strains",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40309315/"
    },
    {
        "pmid": "40305928",
        "title": "Advances and challenges in cancer immunotherapy: Strategies for personalized treatment.",
        "abstract": "Cancer immunotherapy transformed oncology harnessing immune system specifically target cancer cells offering reduced systemic toxicity compared traditional therapies review highlight key strategies including adoptive cell transfer ACT immune checkpoint inhibitors oncolytic viral OV therapy monoclonal antibody mAbs mRNAbased vaccines ACT reinfuses enhanced immune cell like tumorinfiltrating lymphocyte TILs combat refractory cancers checkpoint inhibitor eg PD1 CTLA4 blockers restore Tcell activity OV therapy us engineered virus eg TVEC selectively lyse cancer cells advanced mAbs improve targeting precision mRNA vaccine introduce tumorspecific antigen trigger robust immune responses Despite significant progress challenge like immunerelated side effects high costs immunosuppressive tumor microenvironments persist review underscore need combination strategy precision medicine overcome barrier maximize potential immunotherapy personalized cancer treatment",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Precision Medicine",
            "Immunotherapy",
            "Cancer Vaccines",
            "Tumor Microenvironment",
            "Oncolytic Virotherapy",
            "Immune Checkpoint Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40305928/"
    },
    {
        "pmid": "40303072",
        "title": "<i>In Silico</i> Driven Multi-Epitope Subunit Candidate Vaccine against Bovine Tuberculosis.",
        "abstract": "Bovine tuberculosis bTB caused iMycobacterium bovisi pose significant zoonotic economic challenge globally current prevention treatment option limited increasingly complicated emergence multidrugresistant strains study employ reverse vaccinology immunoinformatics design multiepitope subunit vaccine targeting MPB83 ArfA DnaK GrpE LpqH protein iM bovisi Tcell Bcell epitope candidate vaccine predicted evaluated antigenicity allergenicity toxicity promising epitope assembled three vaccine construct bTBV1 bTBV2 bTBV3 using appropriate adjuvants pan HLA DRbinding epitope PADRE linkers construct analyzed physicochemical properties 3D structure cytokine induction stability followed molecular docking bovine CD molecule tolllike receptor TLR9 Among candidates bTBV3 chosen one promising vaccine candidate due high aliphatic index 6760 lowest instability score 2726 strong binding affinity Molecular dynamic simulation result interaction vaccinereceptor complex eigenvalue 2318704e06 show vaccine construct bTBV3 stable iIn silicoi immune simulation findings elevated IgM level increased Th cell populations suggest designed multiepitope vaccine candidate bTBV3 elicits robust humoral cellular immune responses confirming vaccines potential efficacy Additionally codon optimization CAI 0997 GC 54687 iin silicoi cloning facilitated efficient expression iE colii study highlight potential bioinformaticsdriven approach developing effective subunit vaccine bTB providing foundation experimental validation future application combating pervasive zoonotic disease bovine tuberculosis",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Tuberculosis Vaccines",
            "Vaccines, Subunit",
            "Tuberculosis, Bovine",
            "Mycobacterium bovis",
            "Epitopes, B-Lymphocyte",
            "Epitopes, T-Lymphocyte",
            "Molecular Docking Simulation",
            "Computer Simulation",
            "Epitopes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303072/"
    },
    {
        "pmid": "40303052",
        "title": "Pathogenic Characteristics of Five Different Lineage of Korean PRRSV-2 Isolates (NADC30-Like, VR2332-Like, LKA, LKB, and LKC).",
        "abstract": "Porcine reproductive respiratory syndrome virus PRRSV significant pathogen worldwide swine industry virus show high genetic variation coupled broad range virulence pigs Although multiple lineage virus prevalent throughout Korea characteristic lineagewise pathogenicity largely unknown Therefore study designed analyze compare pathogenicity 11 representative Korean PRRSV2 isolates selected PRRSV2 lineage circulating Korea NADC30like VR2332like three nationspecific lineage lineage KOR LKA lineage KOR B LKB lineage KOR C LKC continuously prevalent nation Eleven group pig experimentally infected one Korean PRRSV2 isolate four consecutive animal experiments Body weight body temperature recorded 4week challenge experiment period virological serological histopathological test performed collected samples data animal experiment integrated two indicatorsexcretion clinical signsthrough correlation principal component analysis PCA Metaanalysis used compare PRRSV2 isolates using indicator Based analyses L1C virus used study JB15NP31GB JB15NPJ73GN similar NADC30like strains exhibited low moderate level excretion clinical signs lineage 5 L5 modified live vaccine MLVvariant strain exhibited high level excretion compared PRRSV2 isolates However L5 variant caused mild clinical signs except JB15NPJ4GN showed 4th highest clinical sign indicator Among Korean lineage LKA LKB LKC two LKB strain GGYC45 JB15NPJ10GN virulent showed highest mortality challenge hand LKA LKC virus displayed lower excretion indicator L5 strains higherranked clinical sign indicator lowvirulence L5 MLV variants conclusion PRRSV prevalent Korea diverse excretion clinical characteristics certain lineage highly pathogenic result offer useful insight prevent spread PRRSV improve efficacy vaccine future",
        "mesh_terms": [
            "Animals",
            "Swine",
            "Porcine respiratory and reproductive syndrome virus",
            "Porcine Reproductive and Respiratory Syndrome",
            "Republic of Korea",
            "Virulence",
            "Phylogeny"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303052/"
    },
    {
        "pmid": "40295746",
        "title": "Toll-like receptor response to Zika virus infection: progress toward infection control.",
        "abstract": "Infection Zika virus ZIKV pose threat human health improved understanding host Tolllike receptor response disease onset viral clearance vivo vitro may lead development therapeutic prophylactic intervention viral infections Currently clinically approved ZIKV vaccine available highlighting need development study discus progress Zika vaccine including advance use Tolllike receptor agonist vaccine adjuvant enhance vaccine efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40295746/"
    },
    {
        "pmid": "40290636",
        "title": "A Reverse Vaccinology and Immunoinformatic Approach for the Designing of a Novel mRNA Vaccine Against Stomach Cancer Targeting the Potent Pathogenic Proteins of <i>Helicobacter pylori</i>.",
        "abstract": "iHelicobacter pylorii infection stomachs epithelial cell significant risk factor stomach cancer Various iH pylorii protein CagA GGT NapA PatA urease VacA targeted design 2 messenger RNA mRNA vaccines V1 V2 using bioinformatics tools Physicochemical parameters secondary tertiary structure molecular docking dynamic simulation codon optimization RNA structure prediction also estimated developed vaccines Physicochemical analysis revealed developed vaccine soluble GRAVY  0 basic pI  7 stable aliphatic index  80 secondary tertiary structure vaccine demonstrated robustness docking tolllike receptor TLRs revealed vaccine potential affinity TLR2 V1 11323 kJmol V2 10936 kJmol TLR4 V1 10427 kJmol V2 12012 kJmol molecular dynamic simulation confirmed dynamic stability Structural analysis V1 50596 kcalmol V2 63492 kcalmol mRNA vaccine underscored stability addition vaccine showed considerable rise count B cell extended activation cell also observed vaccines suggesting potential longlasting immunity offering enhanced protection iH pylorii finding suggest potential longlasting immunity iH pylorii also offer hope future stomach cancer prevention Notably study emphasizes need subsequent animal humanbased study confirm promising results",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40290636/"
    },
    {
        "pmid": "40271995",
        "title": "Epidemiology and evolutionary dynamics of H9N2 avian influenza virus in Bangladesh.",
        "abstract": "Low pathogenicity avian influenza LPAI H9N2 enzootic Bangladeshi poultry since 2006 H9N2 outbreak decrease egg production growth pose risk human health role avian host persistence evolution dispersion H9N2 poorly understood Bangladesh Hence study unveils intricate role major host specie virus maintenance evolution temporal seasonal pattern H9N2 Bangladesh 2006 2023 Multinomial logistic regression analysis indicated circulation H9N2 different specie interface significantly influenced seasons Bayesian phylogenetic analysis H9N2 sequence Bangladesh revealed two distinct lineages G1 Eurasian G1 lineage split two clusters coexisting 2019 point one cluster persisted Bayesian phylodynamic analysis G1 lineage unveiled frequent bidirectional viral transition among ducks chickens quails Chickens might pivotal source H9N2 Bangladesh higher number viral transition chicken duck quails Quails appear acquire viral transition chicken rather ducks suggesting quail epizootics primarily triggered spillover event chickens result suggest viral circulation commercial chicken despite vaccination vaccination approach revised assess vaccine efficacy extension vaccination backyard chicken quails",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Influenza A Virus, H9N2 Subtype",
            "Influenza in Birds",
            "Chickens",
            "Phylogeny",
            "Poultry Diseases",
            "Ducks",
            "Evolution, Molecular",
            "Quail",
            "Bayes Theorem",
            "Humans",
            "Seasons"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40271995/"
    },
    {
        "pmid": "40267919",
        "title": "Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.",
        "abstract": "BackgroundIn global scenario public health cervical cancer pose major threat high mortality rates especially women New incidence case prevalence vary across different regions recently shown GLOBOCAN data development cervical cancer primarily due persistent infection highrisk genotype human papillomavirus HPV multifaceted process influenced genetic environmental lifestyle factorsPurposeThe goal study thoroughly investigate cervical cancer including etiology molecular mechanisms progression diagnosis strategies current therapies review highlight transformative power HPV vaccination screening program curbing diseases burden potentially promising novel approach like immunotherapy targeted therapyResearch DesignThis narrative review article summarizes previous literature regarding cervical cancer term molecular mechanism etiology clinical developments preventionStudy SampleThe review encompassed study diverse sources including experimental observational clinical research published 1992 2025Data Collection andor AnalysisData collected comprehensive literature search using database PubMed Scopus Cochrane Library defined inclusion exclusion criteriaResultsNonetheless gap research controversy regarding vaccine coverage screening practices treatment accessibility poor populations Precision medicine trend emerging along new biomarkers early detection personalized treatment also form part discussion Key finding include critical role prevention measure controlling global impact cervical cancerConclusionsThe paper synthesizes existing knowledge identifies gap require research significant augmenting prevention diagnosis treatment cervical cancer towards addressing public health implication worldwide",
        "mesh_terms": [
            "Humans",
            "Uterine Cervical Neoplasms",
            "Female",
            "Papillomavirus Infections",
            "Papillomavirus Vaccines",
            "Early Detection of Cancer",
            "Papillomaviridae",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40267919/"
    },
    {
        "pmid": "40267616",
        "title": "Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide.",
        "abstract": "Escherichia coli powerful costeffective platform producing recombinant proteins However E coli produced protein lack sidechain glycosylation may misfolded due nonnative disulfide bonds often leading poor immunogenicity result commonly perceived unsuitable use antiviral vaccine antigens study address challenge using small 12 kDa envelope protein domain III Japanese encephalitis virus JEVEDIII model demonstrate low immunogenicity E coli produced protein effectively overcome employing solubilitycontrolling peptide tag SCPtag composed five isoleucine C5I E coliproduced JEVEDIII oligomerized 100 nm Rh soluble oligomers upon attachment C5Itag whereas untagged JEVEDIII remained monomeric Rh ∼ 19 nm C5Itag significantly enhanced antiJEV EDIII IgG titers evidenced ELISA increased population memory cell spleen assessed flow cytometry notably C5Itagged JEVEDIII elicited neutralizing antibodies confirmed FRNTsub50sub neutralization assay using live JEV finding suggest oligomerization via SCPtagging offer promising adjuvantfree approach producing neutralizing antibody longterm cell memory paving way developing E coli produced protein domainbased vaccines",
        "mesh_terms": [
            "Encephalitis Virus, Japanese",
            "Antibodies, Neutralizing",
            "Escherichia coli",
            "Animals",
            "Viral Envelope Proteins",
            "Antibodies, Viral",
            "Encephalitis, Japanese",
            "Japanese Encephalitis Vaccines",
            "Mice",
            "Solubility",
            "Female",
            "Mice, Inbred BALB C",
            "Immunoglobulin G",
            "Recombinant Proteins",
            "Peptides",
            "Protein Domains"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40267616/"
    },
    {
        "pmid": "40266130",
        "title": "Navigating the Complexities of HIV Vaccine Development: Lessons from the Mosaico Trial and Next-Generation Development Strategies.",
        "abstract": "bBackgroundObjectivesb development effective HIV vaccine faced persistent challenges evidenced recent discontinuation Mosaico phase 3 trial study aim critically examine obstacle encountered HIV vaccine development focus Mosaico trial tested Ad26Mos4HIV vaccine among 3900 participant across multiple countries also explore emerging vaccine technology potential overcoming challenges reflecting lesson previous trial inform future strategies bMethodsb reviewed Mosaico trials approach involved testing efficacy Ad26Mos4HIV vaccine compared outcome Mosaico trial major HIV vaccine trials including HVTN 702 Imbokodo RV144 explored limitation immune response elicited Mosaico vaccine review focused generation broadly neutralizing antibody bNAbs challenge related antigenic diversity Bcell engagement Emerging vaccine technologies viruslike particle VLPs nanoparticles SOSIP trimers mRNA platforms also analysed scalability immune durability potential advance HIV vaccine development bResultsb Mosaico trial discontinued due insufficient efficacy reducing HIV acquisition primarily due inability vaccine induce bNAbs crucial targeting diverse HIV1 strains major challenge inadequate engagement germline Bcell precursors compounded antigenic diversity virus analysis showed emerging vaccine platforms VLPs nanoparticles SOSIP trimers mRNAbased approaches hold promise present challenge related scalability durability immune responses role cell adjuvant enhancing vaccine efficacy also highlighted critical integrating humoral cellular immunity bConclusionsb Mosaico trial well major HIV vaccine trials underscore need multipronged approach incorporates antibody Tcell response tackle complexity HIV1 Future effort HIV vaccine development must focus inducing bNAbs generating robust Tcell responses utilizing scalable vaccine platforms integration artificial intelligence AI vaccine design offer new opportunity optimize immunogenic targets could significantly improve potential durable broad immune protection development successful HIV vaccine 2030 achievable relies leverage advanced technology including artificial intelligence innovation insight past trial data",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40266130/"
    },
    {
        "pmid": "40256633",
        "title": "Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.",
        "abstract": "comprehensively compare disease burden among patient RA PsA using PatientReported Outcome Measurement Information System PROMIS score identify distinct patient cluster based comorbidity profile PROMIS outcomes Data global COVID19 Vaccination Autoimmune Diseases COVAD 2 esurvey analysed Patients RA PsA undergoing treatment DMARDs included PROMIS score global physical health global mental health fatigue 4a physical function short form 10a comorbidities variable compared among three groups stratified disease activity status Unsupervised hierarchical clustering eXtreme Gradient Boosting feature importance analysis performed identify patient subgroup based comorbidity profile PROMIS outcomes study included 2561 patient 1907 RA 311 PsA 343 AS adjusting demographic factors significant difference PROMIS score observed among three groups regardless disease activity status Clustering analysis identified four distinct patient groups low burden comorbid PsAAS low burden depression highburden RA Feature importance analysis revealed PROMIS global physical health strongest determinant cluster assignment followed depression diagnosis comorbid PsAAS highburden RA cluster showed higher prevalence comorbidities 5647 697 respectively depression 4118 4167 respectively along poorer PROMIS outcomes Disease burden inflammatory arthritis determined complex interplay factors physical health status depression playing crucial roles identification distinct patient cluster suggests need paradigm shift towards integrated care approach equally emphasize physical mental health regardless underlying diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40256633/"
    },
    {
        "pmid": "40253094",
        "title": "Finalising the WHO Pandemic Agreement for a safer future.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40253094/"
    },
    {
        "pmid": "40252689",
        "title": "The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.",
        "abstract": "Typhoid fever remains substantial public health challenge lowincome middleincome countries 2023 typhoid conjugate vaccine TCVs introduced six country globally 50 million dos distributed TCVs deployed need observational study assess vaccine effectiveness field aimed evaluate validity different observational study design estimating vaccine protection compared different observational experimental study design assessing vaccine effectiveness reanalysing data TyVAC Bangladesh trial participantblinded observerblinded clusterrandomised controlled trial done Mirpur Dhaka Bangladesh 150 geographical cluster randomly assigned 11 receive either TCV Japanese encephalitis vaccine Eligible child aged 9 month 15 year offered single dose vaccine randomly assigned cluster residence baseline vaccination done April 15 May 15 2018 compared estimate vaccine effectiveness clusterrandomised controlled trial analysiswhich assessed risk bloodcultureconfirmed typhoid fever among recipient TCV versus recipient Japanese encephalitis vaccinewith estimate cohort study testnegative casecontrol study design TND analyses compared recipient TCV nonvaccinees 75 geographical cluster TCV administered conducted negativecontrol exposure NCE negativecontrol outcome NCO analysis bias indicators 41 344 67 62 025 ageeligible child study area received TCV Japanese encephalitis vaccine baseline vaccination campaign Among 62 025 ageeligible children 5582 bloodculture specimen collected passive surveillance including 2546 46 specimen 75 TCV clusters estimated vaccine efficacy 89 95 CI 8193 clusterrandomised controlled trial analysis 79 7086 cohort design 88 7993 TND pannegatives used testnegative controls 90 7596 TND specimen positive pathogen Salmonella enterica serotype Typhi used testnegative controls Using NCE analysis Japanese encephalitis vaccination associated increased risk typhoid fever compared nonvaccinees 75 Japanese encephalitis cluster cohort design incidence rate ratio 1·98 95 CI 1·562·52 significant association Japanese encephalitis vaccination typhoid fever found TND Similarly increased risk nontyphoid infection observed cohort NCO analysis comparing vaccinee nonvaccinees Japanese encephalitis vaccine cluster TCV clusters TND NCO analyses finding suggests TND provides reliable estimate TCV effectiveness whereas cohort design bias vaccine effectiveness estimates possibly due unmeasured confounding effects healthcareseeking behaviours NCE NCO approach useful tool identifying biases Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Typhoid Fever",
            "Bangladesh",
            "Infant",
            "Child",
            "Child, Preschool",
            "Vaccines, Conjugate",
            "Male",
            "Adolescent",
            "Female",
            "Research Design",
            "Vaccine Efficacy",
            "Japanese Encephalitis Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40252689/"
    },
    {
        "pmid": "40247005",
        "title": "Functional T cell response to COVID-19 vaccination with or without natural infection with SARS-CoV-2 in adults and children.",
        "abstract": "Severe COVID19 rare child suggesting difference immune response child adults Limited information available cellular immunity modulated COVID19 vaccination prior infection whether differentially modulated child compared adults Here aimed compare COVID19 vaccineinduced functional cell response adult child without previous SARSCoV2 infection Adults 1845 years n  45 child 510 years n  51 received PfizerBioNTech COVID19 vaccine remained unvaccinated previously infected SARSCoV2 selected two crosssectional SARSCoV2 serosurveillance study conducted Bangladesh Plasma nucleocapsid Nspecific antibody measured electrochemiluminescence immunoassay IFNγ perforin granzyme B secreting cell assessed using ELISpot assay Vaccination adult without previous infection induced higher frequency IFNγ granzyme B secreting lymphocyte compared unvaccinated adults increased IFNγ expression vaccinated children Previous infection increased IFNγ response unvaccinated adult only Unvaccinated child showed higher granzyme B expression compared adult irrespective infection status vaccinated individuals prior infection induced perforin expression adult children Children showed slightly different functional cell response adult response COVID19 vaccination infection mRNA vaccination provided higher IFNγ response adult children induced cytotoxic lymphocyte CTL response adult only Future study may evaluate impact type COVID19 vaccine functional cell immunity child confirm findings",
        "mesh_terms": [
            "Humans",
            "Child",
            "Adult",
            "COVID-19",
            "Adolescent",
            "Male",
            "SARS-CoV-2",
            "Child, Preschool",
            "Middle Aged",
            "Female",
            "Young Adult",
            "Interferon-gamma",
            "T-Lymphocytes",
            "COVID-19 Vaccines",
            "Granzymes",
            "Antibodies, Viral",
            "Vaccination",
            "Cross-Sectional Studies",
            "Immunity, Cellular",
            "Perforin",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40247005/"
    },
    {
        "pmid": "40239175",
        "title": "Optimal control analysis for the transmission of Nipah infection with imperfect vaccination.",
        "abstract": "paper present innovative mathematical model assessing dynamic optimal control Nipah virus NiV imperfect vaccination model formulation considers transmission contaminated food humantohuman contacts also incorporates potential virus transmission contact deceased body infected NiV Initially NiV model assessed theoretically identifying three distinct equilibrium states NiVendemic equilibrium state NiVfree equilibrium state equilibrium state involving infected flying foxes Furthermore stability result model case constant control thoroughly analyzed NiVfree equilibrium parameter model estimated based infected case documented Bangladesh 2001 2017 perform sensitivity analysis determine influential parameter formulate effective timedependent controls Numerical simulation indicate optimal course action eradicating disease provide comparative analysis controlling infection constant timevarying interventions simulation confirms implementation timevarying intervention effective minimizing disease incidence",
        "mesh_terms": [
            "Henipavirus Infections",
            "Nipah Virus",
            "Humans",
            "Animals",
            "Vaccination",
            "Bangladesh",
            "Models, Theoretical",
            "Computer Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40239175/"
    },
    {
        "pmid": "40230444",
        "title": "Changes in enteric fever trends during the COVID-19 pandemic from the Surveillance for Enteric Fever in Asia Project: a cross-sectional study.",
        "abstract": "Surveillance Enteric Fever Asia Project SEAP conducted blood culture surveillance iSalmonella entericai serotype Typhi iSi Typhi Paratyphi iSi Paratyphi provide evidence base prevention control measure Bangladesh Nepal Pakistan October 2020 September 2022 conducted prospective clinical surveillance retrospective laboratory surveillance health facility Dhaka Bangladesh Kathmandu Kavrepalanchok Nepal Karachi Pakistan Patients eligible outpatient three day fever last week Nepal Pakistan inpatient eligible suspected confirmed enteric fever Bangladesh inpatient confirmed enteric fever enrolled Patients blood cultureconfirmed enteric fever identified hospital laboratory laboratory network site also enrolled Patients completed interview medical record reviewed abstracted enrolled patient blood culture performed Antibiograms performed characterize drug sensitivity summarized data descriptively total 17593 patient enrolled 19 facilities these 8410 patient cultureconfirmed enteric fever Case count country decreased early stage COVID19 pandemic increased time Bangladesh Pakistan Case count remained low throughout study period Nepal countries typhoid common paratyphoid proportion paratyphoid case ranged 84 Pakistan 16 Nepal Extensively drugresistant typhoid common Pakistan 69 detected Bangladesh Nepal Cases enteric fever decreased COVID19 pandemic though clear much decrease relates true change transmission versus healthseeking behavior project funded Gates Foundation INV008335",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40230444/"
    },
    {
        "pmid": "40823266",
        "title": "Assessing Vaccination Coverage Among Healthcare Workers in Primary Healthcare Facility in Najran City, Saudi Arabia.",
        "abstract": "Insufficient vaccination coverage among healthcare worker HCWs contributes nosocomial outbreak avoidable deaths study assesses vaccine hesitancy among HCWs primary healthcare facility identifies contributing factor Najran City Saudi Arabia crosssectional study conducted August 2023 among healthcare worker HCWs various healthcare facility providing primary care study utilized questionnaire developed accordance World Health Organization WHO Centers Disease Control Prevention CDC guidelines covering sociodemographic medical characteristics vaccination profile 19 items evidence vaccination status multistage sampling technique employed obtain representative sample involving random selection HCWs various category physicians pharmacists dentists nurses laboratory technicians radiology technicians paramedics clustering willing participant facility type Among 591 healthcare worker HCWs 577 male 458 aged 3140 years Vaccination compliance rate varied highest rate observed third COVID19 dose 863 hepatitis B 812 influenza 783 lowest rate Tdap pregnancy 277 Immunization documentation primarily evidenced vaccine record 675 lab test 518 disease confirmation 369 study 709 partially 191 fully vaccinated 10 unvaccinated Regarding immunization documentation 57 partial 157 complete 272 incomplete Significant predictor unvaccinated included male sex p0001 Saudi nationality p0030 technicianparamedic profession p0001 Additionally HCWs experiencing burnout likely unvaccinated p0006 Multivariate analysis revealed techniciansparamedics 274 time likely unvaccinated physician AOR2743 95 CI11406600 p0024 study highlight significant gap vaccination coverage among HCWs working primary healthcare facility 191 fully vaccinated Factors male gender burnout contribute vaccine hesitancy address gaps future direction targeted educational interventions burnout mitigation mobile vaccination units awareness campaign recommended Additionally supportive measure manage burnout crucial improving vaccination rate protecting public health",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823266/"
    },
    {
        "pmid": "40821294",
        "title": "Beyond Heart Failure: A Case of Missed Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis.",
        "abstract": "Antineutrophil cytoplasmic antibodyassociated vasculitis abbreviated ANCAassociated vasculitis AAV presenting pauci‑immune glomerulonephritis may misdiagnosed elderly individual comorbid cardiovascular disease present case 75yearold female type 2 diabetes mellitus hypertension atrial fibrillation presumed heart failure preserved ejection fraction HFpEF developed progressive renal decline misattributed diuretic cardiorenal syndrome eight months Workup revealed myeloperoxidase antineutrophil cytoplasmic antibody MPOANCA positivity renal biopsy confirmed pauciimmune focal proliferative glomerulonephritis Induction therapy high‑dose glucocorticoid oral cyclophosphamide failed avert dialysis dependency case reflects interpretation Nterminal proBtype natriuretic peptide NTpro BNP chronic kidney disease CKD limited overlapping symptom complicate diagnosis Current clinical guideline recommend early ANCA testing biopsy‑confirmed diagnosis induction therapy combining glucocorticoid either rituximab cyclophosphamide without avacopan plasma exchange may considered rapidly progressive glomerulonephritis case underscore importance early nephrology referral ANCA serological screening prompt renal biopsy avert irreversible renal injury despite guideline‑adherent therapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821294/"
    },
    {
        "pmid": "40818935",
        "title": "Exploring the gut microbiota associated with peripheral nerve invasion in colorectal cancer patients and constructing predictive models.",
        "abstract": "study aim explore difference composition abundance biological function gut microbiota colorectal cancer CRC patient peripheral nerve invasion PNI without peripheral nerve invasion NPNI Additionally tried construct machinelearning predictive model incorporating identified microbiota characteristic explore impact gut microbiota CRCPNI progression search new noninvasive microbiological indicator CRCPNI Finally successfully developed predictive model predict PNI CRC patient leveraging microbial biomarkers innovative approach expected offer novel strategy early detection CRC metastasis thereby facilitating informed decision regarding treatment options study included 132 colorectal cancer CRC patients divided two separate group according whether exhibited PNI gut microbiota participant subjected 16S rRNA gene sequencing followed thorough analysis identify significant difference groups applied cell sorting algorithm convert transcriptome sequencing data obtained 8 colorectal cancer patient matrix representing immune cell abundance Following this matrix utilized investigate association among PNIrelated distinct gut microbiota immune cells immunerelated genes PNIrelated differentially expressed gene or molecular markers pathways well association KEGG pathways Based differential gut microbiota constructed Random Forest RF Multilayer Perceptron MLP model predict PNI CRC patients Comparative analysis αdiversity βdiversity gut microbiota CRC patient without PNI revealed statistically significant difference P  005 However Linear Discriminant Analysis effect size LEfSe identified 35 distinct gut microbiota 28 specie enriched PNI group 7 specie significantly enriched NPNI group analyzing gut microbiota significantly associated PNI successfully constructed predictive model using RF MLP predict occurrence PNI CRC patients model demonstrated robust performance PNI NPNI groups 35 gut microbiota specie exhibited significant variation abundance differential intestinal microbiota associated PNI colorectal cancer may modulate neuroinvasion process via variety potential biological mechanisms RF MLP predictive model show considerable accuracy predicting CRCPNI status reference value",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818935/"
    },
    {
        "pmid": "40817159",
        "title": "The lung immune prognostic index stratifies the occurrence of checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients: a multi-institutional cohort study.",
        "abstract": "Lung immune prognostic index LIPI associated survival outcome patient nonsmall cell lung cancer NSCLC receiving immunotherapy association occurrence checkpoint inhibitor pneumonitis CIP unclear retrospectively included 1824 patient advanced NSCLC received immune checkpoint inhibitor ICIs two institutions Cox regression analysis cumulative incidence curve used evaluate predictive value LIPI Additionally performed competing risk analysis using FineGray regression cumulative incidence curves median followup 15 months 99 patient developed CIP Compared good LIPI group intermediate LIPI group HR 187 P  0007 poor LIPI group HR 439 P  0001 higher risk CIP Furthermore found LIPI independent predictor intermediategrade CIP intermediate LIPI HR 211 P  0056 poor LIPI HR 451 P  0002 highgrade CIP intermediate LIPI HR 694 P  0014 poor LIPI HR 4401 P  0001 lowgrade CIP intermediate LIPI HR 131 P  0392 poor LIPI HR 072 P  0656 Similar result obtained competing risk analysis LIPI grade show potential predicting risk CIP immunotherapy could valuable clinical management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817159/"
    },
    {
        "pmid": "40817111",
        "title": "Individual-level characteristics and geospatial factors associated with cervical cancer screening participation in Alberta, Canada: a population-based cross-sectional study.",
        "abstract": "Cervical cancer fourth common cancer woman worldwide Effective primary prevention human papillomavirus vaccination secondary prevention screening prevent cervical cancer cases Cervical cancer screening uptake varies among woman underserved populations Research add understanding individual geographic arealevel characteristic woman screening status valuable public health intervention planning study aimed identify characteristic related cervical cancer screening status study population included woman age 28 69 year Alberta Data extracted administrative health data source linked Alberta Cervical Cancer Screening Program database determine screening status Descriptive bivariate analysis conducted describe variation cervical cancer screening status individuallevel sociodemographic health system factors geographic characteristics Multinomial logistic regression analysis conducted investigate relationship characteristic screening participation Geospatial analysis including heat map used visualize variation screening participation across province GetisOrd Gi hotspot analysis used determine location magnitude spatial autocorrelation study included 933965 eligible women Compared currently uptodate screening record screening tend older OR 363 95 CI 357 370 reside South Zone OR 151 95 CI 147 155 health system nonusers OR 295 95 CI 286 304 see general practitioner OR 1386 95 CI 1332 1443 usual provider care OR 3227 95 CI 3141 3315 statistically significant hot spot woman overdue record cervical cancer screening North Central Calgary Zones study found cervical cancer screening participation varied across geographical health system sociodemographic characteristic identified cluster region higher proportion woman underscreened Alberta Canada Overall finding help inform design intervention aim improve cervical cancer screening participation among underserved groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817111/"
    },
    {
        "pmid": "40815154",
        "title": "Recent advances in exercise immunometabolism: Immune cell bioenergetics, muscle-immune cell interactions, and potential dietary adjuvants.",
        "abstract": "Exercise profoundly alters immunological process improve overall health immunity link immune cell metabolism function prompted study immune cell bioenergetics following acute exercise role muscleresident immune cell training adaptations review highlight recent work area discusses potential dietary approach boosting exerciseinduced immunometabolic benefits Human study highlight ability exercise alter immune cell bioenergetics also reporting accompanying change immune cell function Rodent study involving moderate exercise report improved innate adaptive immune cell phenotype accompanied increased mitochondrial size bioenergetic function Various muscle resident immune cell subpopulation including macrophages mast cells regulatory cell also appear involved adaptive response exercise Fasting exogenous ketones mitochondrial enhancing compound eg sulforaphane urolithin A could theoretically potentiate immunometabolic benefit exercise based independent effects evidence combined intervention currently lacking Exercise dietary manipulation independently alter immunometabolic pathway could combined maximize associated health benefits may benefit cannot meet physical activity guideline want maximize exercise adaptation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815154/"
    },
    {
        "pmid": "40813693",
        "title": "The role of skin testing, drug challenge and IFN-γ ELISpot in delayed hypersensitivity to iodinated contrast media.",
        "abstract": "use vivo ex vivo diagnostic tool delayed hypersensitivity reaction DHRs associated iodinated contrast medium ICM currently illdefined evaluate role vivo ex vivo diagnostic tool DHRs occurring 6 h following intravenous lowosmolality ICM conducted prospective multicenter international cohort study patient recruited two tertiary care adult allergy clinics Austin Health Australia McGill University Health Centre Canada Eligible participant adult reported DHR receiving ICM vivo testing skin testing intravenous challenge performed identify alternative agent Ex vivo testing using interferonγ enzymelinked ImmunoSpot assay performed four Australian patient explore diagnostic performance culprit ICM identified dIDT 1720 85 320 15 challenge necessary confirm delayed hypersensitivity patient positive dIDT iohexol positive iodixanol 1515 100 34 75 34 75 46 67 35 60 positive iopromide ioversol iopamidol iobitridol respectively Overall 720 35 patient tolerated challenge alternative ICM IFNγ release assay negative implicated ICM 4 patient confirmed DHR positive dIDT dIDT allowed confirmation cellmediated allergy implicated ICM 85 patient strong clinical suspicion DHR identification noncrossreactive ICM 35 patients IFNy ELISpot useful four patient tested",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813693/"
    },
    {
        "pmid": "40806058",
        "title": "Histamine Metabolism in IBD: Towards Precision Nutrition.",
        "abstract": "Patients Inflammatory Bowel Disease IBD exhibit dysregulated immune response may exacerbated bioactive compounds histamine Current dietary guideline IBD primarily focus symptom management flareup prevention yet targeted nutritional strategy addressing histamine metabolism remain largely unexplored narrative review aim summarize existing literature complex interplay IBD histamine metabolism propose novel dietary framework managing IBD progression patient histamine intolerance HIT Relevant study identified comprehensive literature search PubMedMEDLINE Google Scholar ScienceDirect Scopus Web Science proposed lowhistamine diet LHD aim reduce overall histamine burden body two primary strategies 1 minimizing exogenous intake limiting highhistamine histaminereleasing food 2 reducing endogenous histamine production modulating gut microbiota composition specifically targeting histamineproducing bacteria parallel identifying individual histamineintolerant understanding role histaminedegrading enzymes diamine oxidase DAO histamineNmethyltransferase HNMT emerging important area focus Despite growing interest role histamine mast cell activation gut inflammation clinical trial investigated effect lowhistamine diet IBD populations Therefore future research prioritize implementation LHD intervention IBD patient evaluate generalizability clinical applicability",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806058/"
    },
    {
        "pmid": "40801169",
        "title": "Interventions for anal canal intraepithelial neoplasia.",
        "abstract": "Anal intraepithelial neoplasia AIN dysplasia anal transitional epithelium associated human papillomavirus HPV infection Highgrade lesion potential develop anal cancer incidence prevalence anal cancer increasing last decades Certain group  including people living HIV men sex men MSM suppressed immune system  high risk developing AIN Targeted excision using ablative treatment electrocauterisation infrared coagulation cryotherapy used firstline therapeutic strategies option include topical treatment immunomodulators imiquimod cytostatics fluorouracil Ideally treatment low risk complication result low risk recurrence first update review originally published 2012 assess effect therapeutic intervention anal intraepithelial neoplasia regardless gender age comorbidity used CENTRAL MEDLINE Embase five trial registers together reference checking citation searching contact study author identify study included review latest search date 16 April 2025 included randomised controlled trial RCTs assessed type intervention AIN excluded clusterrandomised crossover trials excluded people histological diagnosis anal carcinoma Pagets disease Bowenoid papulosis used standard methodological procedure expected Cochrane primary outcome interest were eradication defined absence histologic criterion presence normal epithelium scarring complete absence dysplasia development anal cancer human papillomavirus HPV eradication assessed certainty evidence using GRADE Five RCTs met inclusion criteria randomising total 4907 participants included participant adult living HIV CD4 cell count 300 cellsμL median participant age ranged 45 51 years participant male Two study multicentre conducted USA remaining study conducted outpatient clinic Spain Netherlands UK considered overall risk bias high one study moderate four main reason concern bias openlabel design high dropout rates study different intervention outcomes precluding metaanalysis inclusion two multiarmed study mean synthesised evidence nine separate comparisons Here summarise result largest study 4459 randomised participants comparing highresolution anoscopyguided treatment active monitoring summarise result study main review study comparing highresolution anoscopy HRAguided treatment active monitoring assess four reviews outcome interest eradication HPV eradication histological downgrading lesions recurrence AIN Results three remaining outcome  development anal cancer quality life adverse event  follows HRAguided treatment group four per 1000 04 participant developed anal cancer active monitoring group nine per 1000 09 participant developed anal cancer median followup 25 28 month risk ratio RR 043 95 confidence interval CI 020 093 P  003 1 study 4446 participants lowcertainty evidence active monitoring group increased impact psychological function inclusion 28 day inclusion treatment group difference physical symptoms impact physical functioning impact psychological functioning inclusion 28 day inclusion Two per cent participant treatment arm 02 active monitoring arm reported adverse events adverse event mild pain RR 107 95 CI 385 2979 P  0001 1 study 4446 participants lowcertainty evidence included study focused people living HIV may limit applicability result HIVnegative people assessed certainty evidence low outcome across nine comparisons highlighting lack highquality evidence intervention AIN finding suggest HRAguided treatment may lower anal cancer risk evidence uncertain evaluated efficacy cidofovir sinecatechins infrared coagulation HRAguided electrocautery imiquimod fluorouracil eradicating AIN eradication rate 14 62 followup period ranging four week 33 months evidence effectiveness treatment uncertain study intervention sufficient power duration required determine efficacy interventions Studies addressing treatment HIVnegative cohort also needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801169/"
    },
    {
        "pmid": "40797037",
        "title": "Risk factors of cytomegalovirus reactivation in patients with rheumatic musculoskeletal diseases undergoing remission induction therapy with high-dose glucocorticoids; a prospective short-term cohort study.",
        "abstract": "elucidate risk factor cytomegalovirus CMV infection involvement immunity status CMV infection patient rheumatic musculoskeletal disease remission induction therapy Patients rheumatic musculoskeletal disease underwent induction therapy highdose glucocorticoid consecutively enrolled patient screened CMVIgG baseline monitored weekly CMV pp65 antigen polymorphonuclear leukocyte peripheral blood discharge titre antibody individual viral antigen examined using cellbased flow cytometry total 157 patient 136 CMVIgGpositive 21 CMVIgGnegative enrolled CMV infection occurred 52 331 patients CMVIgGpositive 382 CMVIgGpositive patients Multivariable analysis revealed initial prednisolone dose  091 mgkgday odds ratio OR 45 P  001 intravenous cyclophosphamide OR 33 P  001 diabetes mellitus OR 48 P  001 history malignancy OR 26 P  004 independent relevant risk factor CMV infection titre CMVIgG antibody individual CMV antigen significant CMV infection lymphocyte count significantly decreased baseline CMV infection 985µL v 622µL P  003 CMV infection group treated antiCMV agents risk factor CMV infection shortterm initiation induction therapy patient rheumatic musculoskeletal disease treatment regimen comorbidities Decreased lymphocyte count relevant humoral immunity CMV infection necessity antiCMV agents Key Points • CMV infection remission induction therapy caused reactivation latent infection • risk factor shortterm CMV infection include treatment regimen comorbidities • Decreased lymphocyte count relevant humoral immunity CMV infection necessity antiCMV agents",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797037/"
    },
    {
        "pmid": "40796288",
        "title": "[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)].",
        "abstract": "standardize lung cancer prevention treatment measure China enhance quality diagnosis treatment improve patient prognosis provide evidencebased medical guidance clinician levels Chinese Medical Association convened expert respiratory medicine oncology thoracic surgery radiotherapy imaging pathology develop Chinese Medical Associations Clinical diagnosis treatment guideline lung cancer 2025 edition consensus resulted several update 2024 version screening section new recommendation added specify population advised undergo lung cancer screening also emphasizes individual high risk lung cancer fully informed potential benefit risk lowdose CT LDCT screening undergoing examination advancement treatment options update made recommended genetic testing patient early midstage postoperative advanced nonsmall cell lung cancer NSCLC patient advanced epidermal growth factor receptor EGFR mutations addition broader range monotherapy options application combination therapy may offer better disease control certain patients Furthermore treatment option approved patient undergoing immunotherapybased neoadjuvant treatment develop resistance EGFR tyrosine kinase inhibitor TKIs patient previously limited treatment options KRAS G12C mutations HER2 mutations small cell lung cancer resistance development approval novel drug brought significantly improved efficacy prognosis recommendation based stateapproved drug applications international guidelines current clinical practice China integrating latest evidencebased medical research screening diagnosis pathology genetic testing immune molecular marker detection treatment methods followup care goal provide comprehensive reasonable recommendation clinicians imaging specialists laboratory technicians medical staff levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796288/"
    },
    {
        "pmid": "40796286",
        "title": "[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)].",
        "abstract": "standardize lung cancer prevention treatment measure China enhance quality diagnosis treatment improve patient prognosis provide evidencebased medical guidance clinician levels Chinese Medical Association convened expert respiratory medicine oncology thoracic surgery radiotherapy imaging pathology develop Chinese Medical Associations Clinical diagnosis treatment guideline lung cancer 2025 edition consensus resulted several update 2024 version screening section new recommendation added specify population advised undergo lung cancer screening also emphasizes individual high risk lung cancer fully informed potential benefit risk lowdose CT LDCT screening undergoing examination advancement treatment options update made recommended genetic testing patient earlyand midstage postoperative advanced nonsmall cell lung cancer NSCLC patient advanced EGFR mutations addition broader range monotherapy options application combination therapy may offer better disease control certain patients Furthermore treatment option approved patient undergoing immunotherapybased neoadjuvant treatment develop resistance epidermal growth factor receptor EGFRtyrosine kinase inhibitor TKI patient previously limited treatment options KRAS G12C mutations HER2 mutations small cell lung cancer resistance develops approval novel drug brought significantly improved efficacy prognosis recommendation based Stateapproved drug applications international guidelines current clinical practice China integrating latest evidencebased medical research screening diagnosis pathology genetic testing immune molecular marker detection treatment methods followup care goal provide comprehensive reasonable recommendation clinicians imaging specialists laboratory technicians medical staff levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796286/"
    },
    {
        "pmid": "40791600",
        "title": "The Role of SR-BI in sepsis: leveraging mechanistic insights to advance precision steroid therapy.",
        "abstract": "According Surviving Sepsis Campaign 503 septic shock patient received steroidglucocorticoid GC therapy However whether GC therapy beneficial might benefit hotly debated Initial guideline recommended GC therapy septic patient adrenal insufficiency since retracted Recent study using animal model adrenal insufficiency shed light mechanisms demonstrating adrenal stress response part host response essential control inflammatory response sepsis adrenal insufficiency risk factor sepsis perspective review explores limitation GC therapy lens GC biology particular focus role scavenger receptor class B type SRBI mediating adrenal stress response highlight mechanism SRBImediated adrenal stress response contributes regulation hyperinflammation innate immune responses integrating mechanistic insight limitation GC therapy advocate precision medicine approach GC therapy sepsis selectively applying GC therapy patient adrenal insufficiency without",
        "mesh_terms": [
            "Humans",
            "Sepsis",
            "Animals",
            "Precision Medicine",
            "Adrenal Insufficiency",
            "Glucocorticoids"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791600/"
    },
    {
        "pmid": "40789765",
        "title": "Genetic etiologies associated with non-immune hydrops fetalis delineated by whole exome sequencing: A pilot series and its implications in prenatal genetic counseling.",
        "abstract": "Nonimmune hydrops fetalis NIHF spectrum disease involving heterogeneous etiologies Prenatal application whole exome sequencing WES emerged valuable tool decipher genetic cause structural abnormality detected fetal ultrasound Here reviewed index case NIHF whose genetic etiology delineated WES conducted retrospective study pilot series n  12 NIHF underwent WES outcome systematically reviewed case performed detailed sonographic examination anasarca virology profile karyotyping chromosomal microarray analysis CMA addition WES performed either prenatally postnatally December 2019 July 2024 12 fetus abnormal fluid accumulation fetal compartments despite normal karyotyping CMA underwent WES elucidate potential genetic etiologies Variant interpretation performed accordance guideline American College Medical Genetics Genomics ACMG definitive molecular diagnosis established 12 cases identified disorder including lymphatic abnormality 33 musculoskeletal disorder 30 syndromic condition 17 recurrent case 33 100 received fetal therapy 44 100 definite molecular diagnosis Two survived fetus diagnosed first third trimesters respectively four infant died six couple decided terminate pregnancy due disease progression Two novel founder variant HSPG2 BBS2 found WES effective tool determine genetic diagnosis NIHF case would discover novel causative gene match prenatal phenotype exhibited",
        "mesh_terms": [
            "Humans",
            "Hydrops Fetalis",
            "Female",
            "Pregnancy",
            "Exome Sequencing",
            "Pilot Projects",
            "Retrospective Studies",
            "Adult",
            "Genetic Counseling",
            "Prenatal Diagnosis",
            "Ultrasonography, Prenatal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789765/"
    },
    {
        "pmid": "40787612",
        "title": "Micronutrient and protein-energy supplementation enhance vaccine responses in undernourished children: Evidence from a systematic review.",
        "abstract": "Malnutrition impairs immune function vaccine responses particularly lowincome settings lead reduced seroconversion rate compromised herd immunity children Nutritional intervention proposed enhance vaccine immunogenicity yet evidence remains scattered context specific systematic review assesses impact nutritional interventionsespecially vitamin A zinc supplementation proteinenergy rehabilitationon serological response routine childhood vaccine among malnourished child low middleincome countries Following PRISMA guidelines searched PubMed Embase Cochrane Library Global Health Library study published 2000 2024 Eligible study included randomized trials cohort studies systematic review reporting nutritional supplementation vaccine seroconversion outcome malnourished children 3245 records 42 study met inclusion criteria Vitamin supplementation improved measles vaccine seroconversion 35 especially among deficient children Zinc enhanced response oral vaccine 20 Proteinenergy rehabilitation significantly increased seroconversion rate BCG measles vaccines particularly child recovering severe acute malnutrition Nutritional intervention improve vaccine immunogenicity among malnourished children Integrated strategy combining immunization nutrition service prioritized address immunity gap vulnerable populations",
        "mesh_terms": [
            "Humans",
            "Dietary Supplements",
            "Micronutrients",
            "Child",
            "Vitamin A",
            "Malnutrition",
            "Zinc",
            "Child Nutrition Disorders",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787612/"
    },
    {
        "pmid": "40784905",
        "title": "SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household survey.",
        "abstract": "SARSCoV2 populationbased seroprevalence survey useful estimating extent SARSCoV2 infections may underestimated COVID19 case counts Surveys conducted October 2020 four Nigerian state showed SARSCoV2 seroprevalence ranged 93 Gombe northeast 252 Enugu southeast first COVID19 wave 100 700 time higher official number COVID19 case two states respectively conducted serosurvey second COVID19 wave evaluate extent SARSCoV2 infections attitude COVID19 vaccines COVID19 vaccination coverage two region Nigeria Using World Health Organization WHO Unity protocol 34 enumeration area EAs Federal Capital Territory FCT Northcentral Zone Kano State Northwest Zone sampled June 2021 using probability proportional estimated size 20 household one EA randomly selected consenting assenting member household asked risk behaviors adult 18 year the eligible population COVID19 vaccination Nigeria responded question COVID19 vaccine attitude receipt Blood nasaloropharyngeal sample taken consenting assenting household members Blood sample collected tested Luminex xMAP® SARSCoV2 MultiAntigen IgG Assay swab reversetranscriptasePCR RTPCR Overall response rate 768 FCT n  1505 blood draws 804 Kano State n  2178 blood draws Following second COVID19 wave Nigeria 40 resident FCT 403 95 CI 347459 Kano State 426 95 CI 394458 evidence prior SARSCoV2 infection active SARSCoV2 infection detected RTPCR either FCT Kano State FCT Kano State 34 16 people surveyed reported receipt COVID19 vaccine three month vaccine available country FCT 775 adult aware COVID19 vaccines 469 reported willingness receive them Kano State 487 adult aware COVID19 vaccines 611 willing receive them regions 84 reporting unwillingness accept COVID19 vaccine cited concern vaccine safety Serosurvey finding revealed SARSCoV2 infection far widespread Federal Capital Territory Kano State indicated reported case numbers Despite high awareness COVID19 vaccine uptake remained low primarily due concern vaccine safety result highlight urgent need targeted risk communication address vaccine hesitancy improve coverage Serosurveys provide valuable insight guide public health intervention future pandemic preparedness Nigeria",
        "mesh_terms": [
            "Humans",
            "Nigeria",
            "COVID-19",
            "Seroepidemiologic Studies",
            "Adult",
            "SARS-CoV-2",
            "Female",
            "Male",
            "COVID-19 Vaccines",
            "Middle Aged",
            "Vaccination Coverage",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Surveys and Questionnaires",
            "Family Characteristics",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784905/"
    },
    {
        "pmid": "40779007",
        "title": "Immunogenicity and safety of the accelerated 2-dose intradermal rabies pre exposure prophylaxis regimen in immunocompetent and immunocompromised pediatric populations: a comparative study.",
        "abstract": "Rabies fatal zoonotic disease India account 35 global rabiesrelated deaths 2018 World Health Organization WHO revised guideline preexposure prophylaxis PrEP 3dose costsaving 2dose intradermal ID regimen study evaluates immunogenicity safety regimen pediatric populations including child exposed immunosuppressant therapy singlecenter prospective comparative followup study conducted tertiary care hospital Participants 518 years enrolled two groups 1 child known immunodeficiency n  31 2 child immunosuppressant therapy n  10 received Vero cell culture rabies vaccine RABIVAXSsup®sup intradermally two site day 0 7 Serum antirabies virus glycoprotein antibody titre assessed day 28 90 180 using ELISAbased assay Booster dos administered insufficient titer ≤ 05 EUml day 28 group achieved 100 seroconversion rate SCR Geometric mean titer GMT 2168 EUml 1547 EUml noknownimmunodeficiency immunosuppressant therapy groups respectively day 90 SCRs 90 70 GMTs 1358 EUml 0962 EUml respectively Booster dos restored titer participant insufficient levels Pain injection site solicited adverse effect 2dose ID PrEP regimen immunogenic safe pediatric populations including immunosuppressed children offer costeffective alternative rabiesendemic regions enhancing compliance accessibility Prospectively registered Clinical Trials Registry India Trial Registration No CTRI202210046777",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779007/"
    },
    {
        "pmid": "40770709",
        "title": "Parental and step-parental attitudes toward childhood vaccination in Kaduna State of Nigeria: a health belief model approach.",
        "abstract": "Childhood vaccination crucial public health intervention prevents spread vaccinepreventable disease reduces childhood morbidity mortality However vaccine hesitancy low immunization rate remain global challenges study aimed explore parents stepparents attitude toward childhood vaccination using Health Belief Model HBM analytical crosssectional survey conducted among 384 parent stepparents 1845 years diverse socioeconomic background Kaduna State Nigeria Participants selected consecutive sampling eligible individual completed questionnaire evaluating attitude toward childhood vaccination Data analyzed using attended Barau Dikko Teaching Hospital BDTH data collection period HBM SPSS version 29 employing descriptive statistic inferential tests including independent ttest OneWay ANOVA pvalue ≤ 005 considered statistically significant Participants perception moderate different dimension health belief HB Perceived susceptibility severity barrier moderate concern level Mean  237 SD  0576 Mean  215 SD  0653 Mean  254 SD  0585 respectively Parents positive attitude towards vaccination benefit Mean  386 SD  0735 moderate cue action Mean  275 SD  0677 health motivation Mean  363 SD  0865 Independent ttests showed gender p  016 residency p  005 associated health belief score However parental status variable substantial association HB score p  001 Oneway ANOVA test found significant association HB score age tribe marital status employment status family income religion p  098 075 005 037 059 060 respectively light findings clear addressing perceived barrier augmenting cue action critical fostering positive parental health behaviors particularly regarding childhood vaccination although study needed confirm results Capitalizing favorable perception vaccination benefit cultivating existing health motivation emerge effective strategy promoting health",
        "mesh_terms": [
            "Humans",
            "Nigeria",
            "Adult",
            "Male",
            "Female",
            "Parents",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Adolescent",
            "Young Adult",
            "Health Belief Model",
            "Health Knowledge, Attitudes, Practice",
            "Vaccination",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770709/"
    },
    {
        "pmid": "40770695",
        "title": "The role of religious leaders in the acceptance of COVID-19 vaccinations: a systematic review.",
        "abstract": "development COVID19 vaccine progressing rapidly vaccination acceptance posed many challenge different communities study systematically reviewed impact religious leader acceptance COVID19 vaccinations also examined religious leaders role shaping followers vaccination decision explored strategy religious organization use promote vaccination COVID19 study followed Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines primary database used search literature PubMed Web Science WOS Scopus ProQuest ScienceDirect Google Scholar identify relevant published literature title systematic review divided two key components keywords related COVID19 vaccination religious leaders along synonyms review analyzed seven article using content analysis explore diverse role religious leader COVID19 vaccination acceptance analysis identified two key themes positive contribution religious leader promoting vaccination negative neutral roles highlighting differing perspective influence pandemic Engaging religious leader disseminating adopting national global health initiatives capacity building training trust building collaboration health providers dialogue community COVID19 vaccination program powerful strategy advance World Health Organization WHO goals",
        "mesh_terms": [
            "Humans",
            "COVID-19 Vaccines",
            "COVID-19",
            "Leadership",
            "Vaccination Hesitancy",
            "Patient Acceptance of Health Care",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770695/"
    },
    {
        "pmid": "40770596",
        "title": "Influenza vaccination uptake of health care workers in a tertiary hospital: Findings from qualitative research in Mysuru, India.",
        "abstract": "Vaccinating health care worker HCWs common way prevent influenzarelated infection transmission patient absenteeism HCWs India influenza contributes 130000 death per year yet vaccination uptake HCWs low Fifteen percent HCWs received one vaccination 5 years study explored social context influenza vaccine uptake among HCWs including physicians nurse medical student teaching hospital Mysuru South India generate insight inform influenza vaccination campaign targeting HCWs Qualitative methods including indepth interview HCWs structured observation various department hospital applied result indicate influenza vaccination uptake among HCWs low due personal factor related little perceived personal threat emphasis prevention technique avoid transmission cost vaccine needle anxiety Besides institutional factors absence recommendation superior lack promotion campaign contribute low uptake conclusion HCW vaccination education promotion regarding diminishing personal transmission risk influenza virus uniform vaccination guideline strategy improve access including burdened cost vaccine suggested",
        "mesh_terms": [
            "Humans",
            "India",
            "Influenza, Human",
            "Influenza Vaccines",
            "Qualitative Research",
            "Tertiary Care Centers",
            "Female",
            "Male",
            "Adult",
            "Health Personnel",
            "Vaccination",
            "Interviews as Topic",
            "Attitude of Health Personnel",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770596/"
    },
    {
        "pmid": "40770333",
        "title": "Evaluation of risk factors for poor wound healing after cesarean delivery in patients with gestational diabetes mellitus: a retrospective study.",
        "abstract": "Poor wound healing PWH significant complication following cesarean deliveries particularly patient gestational diabetes mellitus GDM due hyperglycemiainduced immune dysfunction impaired wound healing Identifying specific risk factor essential developing effective preventive strategy improving maternal outcomes retrospective study conducted January 2020 August 2023 followed STROBE guidelines total 268 GDM patient underwent cesarean delivery included 5 lost followup yielding 982 followup rate Patients divided two groups PWH group n  26 control group n  242 Comprehensive data maternal age gestational age prepregnancy BMI IVFET use uterine scarring surgery type emergency vs elective operative time infection Candida albicans Group B Streptococcus collected Statistical analysis included Chisquare Fishers exact tests multivariate logistic regression identify independent risk factor PWH overall incidence PWH 97 majority superficial infections including suture reaction 385 bleeding exudation 308 abscess 154 fat liquefaction 115 Deep infection rare 38 presenting endometritis case pelvic abscess Multivariate logistic regression identified following significant independent risk factor PWH premature rupture membrane OR  1088 95 CI 1707125 P  0002 Candida infection OR  577 95 CI 1891865 P  0003 emergency cesarean delivery OR  232 95 CI 102548 P  0047 scarred uterus OR  368 95 CI 143939 P  0006 prolonged operative time ≥ 1 h  255 95 CI 102373 P  0031 Prolonged operative time premature rupture membrane PROM emergency cesarean delivery uterine scarring identified independent risk factor PWH GDM patients Candida infection also showed statistical association based limited case number interpreted cautiously Targeted perioperative strategy may help reduce PWH risk population",
        "mesh_terms": [
            "Humans",
            "Female",
            "Retrospective Studies",
            "Pregnancy",
            "Cesarean Section",
            "Diabetes, Gestational",
            "Adult",
            "Risk Factors",
            "Wound Healing",
            "Postoperative Complications",
            "Surgical Wound Infection"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770333/"
    },
    {
        "pmid": "40765649",
        "title": "Cyclic Thrombocytopenia Treated With Platelet Transfusion and Oral Preparation Containing Hyaluronic Acid (Oralvisc).",
        "abstract": "Cyclic thrombocytopenia CTP rare disorder characterized periodic platelet fluctuation substantial amplitude low high Currently standardized guideline treatment patient CTP generally respond standard ITP treatments including corticosteroids splenectomy intravenous immunoglobulin present case chronic CTP failed multiple therapy used immune thrombocytopenia resolution mucocutaneous bleeding supportive platelet transfusion platelet nadir Eventually patient normalization platelet count applied oral preparation containing hyaluronic acid Oralvisc concomitant osteoarthritis effect Oralvisc platelet count retained discontinuation drug suggest supportive platelet transfusion nadir thrombocytopenia effective management option symptomatic patients Antiinflammatory medications suppressing bradykinin leptin may applied alleviate platelet fluctuation improve symptoms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765649/"
    },
    {
        "pmid": "40765002",
        "title": "Neisseria Meningitidis Carriage Among Hajj and Umrah Pilgrims: A Systematic Review and Meta-Analysis.",
        "abstract": "Meningococcal meningitis MM caused bacterium Neisseria meningitidis represents considerable public health concern Hajj Umrah pilgrimages mass gathering close quarter associated event create environment enhances transmission potentially lifethreatening infection Despite mandatory vaccination policies concern persist regarding carriage rate potential outbreaks heightened several factors systematic review singlearm metaanalysis aimed evaluate carriage Neisseria meningitidis NM vaccination status among pilgrims systematic review metaanalysis conducted according PRISMA guidelines focusing Muslim pilgrim nationality participated mass gathering Hajj Umrah Makkah Saudi Arabia performed comprehensive search four electronic database PubMed Scopus Web Science Cochrane Central Register Controlled Trials inception April 2024 Eligible study reported N meningitidis carriage prevalence serogroups vaccination status among Hajj Umrah pilgrims primary outcome measured overall carriage prevalence Neisseria meningitidis determined time assessment Data synthesized using randomeffects models 417 study initially screened 21 study 23552 participants included systematic review metaanalysis consisted nine studies carriage prevalence NM Hajj 16 increasing 34 Hajj Prior Hajj estimate serogroup W recorded 0003 95 CI 0001 0006 0068 95 CI 014 015 respectively Following Hajj estimate shifted 0001 95 CI 0000 0002 serogroup 0072 95 CI 0037 0108 serogroup W Vaccination status varied gap among domestic pilgrims along presence ciprofloxacin resistance certain strains Saudi Arabias commendable sustained commitment proactive prevention strategy Hajj Umrah reduced Neisseria meningitis cases Nonetheless carriage variability rising antimicrobial resistance Neisseria meningitidis highlight need enhanced surveillance alternative prophylaxis strategy highrisk populations finding study remain inconclusive due significant heterogeneity underscore need comprehensive wellstructured primary study gather strong evidence",
        "mesh_terms": [
            "Humans",
            "Neisseria meningitidis",
            "Saudi Arabia",
            "Islam",
            "Meningitis, Meningococcal",
            "Carrier State",
            "Mass Gatherings",
            "Meningococcal Vaccines",
            "Prevalence",
            "Meningococcal Infections",
            "Crowding"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765002/"
    },
    {
        "pmid": "40764930",
        "title": "Repair of infarcted myocardium by skeletal muscle-derived mesenchymal stromal cells delivered by a bioprinted collagen patch.",
        "abstract": "Mesenchymal stromal cell MSC commonly investigated postinfarction cardiac repair angiogenic antiinflammatory immunomodulatory properties However autologous source bone marrow adipose tissue require substantially invasive harvest procedure allogeneic MSC cord raise issue batch batch variability study assessed effect another underinvestigated cell source skeletal muscle whose autologous MSC feature clinically appealing advantage retrievable minimally invasive microbiopsy MSC differentiated induced pluripotent stem cell iPSC selected control also look clinically attractive high scalability high degree reproducibility vitro musclederived md MSC exhibited typical MSC feature including trilineage differentiation potential robust angiogenic antiinflammatory antifibrotic immunemodulatory effects Overall outperformed iPSCMSC raised safety concern linked persistence pluripotencyassociated markers thus chosen subsequent vivo evaluation rat model left ventricular LV dysfunction induced ischemiareperfusion end mdMSC embedded collagen bioprinted gel resulting epicardiallydelivered patch significantly improved LV ejection fraction compared cellfree patch shamoperated controls Transcriptomic analysis revealed benefit accompanied downregulation fibrosis apoptosis inflammationrelated genes exploratory proofofconcept study thus suggests mdMSC offer attractive alternative combine autologous origin minimally invasive harvest procedure Bioprinting cell collagen bioink allows generate patch endowed cardioreparative properties",
        "mesh_terms": [
            "Mesenchymal Stem Cells",
            "Myocardial Infarction",
            "Animals",
            "Mesenchymal Stem Cell Transplantation",
            "Rats",
            "Collagen",
            "Cell Differentiation",
            "Muscle, Skeletal",
            "Induced Pluripotent Stem Cells",
            "Male",
            "Bioprinting",
            "Humans",
            "Myocardium"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764930/"
    },
    {
        "pmid": "40764083",
        "title": "Association between initial lipid and lipoprotein levels, oxidative stress indicators and clinical efficacy of intravenous methylprednisolone in moderate-to-severe thyroid-associated ophthalmopathy: protocol for a real-world prospective cohort study.",
        "abstract": "Thyroidassociated ophthalmopathy TAO common orbital disease adults autoimmune disease orbital periorbital tissues Typical ocular symptom TAO include periorbital oedema conjunctival congestion oedema eyelid retraction exophthalmos restrictive strabismus etc Hypercholesterolaemia considered one modifiable risk factor TAO However unclear whether lipid level related TAO activity severity intravenous glucocorticoid GC therapeutic effect study aim evaluate association initial lipid lipoprotein levels clinical feature TAO efficacy intravenous methylprednisolone patient moderatetosevere TAO well explore oxidative stressrelated mechanism involved realworld prospective cohort study recruit 178 patient moderatetosevere TAO receive two intravenous methylprednisolone regimens respectively primary outcome improvement composite index 3 month baseline treatment secondary outcome including ocular features change serological characteristic major adverse events study protocol approved ethic committee Xiangya Third Hospital Central South University Kuai241012 29 November 2024 study conducted according guideline Declaration Helsinki Participants informed purpose content study complete written informed consent form recruited finding published peerreviewed journal well report relevant conferences Chinese Clinical Trial Registry ChiCTR2400094094 Registered 17 December 2024",
        "mesh_terms": [
            "Humans",
            "Graves Ophthalmopathy",
            "Methylprednisolone",
            "Prospective Studies",
            "Oxidative Stress",
            "Glucocorticoids",
            "Lipids",
            "Lipoproteins",
            "Adult",
            "Administration, Intravenous",
            "Treatment Outcome",
            "Severity of Illness Index",
            "Female",
            "Male",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764083/"
    },
    {
        "pmid": "40763975",
        "title": "[Analysis of a child with Congenital leukemia and mosaicism trisomy 21 syndrome without GATA1 gene mutation].",
        "abstract": "explore genetic characteristic pathogenesis child mosaicism trisomy 21 Congenital leukemia CL child admitted Ningbo Women Childrens Hospital March 2023 selected study subject retrospective analysis carried clinical data laboratory test results immunophenotyping genetic characteristic child study approved Medical Ethics Committee Hospital Ethics No EC2024063 Whole genome sequencing WGS revealed child mosaicism trisomy chromosome 21 ratio approximately 74 addition copy number variation involving multiple OMIM gene could explain clinical phenotype detected rated pathogenic based guideline American College Medical Genetics Genomics ACMG pathogenic variant detected GATA1 gene Blood immune typing child conformed immunophenotype acute myeloid leukemia child trisomy 21 even absence GATA1 gene variants occurrence CL monitored early diagnosis treatment great significance improving prognosis",
        "mesh_terms": [
            "Child, Preschool",
            "Humans",
            "DNA Copy Number Variations",
            "Down Syndrome",
            "GATA1 Transcription Factor",
            "Leukemia",
            "Mosaicism",
            "Mutation",
            "Retrospective Studies",
            "Whole Genome Sequencing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763975/"
    },
    {
        "pmid": "40760409",
        "title": "Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring.",
        "abstract": "Acute respiratory tract infection ARI including COVID19 significant global health challenge pandemic potential Understanding factor influencing ARI susceptibility severity different population crucial pandemic preparedness mitigation investigated epidemiological risk factor COVID19 susceptibility severity Israeli population Participants took COVID19 PCR test July 2021 August 2022 completed online survey including demographics comorbidities infection vaccination status identified factor associated SARSCoV2 infection disease severity using logistic regression compared result global literature included 2128 participants 823 participant tested positive SARSCoV2 Individuals without COPD BMI  30 higher infection odds aOR  621 95 CI1422725 aOR  154 95 CI102232 respectively High schoollevel education associated increased susceptibility severity compared higher education aOR  155 95 CI11218 aOR  280 95 CI 162486 respectively Hospitalization associated older age p  0001 Vaccination 3 dos significantly reduced infection hospitalization risk compared unvaccinated aOR  0024 95 CI0016004 aOR  037 95 CI 017081 respectively p  005 Compared Arab participants Jewish one less likely infected aOR  148 95 CI102215 p  005 Identified risk factor consistent metaanalyses study countries Similar countries minority group found higher risk therefore risk model predicting ARI susceptibility severity take account",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Male",
            "Female",
            "Middle Aged",
            "Risk Factors",
            "Israel",
            "Adult",
            "Aged",
            "SARS-CoV-2",
            "Severity of Illness Index",
            "Disease Susceptibility",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760409/"
    },
    {
        "pmid": "40760155",
        "title": "Network epidemiological analysis of COVID-19 transmission patterns by age, occupation and residence across four waves in Cyprus.",
        "abstract": "Complex transmission pattern immediately obvious epidemiologists hindering development effective intervention strategies aim develop networkbased tool identify transmission pattern across agegroups occupations locations Infection network constructed using COVID19 contact tracing data provided Cyprus Ministry Health March 2020 May 2021 Transmission pattern withinacross agegroups districts economic activities well presence superspreaders vulnerability different groups assessed using constructed network first four pandemic waves constructed network wave sparse Network analysis showed first wave primarily involved older individual healthcare settings second wave higher infection rate among young adult observed dominant transmission pattern third fourth wave existed i individual similar ages commonly interact ii individual age difference  30 year ie generational gap Crossdistrict pattern revealed transmission likely occur district nearest geographically also followed social trends Furthermore study identified vulnerable occupations Outdegree representing number secondary infection caused individual also investigated pandemic progressed decreased outdegree among older age group 50  likely reflected positive effect vaccination immunity contrast rising value among younger individual probably reflected fewer vaccination active social interactions Age district occupation pattern transmission superspreader concentration guide targeted intervention strategies prioritize vaccination efforts support decisionmaking effective control prevention pandemics",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Cyprus",
            "Adult",
            "Middle Aged",
            "Contact Tracing",
            "Young Adult",
            "Occupations",
            "Male",
            "Adolescent",
            "SARS-CoV-2",
            "Female",
            "Age Factors",
            "Aged",
            "Child",
            "Pandemics",
            "Child, Preschool",
            "Infant"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760155/"
    },
    {
        "pmid": "40759335",
        "title": "Global Approach for Severe Cutaneous Adverse Reactions (GRASS) Survey.",
        "abstract": "Consensus guideline outline recommended management delayed drug hypersensitivity reaction DHR clinical practice largely expertbased may vary significantly across population regions study evaluated approach management healthcare specialist globally regarding DHR including severe cutaneous adverse reaction SCARs assess current practices knowledge availability allergy testing DHR including SCARs among relevant healthcare professional globally GRASS Global AppRoAch Severe Cutaneous Adverse Reactions Survey study prospective webbased survey conducted using Research Electronic Data Capture REDCap platform 10 15minute survey directed 14 allergyimmunology dermatology association international mailing list across 48 countries Among 8561 member contacted answer 130 healthcare provider practicing six continent analyzed respondent identified Caucasian 88130 68 female 79130 61 representing range age group clinical expertise practiced dermatology 69130 53 followed allergyimmunology 46130 354 based urban setting 127130 98 Among 45 respondent 346 managed SCARs 27 60 access multidisciplinary care Practices varied widely clinical phenotype example maculopapular exanthema 63 respondent indicated treating reaction 63130 49 16 1613012 offered desensitization patient education followup 60 60130 462 participant organized followup implicated specialist Significant variability management DHR observed among respondents result highlight need evidencebased protocol standardize guideline managing DHRs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759335/"
    },
    {
        "pmid": "40755993",
        "title": "How Do Polymorphonuclear Counts in Ascitic Fluid Correlate to Hospital Outcome.",
        "abstract": "Polymorphonuclear neutrophil PMNs critical mediator innate immune response level ascitic fluid pivotal diagnosing spontaneous bacterial peritonitis SBP particularly patient liver cirrhosis retrospective study investigates association varying PMN count ascitic fluid hospital outcomes including mortality 30day readmission rates length stay LOS analyzed deidentified data HCA Healthcare hospital July 2013December 2023 focusing patient aged 18 older diagnosis liver cirrhosis underwent paracentesis Patients categorized based PMN count three grouping assess clinical outcomes finding suggest lower PMN count correlate increased mortality particularly group count ≤100 ≤200 cellsmmsup3sup Conversely higher PMN count 201249 cellsmmsup3sup associated reduced odds mortality 30day readmission demonstrated complex associations higher count also linked increased readmission risk highest subgroup Interestingly LOS showed significant difference across PMN levels study underscore nuanced role PMN count prognostication treatment decision cirrhotic patients Given emerging literature questioning strict PMN diagnostic threshold SBP result advocate reconsideration current guideline optimize patient management outcomes investigation warranted delineate implication PMN level context antimicrobial therapy broader clinical strategy liver disease management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755993/"
    },
    {
        "pmid": "40755013",
        "title": "The contribution of minimally invasive tissue sampling compared to antemortem-derived cause of death determination among inpatient child deaths: the minimally invasive tissue sampling in Malawi study.",
        "abstract": "Improved cause death CoD understanding low middleincome country needed reduce child mortality Compared full autopsy minimally invasive tissue sampling MITS using transcutaneous needle sampling feasible socially acceptable validated method aimed quantify additional contribution MITS CoD attribution based clinical record inpatient research data intensive patient characterisation enrolled child aged seven day 59 month died admission acute illness andor severe malnutrition Queen Elizabeth Central Hospital Blantyre Malawi Standard MITS procedure included histologic immunohistochemical microbiologic testing Phase 1 CoD determination based medical record alone Phase 2 also included research data Phase 3 included data including MITS enrolled 29 children Based clinical note alone Phase 1 identified 60 causal 39 contributing conditions 45 45 infectious conditions pathogen identified 15 33 one patients 3 CoD unchanged compared including data Phase 3 Further identified 69 new n  43 adjusted n  26 diagnosis among 28 case 97 majority undernutritionrelated n  22 32 infectious n  41 59 conditions Overall majority final Phase 3 condition also undernutritionrelated n  46 32 infectious n  61 43 pathogen identified 54 89 infectious conditions Klebsiella pneumoniae prevalent aetiology pneumonia sepsis addition MITS clinical inpatient research data led almost 97 case receiving new andor refined diagnoses including microbe identification infectious conditions Pathogens specifically addressed current clinical guidelines Klebisiella pneumoniae commonly identified finding support utility MITS understand CoD even thorough clinical characterisation child hospitalisation",
        "mesh_terms": [
            "Humans",
            "Malawi",
            "Infant",
            "Male",
            "Female",
            "Child, Preschool",
            "Cause of Death",
            "Infant, Newborn",
            "Autopsy",
            "Child Mortality",
            "Specimen Handling",
            "Inpatients"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755013/"
    },
    {
        "pmid": "40751830",
        "title": "Treatment of refractory non-small cell lung cancer with combined infusion of modified CIK cells and PD1 antibody: safety and efficacy.",
        "abstract": "evaluate safety efficacy modified CIK cell combined PD1 antibody treatment refractory nonsmall cell lung cancer NSCLC Fifteen patient refractory NSCLC treated hospital recruited clinical study January 2015 December 2020 patient disease progression completing routine treatment Two 12 patient achieved partial remission 6 stable disease 4 progressive disease serious side effect occurred percentage helper NKTlike cell patient increased significantly immunotherapy P  005 addition antitumor cytokine IL2 INFγ increased significantly P  005 Although antiinflammatory cytokine IL10 change markedly immunotherapy P  005 Karnofsky Performance Scale improved Umbilical cord blood mononuclear cell induced NKTlike cells Induced NKTlike cell powerful cytotoxicity tumor cell line vitro combined PD1 antibody Immunotherapy also significant therapeutic effect refractory NSCLC serious side effect vivo",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Non-Small-Cell Lung",
            "Male",
            "Female",
            "Lung Neoplasms",
            "Middle Aged",
            "Cytokine-Induced Killer Cells",
            "Programmed Cell Death 1 Receptor",
            "Aged",
            "Treatment Outcome",
            "Adult",
            "Cell Line, Tumor",
            "Immunotherapy, Adoptive"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751830/"
    },
    {
        "pmid": "40750869",
        "title": "Association between the systemic immune-inflammation index and anemia among US children: national health and nutrition examination survey (NHANES), 2001-2018.",
        "abstract": "study aimed investigate correlation Systemic immuneinflammation index SII anemia prevalence children study employed crosssectional design analyzing data 8157 participant aged less 18 years SII calculated platelet count×neutrophil countlymphocyte count Anemia defined using World Health Organization WHO guideline based normal hemoglobin HGB value different age genders Logistic regression analyses subgroup analysis sensitivity analysis performed investigate relationship SII anemia study included total 8157patients 409 50 anemia multivariate logistic regression analysis showed higher level SII associated higher risk developing anemia OR  169 95 CI 127225 p  001 relationship SII anemia followed linear patternpvalue nonlinearity005 Subgroup analysis showed significant dependence gender race family size Povertyincome ratio PIR asthma diabetes vitamin except age positive association Furthermore sensitivity analysis confirmed robustness results finding indicate SII level positively linked anemia children Monitoring SII level may facilitate early identification highrisk pediatric anemia groups enabling targeted interventions SII could costeffective simple anemia identification tool though need confirmation via prospective studies approach hold potential enhancing public health policy child health management",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Anemia",
            "Child",
            "Inflammation",
            "Child, Preschool",
            "Nutrition Surveys",
            "United States",
            "Adolescent",
            "Prevalence",
            "Infant",
            "Platelet Count"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750869/"
    },
    {
        "pmid": "40750850",
        "title": "Antimicrobial prescribing patterns among pediatric outpatient encounters in primary healthcare centers in Bujumbura Mairie, Burundi.",
        "abstract": "Understanding prescribing pattern essential developing targeted intervention promote rational antimicrobial use study evaluated antimicrobial prescribing pattern among pediatric outpatient primary healthcare center PHCs Bujumbura Mairie republic Burundi conducted crosssectional study 20 PHCs Bujumbura Mairie Republic Burundi evaluate antimicrobial prescribing patterns collected retrospectively 2022year data medical record using World Health OrganizationInternational Network Rational Use Drugs WHOINRUD core drug indicators According guidelines minimum sample size 600 prescription recommended assess drug use indicators meet requirement total 800 paediatric outpatient prescription sampled Prescriptions inpatient excluded total 497 621 800 prescription contained antimicrobials far exceeding recommendation 20268 Younger patients particularly child five received highest proportion antimicrobial prescription 156 Although generic prescribing 950 adherence National Essential Medicine Lists NEML 958 high fell short benchmark 100 prescription followed monotherapy 928 low average 11 antimicrobial per prescription WHO guideline 1618 Although Accessgroup dominated 713 Watchgroup usage 253 surpassed recommended threshold  20 nonrecommended fixeddose combination also prescribed 34 addition 262 prescription lacked documented indications present study highlight strong adherence essential medicine list generic antimicrobial use However finding also reveal area improvement including need documentation indication reduction utilization Watch group antibiotic use optimize antimicrobial use prevent AMR Burundis paediatric population national research healthcare worker training diagnostics antimicrobial stewardship implementation necessary",
        "mesh_terms": [
            "Humans",
            "Burundi",
            "Cross-Sectional Studies",
            "Child, Preschool",
            "Child",
            "Primary Health Care",
            "Practice Patterns, Physicians'",
            "Infant",
            "Male",
            "Female",
            "Retrospective Studies",
            "Anti-Infective Agents",
            "Adolescent",
            "Drug Prescriptions",
            "Infant, Newborn",
            "Anti-Bacterial Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750850/"
    },
    {
        "pmid": "40750724",
        "title": "Role of Antidrug Antibodies in Oncolytic Viral Therapy: A Dynamic Modelling Approach in Cancer Patients Treated with V937 Alone or in Combination.",
        "abstract": "Oncolytic virus OVs growing immunooncology therapeutic class rely capability activate dormant endogenous antitumor immune response order control eradicate tumor cells Given intrinsic mechanism action biological nature development antidrug antibody ADA represents important aspect consider clinical evaluation ADAs potentially affect viral kinetics andor dynamics ultimately resulting reduction even loss drug efficacy Here present semimechanistic pharmacokineticpharmacodynamic model characterizing interplay V937 neutralizing ADA cancer patient receiving V937 oncolytic virus quantitative framework developed integrating viral load ADA titer 208 cancer patient received V937 following intratumoral intravascular administration monotherapy combination pembrolizumab model successfully captured V937 time course dynamic ADAs different settings showing meaningful impact ADAs viral kinetics Moreover tumor response neither affected preexistence development ADAs explained primary role immune system response quantitative semi mechanistic framework expanded oncolytic virus used explore scenario relevant impact could observed thus supporting development novel oncolytic viral therapies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750724/"
    },
    {
        "pmid": "40750284",
        "title": "Towards novel BIOmarkers to diagnose SEPsis (BIOSEP) in the emergency room: a protocol for a multicentre, prospective cohort study.",
        "abstract": "international Surviving Sepsis Campaign guideline highlight need recognising sepsis timely accurate manner Early diagnosis treatment sepsis crucial associated reduced mortality early stage sepsis heterogeneous clinical sign difficult interpret often leading missed delayed diagnoses well inappropriate late use antibiotics urgent need quickly accurately identify patient potential infection emergency department ED risk progressing along infectionsepsis spectrum study aim compare immune response ED patient presenting suspected infection without sepsis gain insight immune aberration identify novel biomarkers linked increased risk developing sepsis sequelae prospective observational cohort study across three hospital Netherlands conducted Adults presenting ED hospitals suspected infection Modified Early Warning Score 2 higher eligible enrolment aim include 3330 patients main study parameter characterisation host immune metabolic response using multiomics analysis Raman spectroscopy mass spectrometry gut microbiota profiling relation clinical outcome 30day mortality length hospital stay readmission postsepsis sequelae Verbal written informed consent obtained participant legal representatives study approved Amsterdam University Medical Centre Ethics Committee No 20220279 adhere Declaration Helsinki Medical Research Involving Human Subjects Act WMO Research result published peerreviewed journals ClinicalTrialsgov NCT06178822",
        "mesh_terms": [
            "Humans",
            "Biomarkers",
            "Emergency Service, Hospital",
            "Sepsis",
            "Prospective Studies",
            "Netherlands",
            "Multicenter Studies as Topic",
            "Observational Studies as Topic",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750284/"
    },
    {
        "pmid": "40748340",
        "title": "Genetic and Clinical Characteristics of Difficult-To-Treat Crohn's Disease: Trio-Based Exome Sequencing in 24 Families.",
        "abstract": "Difficulttotreat Crohns disease DTTCD represents critical unmet need inflammatory bowel disease IBD management However genetic architecture remain poorly understood aimed evaluate genetic characteristic clinical manifestation DTTCD case integrated triobased whole exome sequencing WES longitudinal phenotyping crosssectional cohort study DTTCD patient met International Organization Study Inflammatory Bowel Disease IOIBD criterion firstdegree relative underwent trioWES analysis Treatment persistence remission rate analyzed Genetic variant prioritized via cosegregation analysis American College Medical Genetics Genomics ACMG guidelines functional prediction algorithms Among 24 patient DTTCD 875 failed least two biologics 333 required dual targeted therapy drug persistence declined across treatment line p  00193 Remission rate suboptimal clinical 417 endoscopic 500 TrioWES analysis identified 15 likely pathogenic candidate variant across 12 genes including established monogenic IBD gene XIAP two novel variants pAsp247Glufs19 pSer43X two known variants pArg381X pArg238X genomewide association studiesimplicated IBD risk gene MAML2 PLA2R1 novel candidate variant KIZ LAMA5 SAMD9 etc potentially linked epithelialimmune dysregulation first trioWES study DTTCD reveals high prevalence monogenic XIAP deficiency 167 advocating genetic screening refractory cases Novel candidate gene implicate polygenic mechanism therapeutic resistance Familybased sequencing may used elucidate genetic background DTTCD case guide molecular diagnosis personalized therapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40748340/"
    },
    {
        "pmid": "40746762",
        "title": "The Impact of Holder Pasteurization on Macronutrients, Vitamins, Minerals, and Bioactive Factors in Human Milk Processed in a Milk Bank Setting.",
        "abstract": "Donor human milk recommended nutritionally vulnerable preterm infant however conflicting limited information pasteurization technique used donor milk influence nutritional immune properties Additionally prior pasteurization study often reflective volume equipment used milk bank settings limiting generalizability Evaluate impact Holder pasteurizationperformed milk bank setting using standardized preanalytical handling techniqueson energy macronutrients human milk oligosaccharides vitamins minerals antimicrobial protein content human milk Fifty matched pair raw Holderpasteurized milk sample collected pasteurized milk bank setting provided sampling frame pair unique approved milk bank donor Mothers Milk Bank North Texas total 29 nutrient bioactive factor assessed using variety analytical methods evidence minimal loss 15 copper calcium thiamine nonprotein nitrogen moderate loss immunoglobin concentration 35 extensive loss lactoferrin 80 Holder pasteurization minimal impact energy essential nutrient donor milk including macronutrients human milk oligosaccharides B vitamins minerals Moderate extensive loss antimicrobial protein warrant research alternative preservation techniques",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746762/"
    },
    {
        "pmid": "40745944",
        "title": "HPV vaccine reporting in Taiwan: media and politics, 2005-2018.",
        "abstract": "study analyzes medium coverage HPV vaccine Taiwan 2005 2018 focus adherence World Health Organization WHO medium guideline influence election cycle reporting patterns content analysis 911 article four major newspaper revealed peak 2008 2014 2018 election years coinciding vaccine policy rollouts article 78 percent appeared national news sections medical professional cited 363 percent cases Coverage primarily emphasized vaccine policy 363 percent health education 364 percent 83 percent article portraying HPV vaccination positively 88 percent explicitly endorsing it However 42 percent adhered WHOs medium communication guidelines headline often misaligned article content finding highlight medias advocacy role key political public health events underscoring need improved journalistic practice ensure accurate guidelineconsistent vaccine communication",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745944/"
    },
    {
        "pmid": "40745336",
        "title": "Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre.",
        "abstract": "Cervical cancer CC serious health issue especially low middleincome countries primarily caused human papillomavirus HPV infection particularly genotype 16 18 risk factor include smoking early sexual activity longterm oral contraceptive use Early detection cervical cytology HPV testing vital effective prevention study aimed analyze clinical epidemiological characteristic cervical intraepithelial neoplasia CIN HPVpositive woman Tehran teaching hospital focusing HPV genotype association CIN conducted crosssectional study HPVpositive woman underwent Pap smear testing HPV genotyping via realtime PCR colposcopy biopsy suspected lesions Risk factor like smoking alcohol consumption evaluated statistical analysis performed including ordinal logistic regression Among participants 524 abnormal CIN CIN 311 CIN II 114 CIN III 100 HPV16 prevalent genotype 437 significantly associated severe CIN outcome odds ratio OR  288 95 CI followed HPV18 OR  187 95 CI Smoking increased risk severe CIN OR  153 95 CI older age later age sexual debut correlated better CIN outcomes HPV16 smoking major predictor severe CIN highlighting need targeted intervention HPV vaccination smoking cessation along regular screening lower cervical cancer risks Additional research required evaluate persistence different HPV genotype progression CIN cervical cancer",
        "mesh_terms": [
            "Humans",
            "Female",
            "Papillomavirus Infections",
            "Cross-Sectional Studies",
            "Adult",
            "Genotype",
            "Middle Aged",
            "Uterine Cervical Neoplasms",
            "Uterine Cervical Dysplasia",
            "Iran",
            "Papillomaviridae",
            "Risk Factors",
            "Young Adult",
            "Incidence",
            "Papanicolaou Test"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745336/"
    },
    {
        "pmid": "40738551",
        "title": "Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort study.",
        "abstract": "International guideline recommend administration two dos preexposure hepatitis vaccination people chronic liver disease prevent severe complications aimed describe hepatitis vaccination coverage mortality adult chronic liver disease England retrospective cohort study using routinely collected medical record data OxfordRoyal College General Practitioners Research Surveillance Centre RSC primary care sentinel network included people aged 18 year older diagnosed chronic liver disease Jan 1 2012 Dec 31 2022 primary outcome interest hepatitis vaccination Hepatitis vaccination coverage calculated using number vaccinated people chronic liver disease numerator chronic liver disease population RSC dataset denominator compared individual characteristic vaccination status using descriptive statistics used multistate survival model estimate transition probability four states 1 diagnosis chronic liver disease 2 first hepatitis vaccination 3 second hepatitis vaccination 4 death 664 571 individual aged 18 year older chronic liver disease identified RSC sentinel network population 625 079 individual included analysis 625 079 individual chronic liver disease 13 875 2·2 received first hepatitis vaccination 3007 0·4 received second dose 732 5·3 13 875 vaccinated individual died 101 065 16·5 611 204 individual without vaccination died study period Adjusting death competing risk vaccination likely among younger age quintiles hazard ratio 5·46 95 CI 5·135·81 nonsmokers 1·59 1·541·65 resident urban area 1·28 1·211·35 individual higher socioeconomic status 1·06 1·031·10 individual diagnosis metabolic dysfunctionassociated steatotic liver disease MASLD 1·71 1·641·78 Individuals history harmful alcohol use 0·36 0·320·39 type 1 diabetes 0·46 0·360·57 chronic kidney disease 0·63 0·570·70 mental disorder 0·66 0·640·69 less likely vaccinated lowest risk mortality people chronic liver disease infectious autoimmune aetiology people MASLD Hepatitis vaccine uptake among people chronic liver disease England low disparity age location urban v rural socioeconomic status Steps taken reduce inequality vaccine administration GlaxoSmithKlines Investigator Sponsored Studies Program",
        "mesh_terms": [
            "Hepatitis A Vaccines",
            "Vaccination Coverage",
            "End Stage Liver Disease",
            "England",
            "Retrospective Studies",
            "Sentinel Surveillance",
            "Routinely Collected Health Data",
            "Humans",
            "Male",
            "Female",
            "Adolescent",
            "Young Adult",
            "Adult",
            "Middle Aged",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40738551/"
    },
    {
        "pmid": "40733752",
        "title": "Circulating Antibody's Role During Post-Exposure Prophylaxis, and Beyond for Rabies: A Review.",
        "abstract": "bBackgroundb Since introduction Pasteurs rabies vaccine 1885 rabies prophylaxis postexposure prophylaxis PEP widely administered globally recommendation World Health Organization WHO However 124 documented case PEP failure reported worldwide 1980 2023 Additionally sporadic medium report China showed occasional PEP failure 2017 2024 Rabies remains serious public health problem 150 country regions bMethodsb review summarize PEP procedure recommended Advisory Committee Immunization Practices ACIP WHO also analyze potential contributing factor PEP failure propose concept circulating antibodies discus role PEP Furthermore summarize key guideline clinical trial design US Food Drug Administration FDA Chinas Center Drug Evaluation CDE well latest development monoclonal antibody cocktail therapies bResultsb Adherence core PEP practices wound cleansing infiltration wound immunoglobulin mAbs administration vaccines broader societal involvement crucial preventing rabies infection cases highrisk exposure immunocompromised individuals provision circulating antibody highdose human rabies immune globulin HRIG mAbs utmost importance preventing PEP failure bConclusionsb Early highconcentration circulating antibody important preventing PEP failure Addressing global issue rabies requires involvement entire society collective effort tackle neglected disease achieve WHOs goal zero 30",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733752/"
    },
    {
        "pmid": "40733652",
        "title": "A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers.",
        "abstract": "Yellow fever YF acute hemorrhagic zoonotic disease cause severe liver damage renal failure hemorrhagic shock antiviral treatment available thus vaccination critical preventive measure Although World Health Organization WHO revised guideline regarding need booster vaccination YF rationale single vaccination provides sufficient longterm immunogenicity study evaluated longterm immunity Japanese adult received single dose YF vaccine study evaluated longterm persistence immunogenicity Japanese adult vaccinated YF vaccine observational study enrolled Japanese adult received single YF vaccination 5 year previously Blood sample collected confirming eligibility study serum level antiyellow fever virus YFVneutralizing antibody measured using 50 plaque reduction neutralization test PRNTsub50sub 65 participant comprised 35 male 30 females median age vaccination 34 years time YF vaccination registration 5 26 years participant remained seropositive even long time Statistical analysis showed correlation time elapsed since YF vaccination PRNTsub50sub result indicate single dose YF vaccine provides adequate longterm immunity Japanese adult booster vaccination routinely required finding strongly aid development travel medicine guideline optimization vaccination strategy reducing usage medical resource simplifying health requirement travelers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733652/"
    },
    {
        "pmid": "40731926",
        "title": "The Impact of Yes-Associated Protein 1 (YAP1) Expression Patterns in Locally Advanced Breast Cancer: Associations with Pathological Response and Tumor Features.",
        "abstract": "iBackground Objectivesi Hippo pathway via Yesassociated protein 1 YAP1 regulates cell proliferation apoptosis tissue regeneration Aberrant YAP1 activation linked tumor progression immune evasion various cancers including breast carcinoma despite conflicting evidence prognostic value Preclinical study explored drug targeting YAP1TEAD interactions therapeutic application limited iMaterials Methodsi study included 50 patient locally advanced breast cancer assessed multidisciplinary tumor board underwent neoadjuvant treatment per tumor subtype clinical guidelines Eligibility required pretreatment core biopsy posttreatment surgical resection samples Due absence residual tumor patient achieving complete pathological response posttreatment tissue available analyzable 30 patients YAP1 expression evaluated immunohistochemically nuclear cytoplasmic staining patterns ROC analysis identified cutoff YAP1 expression defining tumor ≥70 nuclear ≥80 cytoplasmic staining iResultsi YAP1 expression significant relationship tumor subtype ipi  0001 frequent HER2positive tumor 556 least frequent luminal tumor 111 YAP1 positivity significantly predicted axillary pathological complete response pCR ipi  001 YAP1positive patients 778 achieved axillary pCR compared 317 YAP1negative patients though YAP1 status breast pCR association insignificant ipi  007 MannWhitney U test indicated higher Ki67 value significantly associated positive YAP1 expression ipi  0028 contrast association ER PR status age tumor size Following treatment statistically significant change YAP1 expression nuclear staining decreasing ipi  0004 cytoplasmic staining increased ipi  0002 YAP1 significantly linked axillary pCR HER2 status Ki67 iConclusionsi Post treatment nuclear YAP1 decreased whereas cytoplasmic expression increased showing localization shift result suggest YAP1 may predict treatment response become future therapeutic target",
        "mesh_terms": [
            "Humans",
            "YAP-Signaling Proteins",
            "Female",
            "Breast Neoplasms",
            "Middle Aged",
            "Adaptor Proteins, Signal Transducing",
            "Transcription Factors",
            "Aged",
            "Adult",
            "Biomarkers, Tumor",
            "Immunohistochemistry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731926/"
    },
    {
        "pmid": "40731762",
        "title": "Multimodal Preoperative Management of Rectal Cancer: A Review of the Existing Guidelines.",
        "abstract": "Rectal cancer management necessitates rigorous multidisciplinary strategy emphasizing precise staging detailed risk stratification inform optimal therapeutic decisionmaking Obtaining accurate histological diagnosis initiating treatment essential Comprehensive staging integrates clinical evaluation thorough medical history analysis assessment carcinoembryonic antigen CEA levels computed tomography CT imaging abdomen thorax Highresolution pelvic magnetic resonance imaging MRI utilizing dedicated rectal protocols critical identifying recurrence risk delineating precise anatomical relationships Endoscopic ultrasound refines staging accuracy determining tumor infiltration depth earlystage cancers preoperative colonoscopy effectively identifies synchronous colorectal lesions earlystage rectal cancer T1T2 N0 M0 radical surgical resection remains standard care although transanal local excision selectively indicated certain T1N0 tumors contrast locally advanced rectal cancer T3 T4 N characterized microsatellite stability proficient mismatch repair optimally managed total neoadjuvant therapy TNT combine chemoradiotherapy oxaliplatinbased systemic chemotherapy Additionally tumor exhibiting high microsatellite instability mismatch repair deficiency respond favorably immune checkpoint inhibitor ICIs evaluation tumor response following neoadjuvant therapy utilizing MRI endoscopic assessments facilitates individualized treatment planning including nonoperative approach patient confirmed complete clinical response comply rigorous followup Recent advancement molecular characterization targeted therapies immunotherapy highlight significant evolution towards personalized medicine effective integration innovation requires enhanced interdisciplinary collaboration improve patient prognosis quality life",
        "mesh_terms": [
            "Humans",
            "Rectal Neoplasms",
            "Preoperative Care",
            "Neoadjuvant Therapy",
            "Practice Guidelines as Topic",
            "Combined Modality Therapy",
            "Neoplasm Staging",
            "Magnetic Resonance Imaging"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731762/"
    },
    {
        "pmid": "40731336",
        "title": "Clinical and immunological predictors of severe pertussis in children: a nomogram-based prediction model.",
        "abstract": "Despite widespread vaccination pertussis remains significant health concern especially infant young children Severe pertussis lead severe complications specific risk factors particularly immunological markers fully understood retrospective case analysis conducted January December 2023 Department Infection Tianjin Second Peoples Hospital Data collected 249 child pertussis 209 common 40 severe cases met inclusion criteria Clinical immunological parameter compared severe common pertussis groups Lasso regression multivariate logistic regression used identify independent risk factors nomogram prediction model constructed validated Key finding included demographic clinical difference severe common pertussis higher rate pneumonia longer hospital stays delayed vaccination severe group Immunological difference showed child severe pertussis altered level humoral cellular immune markers Risk factor severe pertussis included premature birth incomplete vaccination high white blood cell count altered lymphocyte profiles nomogram prediction model showed excellent performance Cindex 0899 strong discriminatory ability AUC  0899 Decision curve analysis demonstrated substantial clinical utility study highlight clinical immunological marker contribute severe pertussis children nomogram prediction model developed provides reliable tool early identification highrisk children improving clinical decisionmaking potential outcome pertussis management",
        "mesh_terms": [
            "Humans",
            "Whooping Cough",
            "Nomograms",
            "Male",
            "Female",
            "Retrospective Studies",
            "Infant",
            "Child, Preschool",
            "Risk Factors",
            "Severity of Illness Index",
            "Child",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731336/"
    },
    {
        "pmid": "40730889",
        "title": "Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma.",
        "abstract": "Immune checkpoint blockade ICB commonly used treatment modality cancer growing list oncologic indications Ototoxicity potential immunerelated adverse event ICB treatment risk hearing loss ICB remains unknown retrospective chart review sought identify individual received ICB available audiometric data treatment order identify clinically meaningful change hearing single center institutional chart review examined hearing function data patient underwent audiometry ICB treatment Measures included pure tone thresholds distortion product otoacoustic emission DPOAEs tympanometry word recognition scores Ototoxicity assessed using American SpeechLanguageHearingAssociation ASHA Common Terminology Criteria Adverse Events CTCAEv50 guideline applicable identified twelve individual newly diagnosed advancedstage Head Neck Squamous Cell Carcinoma HNSCC received neoadjuvant ICB clinical trial Eleven twelve 92 patient 8 male 4 female age 4179 years meet criterion hearing threshold changes One patient demonstrated 10 dB shift two consecutive frequency one ear meeting minimum ASHA criterion significant change Speech audiometry tympanometry identified difference speech understanding middle ear function preand posttreatment Variations DPOAE amplitude noted potentially indicating early outer hair cell damage despite stable audiometric thresholds small data set newly diagnosed advancedstage HNSCC appears low incidence significant hearing change following neoadjuvant ICB treatment Larger prospective study longterm followup needed evaluate lateonset ototoxicity Cancer survivor treated neoadjuvant immune checkpoint blockade advancedstage head neck squamous cell carcinoma HNSCC appear low risk acute hearing loss based study significant change hearing threshold observed subtle alteration cochlear outer hair cell function detected suggesting importance longterm monitoring capture potential delayed effect hearing insight help reassure patient immediate ototoxic risk highlighting need continued vigilance hearing assessment followup",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Middle Aged",
            "Adult",
            "Aged",
            "Retrospective Studies",
            "Squamous Cell Carcinoma of Head and Neck",
            "Immunotherapy",
            "Head and Neck Neoplasms",
            "Neoadjuvant Therapy",
            "Hearing Loss",
            "Hearing",
            "Immune Checkpoint Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40730889/"
    },
    {
        "pmid": "40729527",
        "title": "Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings.",
        "abstract": "panel clinicians subjectmatter experts guideline methodologists convened Alzheimers Association conducted systematic review formulated evidencebased recommendation using bloodbased biomarkers BBMs diagnostic workup suspected Alzheimers disease AD within specialized care settings scope focus individual objective cognitive impairment including mild cognitive impairment MCI dementia undergoing evaluation provider trained experienced memory disorders AD suspected underlying etiology panel conducted systematic review assess diagnostic accuracy BBMs detecting AD pathology BBMs interest included plasma phosphorylatedtau ptau amyloidbeta Aβ test measuring following analytes ptau217 ratio ptau217 nonptau217 ×100 ptau17 ptau181 ptau231 ratio Aβ42 Aβ40 reference standard test included cerebrospinal fluid CSF AD biomarkers amyloid positron emission tomography PET neuropathology panel applied Grading Recommendations Assessment Development Evaluation GRADE approach assess certainty evidence GRADE evidencetodecision EtD Framework develop recommendations key recommendation Clinical Practice Guideline CPG are 1 BBM test ≥90 sensitivity ≥75 specificity used triaging test 2 BBM test ≥90 sensitivity specificity serve substitute amyloid PET imaging CSF AD biomarker testing patient cognitive impairment presenting specialized care memory disorders panel caution user guideline significant variability diagnostic test accuracy many commercially available BBM test meet thresholds especially using single cutoff Additionally test serve substitute comprehensive clinical evaluation healthcare professional used part full diagnostic workup patient cognitive impairment presenting specialized care settings careful consideration pretest probability AD pathology CPG provides performancebased brandagnostic recommendation use BBMs diagnostic workup suspected AD within specialized care settings linking recommendation systematic review associated living updates using robust transparent methodology guideline ensures scientific rigor adaptability sustained relevance evidence evolves Clinicians encouraged stay informed emerging paradigmssuch biomarker combination ratio multithreshold testingthat may refine diagnostic accuracy BBMs field evolves",
        "mesh_terms": [
            "Humans",
            "Alzheimer Disease",
            "Amyloid beta-Peptides",
            "Biomarkers",
            "Cognitive Dysfunction",
            "Practice Guidelines as Topic",
            "tau Proteins",
            "Systematic Reviews as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40729527/"
    },
    {
        "pmid": "40722071",
        "title": "HIV/AIDS-related stigma and discrimination among healthcare providers in Western China: a population-based cross-sectional study.",
        "abstract": "persistence Human Immunodeficiency Virus HIV andor Acquired Immune Deficiency Syndrome AIDSrelated stigma discrimination healthcare setting remains critical issue urgently requires attention effectively control HIVAIDS epidemic study aimed evaluate extent HIVAIDSrelated stigma discrimination explore influencing factor among healthcare provider western China order inform decisionmaking regarding reduction stigma discrimination intervention crosssectional study conducted October 2023 July 2024 24646 with response rate 986 healthcare provider completed survey using concise standardized instrument including sociodemographic workrelated characteristics healthcare institutional policy guidelines attitude opinion people living Human Immunodeficiency Virus PLHIV well discriminatory behaviors Multivariate linear regression analysis performed assess influencing factor HIVAIDSrelated stigma discrimination among healthcare providers proportion healthcare provider expressing concern dressing wound drawing blood 651 603 respectively Approximately 40 participant believed PLHIV care infected others multiple sexual partners Healthcare provider experienced secondary stigma discrimination provision service PLHIV direct stigma discrimination PLHIV 671 respondent agreed PLHIV allowed baby wish 7198 indicated institution related policy guideline protect HIVAIDS patient discrimination HIVAIDSrelated discriminatory behavior higher among healthcare provider lower level education training worked private infectious disease hospital hospital inadequate policies provided face face service PLHIV higher level stigmatizing attitude P  005 HIVAIDSrelated stigma discrimination among healthcare provider prevalent western China factor identified study associated higher HIVAIDSrelated stigma discrimination may provide valuable insight mitigating negative associations coordinated multifaceted approach intervention need implemented effectively reduce HIVAIDSrelated stigma discrimination healthcare settings",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "China",
            "Male",
            "Social Stigma",
            "Female",
            "Adult",
            "Health Personnel",
            "HIV Infections",
            "Middle Aged",
            "Attitude of Health Personnel",
            "Surveys and Questionnaires",
            "Acquired Immunodeficiency Syndrome",
            "Young Adult",
            "Social Discrimination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722071/"
    },
    {
        "pmid": "40718704",
        "title": "A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights.",
        "abstract": "Ulcerative colitis UC pediatric patient often result corticosteroid CS dependency many individual developing resistance conventional treatment antiTNF agents Vedolizumab monoclonal antibody targeting α4β7 integrin shown promise adult populations data efficacy safety child adolescent limited systematic review aim assess effectiveness safety vedolizumab treating UC pediatric patients PRISMA statements guideline followed conducting systematic review December 2024 thorough search carried using keywords associated inflammatory bowel disease IBD vedolizumab pediatric population Cochrane Library EMBASE PubMed Case series child adolescent less 18 year old UC unclassified IBD treated vedolizumab included research Data clinical response mucosal healing corticosteroidfree remission clinical remission adverse event extracted Descriptive statistic used statistical analysis total 14 paper considered current evaluation effectiveness safety vedolizumab Nearly onethird 36 patient UCIBDU experienced clinical remission 6 weeks half patient 14 week 50 48 53 patient 22 weeks respectively Fortyfive percent patient maintained clinical remission 1 year Less 8 UCIBDU patient experienced serious side effects 1534 patient experienced mucosal healing Vedolizumab exhibit promising efficacy favorable safety profile treating pediatric UC sizable portion patient achieving clinical corticosteroidfree remission However due limited sample size lack investigations randomized controlled trial longterm research needed confirm finding develop reliable clinical guideline use child adolescent UC mean even initial finding promising additional better testing required ensure vedolizumab effective safe young patient UC PROSPERO registration number systematic review CRD420250651513",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718704/"
    },
    {
        "pmid": "40718360",
        "title": "Successful Treatment with Secukinumab in a Psoriasis Patient on Hemodialysis.",
        "abstract": "Moderate severe psoriasis reported independent risk factor IgA nephropathy IgAN IgAN characterized episodic microscopic hematuria progress endstage renal disease ESRD Managing therapeutic intervention psoriasis patient requiring dialysis due ESRD present significant challenges present case severe plaque psoriasis patient concurrently diagnosed IgAN dependent hemodialysis past two months condition worsened without identifiable triggers Physical examination revealed generalized scaly plaque scalp trunk extremities resulting Psoriasis Area Severity Index PASI score 192 Laboratory test confirmed endstage renal insufficiency abnormality detected Consequently patient prescribed subcutaneous secukinumab following standard regimen achieved complete resolution symptom eight week treatment experienced recurrence oneyear followup kidneyrelated parameter remained stable secukinumab therapy summarize case report discusses patient severe psoriasis also concurrent IgAN ESRD successfully treated secukinumab reinforces rapid efficacy enduring safety secukinumab managing psoriasis hemodialysisdependent patient IgAN comorbidity Zeno Fratton et al reported interleukin IL17AF inhibitor effectively treat moderatetosevere psoriasis patient chronic kidney disease CKD However study necessary develop evidencebased guideline biologic selection within vulnerable population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718360/"
    },
    {
        "pmid": "40714362",
        "title": "Short CIAFU recommendations on the screening and management of asymptomatic bacteriuria in immunocompromised patients.",
        "abstract": "Immunosuppression refers functional quantitative reduction immune defenses resulting diminished ability combat microbial pathogens Immunocompromised patient increased risk severe infections associated elevated morbidity mortality routine clinical practice urine culture often performed systematically patient considered risk infection regardless urinary symptoms aim detecting subsequently treating potential asymptomatic bacteriuria study aimed assess clinical relevance screening potentially treating asymptomatic bacteriuria immunocompromised individuals comprehensive literature search conducted using PubMed Medline without restriction language year publication complemented exploration scientific grey literature including expert report guideline professional societies Studies selected using following keywords antibiotic treatment urinary tract infection asymptomatic bacteriuria bacteriuria pyelonephritis cystitis immunodeficiency diabetes renal transplant neurogenic bladder cirrhosis pregnancy antimicrobial resistance abstract fulltext article reviewed synthesis finding subsequently evaluated member CIAFU expert committee formulated consensual recommendation possible Across reviewed literature clear benefit identified screening treating asymptomatic bacteriuria immunocompromised patients recommended screen treat asymptomatic bacteriuria immunocompromised patients except specific wellestablished scenarios Treating asymptomatic bacteriuria reduce infection risk rather increase likelihood adverse effect contributes development antimicrobial resistance associated morbidity mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714362/"
    },
    {
        "pmid": "40714040",
        "title": "Scientific and medical evidence informing expansion of hepatitis B treatment guidelines.",
        "abstract": "Chronic hepatitis B treatment relies nucleoside nucleotide analogue drug suppress hepatitis B virus HBV replication normalise liver enzymes slow disease progression excellent safety profiles Treatment curative patient remain risk cirrhosis hepatocellular carcinoma Treatment guideline generally restricted antiviral therapy individual high HBV DNA elevated ALT hepatic fibrosis often requiring longitudinal testing scarcely available resourcelimited settings Consequently fewer 3 people living HBV infection receiving antiviral therapy Guidelines China recently broadened access criterion antiviral therapy people fall outside guideline could still benefit treatment initiation pathological process induced HBV infection still active patients present benefit risk expanding treatment eligibility believe benefit reduced hepatic damage carcinogenic stimulus greatly outweigh risks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714040/"
    },
    {
        "pmid": "40714036",
        "title": "Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines.",
        "abstract": "Chronic hepatitis B associated considerable morbidity mortality worldwide People living hepatitis B face physical emotional social professional impacts reducing quality life Treatment nucleoside nucleotide analogue reduces risk liver cirrhosis liver cancer improves quality life However people globally offered access affordable longterm antiviral treatment Moreover little progress made towards meeting hepatitis B elimination targets global landscape shifting towards expanding treatment criteria discussion surrounding patient community perspective inadequate view treatment eligibility hepatitis B virus infection public health patientcentred approach Here discus potential benefit risk expansion implementation considerations public health questions data need surrounding expansion treatment eligibility conclude strong public health community rationale expanding treatment eligibility people living chronic hepatitis B",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714036/"
    },
    {
        "pmid": "40713827",
        "title": "Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhibitors: updated results from cohort 5 in the DUBHE-L-201 study.",
        "abstract": "Iparomlimab tuvonralimab QL1706 bifunctional antiprogrammed death1cytotoxic Tlymphocyte antigen4 antibody combination bevacizumab doublet chemotherapy tolerable showed preliminary antitumor activity advanced nonsmall cell lung cancer NSCLC DUBHEL201 study Here report updated data longterm survival prognosis safety cohort 5 Epidermal growth factor receptor EGFRmutant patient progressed EGFRtyrosine kinase inhibitor TKIs enrolled cohort 5 received QL1706 5 mgkg combined bevacizumab pemetrexed carboplatin threeweek cycle four cycle followed maintenance therapy QL1706 bevacizumab pemetrexed Survival outcome adverse event followed up July 5 2024 median duration response progressionfree survival PFS overall survival OS 31 patient cohort 5 1133 month 95 confidence interval CI 4171991 851 month 95 CI 5721331 2651 month 95 CI 1281not reached respectively 23 742 patient received subsequent anticancer therapy disease progression median PFS 1002 months median PFS 851 month vs 595 months P  0622 median OS 3019 month vs 1068 months P  0177 appeared longer patient 21L858R mutation compared 19Del although difference statistically significant Grade ≥ 3 treatmentrelated adverse event occurred 13 419 patients Nineteen 613 patient immunerelated adverse events one 32 grade ≥ 3 new safety signal observed QL1706 combining pemetrexed carboplatin bevacizumab showed longterm favorable prognosis manageable safety profile advanced EGFRmutant patient NSCLC failure EGFRTKIs",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Antibodies, Bispecific",
            "Antibodies, Monoclonal, Humanized",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Bevacizumab",
            "Carcinoma, Non-Small-Cell Lung",
            "Cohort Studies",
            "ErbB Receptors",
            "Lung Neoplasms",
            "Mutation",
            "Pemetrexed",
            "Protein Kinase Inhibitors",
            "Tyrosine Kinase Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40713827/"
    },
    {
        "pmid": "40711677",
        "title": "Utility of echocardiographic parameters in predicting cardiac immune-related adverse events in Japanese patients undergoing immune checkpoint inhibitor therapy.",
        "abstract": "Immune checkpoint inhibitor ICIs transformed cancer treatment associated immunerelated adverse events including cardiac immunerelated adverse event cardiac irAEs Early identification patient risk cardiac irAEs crucial echocardiographic parameter may serve valuable predictors study aimed evaluate predictive utility echocardiographic index assessing cardiac irAE risk Japanese patient receiving ICI therapy retrospective study analyzed patient treated ICIs University Fukui Hospital November 2015 October 2018 Cardiac irAEs defined according ESC guidelines Among 73 patients six 8 developed cardiac irAEs fatalities Echocardiographic assessment ICI initiation revealed patient later developed cardiac irAEs significantly lower ejection fraction EFs p  005 Receiver operating characteristic analysis demonstrated left ventricular endsystolic diameter LVDs area curve AUC  0660 EFs AUC  0797 moderate predictive value cardiac irAEs KaplanMeier analysis showed higher probability cardiac irAEs patient LVDs EFs beyond specific threshold p  001 Poisson regression analysis indicated decreasing risk cardiac irAEs time ICI initiation Baseline echocardiographic parameters particularly LVDs EFs useful predictor cardiac irAEs patient receiving ICI therapy Early echocardiographic evaluation may facilitate risk stratification improve monitoring strategy cardiac irAEs UMIN000023840",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40711677/"
    },
    {
        "pmid": "40711508",
        "title": "Cocoon Vaccination Among Mothers of Very Preterm Infants.",
        "abstract": "Preterm survivor risk acquiring communicable disease postdischarge Cocoon strategy immunization close contact prevent infection vulnerable individuals study assessed coverage cocoon vaccine among mother preterm infants retrospective study analyzed proportion mother preterm  30 weeks infant received eligible cocoon vaccine tetanus diphtheria acellular pertussis Tdap influenza varicella antenatal postnatal period Seventyfive 159 472 mother received three cocoon vaccines median postnatal age receiving vaccine 38 23 55 days Influenza Tdap vaccine administered 641 485 mothers respectively either antenatally postnatally 492 34 69 father covered cocoon vaccines Less 50 mother compliant cocoon vaccination protocol call intensive effort towards improving vaccine coverage among close contact highrisk infants",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40711508/"
    },
    {
        "pmid": "40705454",
        "title": "Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis.",
        "abstract": "Background  AimsLiver cirrhosis characterized chronic inflammation fibrosis Th17 cell playing crucial role progression Recent evidence suggests dietary salt influence immune disease modulating Th17 differentiation study assessed impact dietary salt Th17driven inflammation patient compensated cirrhosis explored effect liver injury mouse modelsMethodsA nondrug openlabel nonrandomized study involved 37 patient compensated cirrhosis given personalized guideline reduce salt intake three months Changes Th17driven inflammation liver function marker assessed baseline salt restriction parallel impact highsalt diet hepatic CD4 cell analyzed mouse model acute liver injury fibrosis ResultsHigh salt intake associated Th17mediated inflammation correlated marker impaired liver function patients Importantly moderating salt intake personalized nutritional intervention sufficient reduce CD4 cell mediated inflammation Furthermore analysis RNAseq data revealed enrichment saltinduced Th17 gene signature liver tissue peripheral cell patient liver disease Similarly mouse fed high salt diet showed hepatic enrichment Th17 cell exacerbated liver fibrosis upon injury Mechanistic study revealed high sodium condition activated NFκB induced IL6 production hepatocytes may promote Th17 responsesConclusionDietary salt exacerbates Th17driven inflammation contributes cirrhosis progression Salt reduction may represent viable therapeutic approach manage inflammation compensated cirrhosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40705454/"
    },
    {
        "pmid": "40705199",
        "title": "Proteomic profiling reveals dynamic regulation of vesicle trafficking across glioma grades.",
        "abstract": "Gliomas highly heterogeneous central nervous system tumor evolve progressive molecular reprogramming cell proliferation adhesion mechanism wellcharacterized contribution vesicle trafficking glioma progression remains underexplored study aimed characterize proteomic change across glioma grades performed untargeted quantitative proteomic profiling glioma tissue across grade IIV using combination Tandem Mass Tag TMT11plex labeling highresolution liquid chromatographymass spectrometry LCMS Tissue sample processed using filteraided sample preparation FASP analyzed using µPAC reversephase HPLC system coupled highresolution mass spectrometer Protein identification quantification conducted database searching validated stringent quality control criteria identified 4400 protein across samples revealing dynamic gradespecific shift vesicle trafficking Grade II glioma showed upregulation exocytic protein eg synaptotagmin syntaxin clathrin suppression dynamin suggesting enhanced vesicular secretion Grade III tumor exhibited opposite trendmarked downregulation exocytic component concurrent activation clathrinmediated endocytosis Grade IV glioma displayed hybrid profile partial reactivation exocytic machinery alongside sustained endocytic activity indicative vesicular plasticity study highlight synaptic vesicle cycle progressively remodeled pathway glioma biology finding suggest vesicle trafficking critical underrecognized feature glioma pathogenesis may represent novel axis therapeutic exploration",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40705199/"
    },
    {
        "pmid": "40699418",
        "title": "Guidelines for RNA Analysis by Reverse Transcription Quantitative Polymerase Chain Reaction.",
        "abstract": "Reverse transcription quantitative polymerase chain reaction RTqPCR stand essential molecular biology tool analyzing gene expression offering precise accurate measure gene expression levels significance critical unraveling cellular process deciphering complexity disease mechanisms chapter detail comprehensive methodology obtaining highquality RNA cell culture followed RNA extraction columnbased purification steps reverse transcription RT convert RNA complementary DNA cDNA quantitative PCR qPCR performed Protocols utilizing oligodT random hexamers cDNA synthesis described Furthermore employed two different assay qPCR TaqMan SYBR Green ensure thorough examination gene expression technique valuable resource researcher want study gene expression wide range biological contexts",
        "mesh_terms": [
            "RNA",
            "Reverse Transcriptase Polymerase Chain Reaction",
            "Humans",
            "Real-Time Polymerase Chain Reaction",
            "DNA, Complementary",
            "Gene Expression Profiling"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40699418/"
    },
    {
        "pmid": "40687163",
        "title": "Evaluation of acute flaccid paralysis surveillance system in Kebbi State, Nigeria between 2013-2018.",
        "abstract": "since 1988 polio incidence declined 99 globally 350000 annual case 125 endemic country transmission limited Pakistan Afghanistan Africa reported wild poliovirus since 2016 effective Acute Flaccid Paralysis AFP surveillance system crucial detecting interrupting polio transmission evaluation assessed Acute Flaccid Paralysis AFP surveillance system Kebbi State Nigeria identify operational gaps using updated Center Disease Control Prevention CDC guideline World Health Organization WHO performance standards study reviewed AFP surveillance data 20132018 conducted stakeholder interview using adapted questionnaire key informant interviews analyzed data using means frequencies proportions among 49 respondents 98 reported case definition investigation form easy use 97 found data tool adaptable changes surveillance officer understood AFP case definition expressed willingness sustain system Key performance indicators including nonpolio AFP rate 246552 stool adequacy 95997 timeliness reporting completeness consistently met standards evaluation concluded AFP surveillance system Kebbi State Nigeria useful simple flexible acceptable sensitive representative timely stable although donor dependency remains concern significant gap lack data 60day followup laboratory feedback Addressing issue important strengthen system",
        "mesh_terms": [
            "Nigeria",
            "Humans",
            "Poliomyelitis",
            "Population Surveillance",
            "Paralysis",
            "Incidence",
            "Surveys and Questionnaires",
            "Acute Disease",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40687163/"
    },
    {
        "pmid": "40685343",
        "title": "Impact of the new Japanese medical specialty system on residents' career choices in general medicine: a nationwide cross-sectional study.",
        "abstract": "General medicine GM formally recognized specialty Japan 2018 address need primary care Understanding factor influencing GM career choice critical recruitment However reforms impact career decisionmaking remains unclear study examined factor influencing GM career choice following introduction new specialty certification identified challenge field secondary analysis national survey data Ministry Health Labour Welfares questionnaire 20182020 clinical training graduate examined posttraining career intention specializing GM focusing factor influencing choice demographics education training contexts Multivariable logistic regression conducted posttraining GM preference dependent variable result expressed adjusted odds ratio aORs 95 confidence interval CIs Among 16674 complete responses 59 229 individual initially interested GM actually pursued posttraining Positive factor included regional quota aOR 310 95 CI 112856 ≤ 1 month GM rotation aOR 339 95 CI 1031114  2 month community medicine CM rotation aOR 1335 95 CI 2407658 desire primary care skill aOR 485 95 CI 2011173 community contribution aspiration aOR 688 95 CI 2751721 influential negative factor perceived ease specialization maintenance aOR 001 95 CI 000012 Among 16445 individual preferred specialties 86 switched GM Extended GM rotation 1≤2 months aOR 354 95 CI 206609 2 months aOR 741 95 CI 4561204 increased likelihood switching Academic interest aOR 036 95 CI 023058 perceived ease maintaining specialization aOR 013 95 CI 003054 negative factors GM rotation may positively influence career choices longer CM rotation potentially increasing interest Establishing clear career path educating resident physician academic characteristic GM remain challenging despite recognition specialty",
        "mesh_terms": [
            "Career Choice",
            "Humans",
            "Cross-Sectional Studies",
            "Japan",
            "Female",
            "Male",
            "Adult",
            "Internship and Residency",
            "General Practice",
            "Surveys and Questionnaires",
            "Specialization",
            "East Asian People"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685343/"
    },
    {
        "pmid": "40685137",
        "title": "Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis.",
        "abstract": "Immune thrombotic thrombocytopenic purpura iTTP thrombotic microangiopathy caused autoantibodymediated ADAMTS13 deficiency Historically splenectomy used multiply relapsing iTTP clinical remission lessen risk relapse treatment plasmarefractory plasmadependent iTTP evaluate effectiveness splenectomy relapse relapsing iTTP remission plasmarefractory palsmadependent iTTP conducted systematic review metaanalysis 2 question related splenectomy iTTP 1 patient relapsing iTTP effect splenectomy iTTP relapse rate 2 patient plasmarefractory plasmadependent iTTP proportion patient achieve clinical remission splenectomy Three electronic database Embase PubMed Scopus searched keywords related thrombotic thrombocytopenic purpura splenectomy screening completed following PRISMA guidelines Twentythree study included representing 62 patient with 2058 year followup underwent splenectomy relapsing iTTP 57 patient with 1739 year followup reported 3 studies underwent splenectomy plasmarefractorydependent iTTP patient underwent splenectomy relapsing iTTP 180 95 CI 266 095 fewer iTTP episode annually splenectomy compared splenectomy patient underwent splenectomy plasmarefractorydependent iTTP proportion patient achieving clinical remission 087 95 CI 076093 2 study included patient received rituximab lowquality evidence support use splenectomy multiply relapsing iTTP decrease relapse rate plasmarefractorydependent iTTP achieve remission noting evidence precedes routine use rituximab iTTP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685137/"
    },
    {
        "pmid": "40684150",
        "title": "COVID-19 infection and its association with severe malaria & dengue: an epidemiological study from Southern India.",
        "abstract": "PostCoronavirus Disease19 COVID19 sequela involve complex biological process alter progression clinical outcome infectious diseases However documented information influence COVID19 development severe malaria dengue Hence study conducted determine association malaria  dengue previous COVID19 infection among adult population Mangalore Taluk describe sociodemographic clinical correlate malaria  dengue casecontrol study conducted among 293 participant positive either malaria dengue November 2022 August 2024 Data collected using proforma contained section demographic details clinical profile comorbidities history COVID19 infection COVID19 vaccination status participant categorised severe disease mild moderate disease based operational definitions data analysed using Statistical Package Social Sciences SPSS version 29 Chisquare test done pvalue less 005 considered statistically significant Binary Logistic Regression analysis used odds ratio estimated total 293 participant included study mean age 367 SD148 years Among them 239 n  70 malaria 761 n  223 dengue malaria 30 n  21 developed severe illness whereas among dengue 358 n  80 developed severe dengue Overall 584 n  171 age group  30 years total 981 n  52 participant dengue fever history COVID19 infection developed severe dengue aOR5593 95 CI71743592 p  0001 compared without Similarly 857 n  12 participant history COVID19 infection developed severe malaria aOR 2637 95 CI 34919874 p  0001 compared difference found statistically significant addition participant belonging lower socioeconomic class higher chance developing severe dengue belonging upper socioeconomic class p  0001 prior history COVID19 infection higher chance developing severe malaria dengue without history COVID19 infection",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "India",
            "Male",
            "Female",
            "Adult",
            "Case-Control Studies",
            "Middle Aged",
            "Dengue",
            "Malaria",
            "SARS-CoV-2",
            "Young Adult",
            "Severity of Illness Index"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684150/"
    },
    {
        "pmid": "40684080",
        "title": "Characteristics of eclampsia not preceded by hypertensive disorders of pregnancy: a case control study.",
        "abstract": "Eclampsia traditionally considered complication hypertensive disorder pregnancy HDP However atypical case occur without preceding HDP pathophysiological mechanism remain unclear study aimed compare clinical feature eclampsia without prior HDP diagnosis retrospectively analyzed 31 singleton pregnancy eclampsia diagnosed nine Japanese perinatal center 2007 2023 Cases classified two groups eclampsia preceded HDP n  14 eclampsia preceded HDP n  17 Clinical characteristics laboratory findings perinatal outcome compared 31 case eclampsia 17 57 preceded HDP remaining case diagnosed HDP prior onset eclampsia eclampsia preceded HDP group compared eclampsia preceded HDP group BMI significantly lower 2207 ± 205 vs 2560 ± 619 kgmsup2sup P  0047 gestational week delivery significantly later median 400 320410 vs 375 260410 weeks P  0020 proportion male neonate significantly higher 588 vs 143 P  0024 comparing onset periodsantepartum intrapartum postpartumthe eclampsia preceded HDP group exhibited highest number case intrapartum period 9 cases eclampsia preceded HDP group showed highest number postpartum period 8 cases Furthermore eclampsia preceded HDP group white blood cell count significantly higher immediately onset 20626 ± 7956 vs 14687 ± 5664 μL P  0039 Atypical eclampsia without preceding HDP show distinct clinical features including later gestational age onset higher intrapartum incidence elevated inflammatory markers finding suggest need investigation alternative pathophysiological mechanism tailored clinical strategy cases",
        "mesh_terms": [
            "Humans",
            "Female",
            "Pregnancy",
            "Eclampsia",
            "Retrospective Studies",
            "Adult",
            "Hypertension, Pregnancy-Induced",
            "Case-Control Studies",
            "Infant, Newborn",
            "Male",
            "Gestational Age",
            "Japan",
            "Pregnancy Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684080/"
    },
    {
        "pmid": "40684072",
        "title": "Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper.",
        "abstract": "Respiratory infection major cause mortality among young child adults particularly elderly underlying medical conditions Many respiratory infections including influenza COVID19 pneumococcal disease respiratory syncytial virus RSV available vaccine antiviral agents However vaccine coverage rate remain low Experts representing broad spectrum medical specialty United Arab Emirates UAE made evidencebased recommendation treating patient considered high risk respiratory infections highlighting gap current practice suggesting strategy improved communication healthcare professional patients effectively manage respiratory infections expert emphasized importance adhering guidelines considering vaccine antiviral treatments strictly following vaccination schedules Early testing upon recognition symptom also encouraged Improving vaccine uptake considered crucial could achieved educating patient disease prevention vaccine role antiviral treatment COVID19 Addressing knowledge gap combating vaccine hesitancy among patient healthcare professional also essential steps Recommendations future initiative include healthcare professional educating public precautionary measure reduce spread respiratory infections Additionally expert agreed clinical management guideline chronic disease updated include preventative strategy vaccines prophylaxis counselling Monitoring performance healthcare facility using key performance indicator also recommended ensure effective management continuous improvement vaccination programs Patient population UAE considered high risk serious disease respiratory infection diverse medical need may access healthcare across wide range setting specialisms Therefore vital healthcare professional across specialism may engage individual able provide appropriate advice managing risk vaccination prompt testing treatment needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684072/"
    },
    {
        "pmid": "40681843",
        "title": "Peripartum sertraline impacts maternal neurobehavioral and neurodegenerative mechanisms in pregnant and postpartum mice.",
        "abstract": "Selective Serotonin Reuptake Inhibitors SSRIs among common medication used depression postpartum lactating people experience increased depression risk However limited understanding peripartum SSRI impact maternal neurobehavioral responses particularly sertraline prescribed SSRI United States US pregnancies administered C57Bl6 female sertraline via noninvasive naturalistic approach 167 mgL drinking water 2 week preconception lactation PND21 equivalent duration nonpregnant controls assessed behavior molecular brain change intrapartum postpartum 1 year age Chronic sertraline reduced depressive anxietylike behaviors Pregnancy decreased anxietylike hedonic behaviors RNA sequencing maternal brain revealed 52 differentially expressed gene DEGs frontal cortex sertraline DEGs overrepresented function related immunity contrast sertraline altered 962 target maternal hypothalamic paraventricular nucleus DEGs overrepresenting neurotransmission neurodegeneration discontinued sertraline aged animal approximately 1 year test neurodegenerative phenotypes one prior litter regardless peripartum sertraline improved aged females spatial learning memory Sertraline regardless postpartum status improved working memory Further found buffering neurodegenerationrelated gene network change increased excitatory synapse density hippocampus peripartum sertraline Peripartum sertraline alters maternal neurobiology behavior pregnancy beyond longterm benefit neurodegenerative processes Pregnancy also exerts own lasting effect learning memory finding might exploited future abrogate neurodegenerative disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40681843/"
    },
    {
        "pmid": "40678818",
        "title": "Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey.",
        "abstract": "Treating rheumatic musculoskeletal disease RMDs pregnancy breastfeeding present significant complexities mainly due inconsistency clinical guidance document reference safety information including summary product characteristic SmPC patient information leaflet PIL assess healthcare professionals HCPs prescribing behaviors comfort levels challenge advising patients focusing discrepancy clinical guidance document SmPCPIL Online survey entitled PRAISE Perception healthcare provider Regarding Antirheumatics pregnancy breastfeeding advice Information patient perSpEctives disseminated HCPs group social media crosssectional survey conducted among 414 HCPs globally Respondents divided prescribers ini  336 nonprescribers ini  78 based selfreported role prescribing antirheumatic medication pregnant breastfeeding patient RMDs survey covered demographics clinical experience confidence prescribing use clinical guidelines experience managing conflicting information guideline SmPCPIL Prescribers likely nonprescribers feel comfortable discussing medication safety pregnancy prescribers found clinical guidance document useful 48 rating very useful 38 extremely useful case conflicting information clinical guidance document SmPCPIL 58 HCPs reported caused confusion tension patientdoctor relationships almost 20 likely very likely discontinue ongoing treatment Clear communication shared decisionmaking common strategy used address patient concerns HCPs often face significant challenge advising patient RMDs use medication pregnancy breastfeeding Conflicting information clinical guidance document SmPCPIL disrupt patientdoctor relationship lead treatment discontinuation potential consequence maternal disease control Improved alignment clinical guidance document SmPCPIL could enhance patient care prevent confusion among HCPs patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678818/"
    },
    {
        "pmid": "40668326",
        "title": "COVID-19 Disruption and Maternal and Child Health Services: Evidence from India.",
        "abstract": "analyze impact COVID19 subsequent lockdown maternal child health service India investigate whether certain population group disadvantaged along social economic geographical dimension experienced differential impacts Utilizing unintended disruption fifth round National Family Health Survey NFHS V due nationwide COVID19 related lockdown create sample child mother exposed COVID19 pandemic lockdowns exposed use multivariable regression examine whether extent antenatal care pregnancy postpregnancy care exposed mother child adversely impacted compared unexposed exposed mother less likely receive two tetanus injections iron folic acid tablet pregnancy less likely stay medical facility 48 hour postdelivery recommended government guidelines critically exposed child lower probability receiving immunization due birth 6weeks 10weeks 14weeks magnitude decline increasing successive immunizations impact even adverse rural area reflected heterogeneity analysis COVID19 pandemic lockdown adversely affected MCH service India even rural India Policy intervention targeted specifically group impacted would needed restore MCH service prepandemic levels Applicable",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40668326/"
    },
    {
        "pmid": "40665314",
        "title": "Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment.",
        "abstract": "use immune checkpoint inhibitor ICI therapy increasing pediatric oncology ICIs cause rheumaticimmune related adverse event RhirAEs inflammatory arthritis myositis case report detail RhirAEs management pediatric population objective assess familiarity pediatric rheumatologist PRs worldwide RhirAEs gauge confidence managing conditions identify knowledge gap guide future educational efforts circulated online survey 2084 PRs via Dr Peter Dent Pediatric Rheumatology Bulletin Board Responses collected June 2024 September 2024 collected data practitioner demographics knowledge ICIs RhirAEs confidence managing RhirAEs preferred educational resources Sixtynine participant responded 55 80 PRs academic centers Despite global distribution 56 81 response came North America Thirtyfour 49 respondent aware ICIs related mechanisms indications side effects 40 58 familiar irAEs Fiftyfive 80 never managed patient RhirAEs Among 1469 21 median number case managed 20 IQR 00 Thirtynine respondent not confident all managing RhirAEs 34 not confident all managing preexisting autoimmune disease PAD ICI users 46 not confident all advising oncology colleague initiating discontinuing ICIs context RhirAEs preexisting autoimmune disease PAD respondent felt completely confident managing conditions Participants identified knowledge gap longterm management acute management recognition diagnosis Fortythree indicated need pediatricspecific clinical guidelines 14 respondent clinical experience treating RhirAEs treatment varied 4 using nonsteroidal antiinflammatory drugs 3 using prednisone 4 combining prednisone methotrexate Longterm management also varied 5 using methotrexate 3 using tumor necrosis factor inhibitors Significant knowledge gap lack confidence exist among PRs managing ICIrelated RhirAEs ICI use increase pediatric oncology PRs exposure RhirAEs follow Targeted educational program clinical guideline may valuable address gaps",
        "mesh_terms": [
            "Humans",
            "Immune Checkpoint Inhibitors",
            "Rheumatologists",
            "Child",
            "Needs Assessment",
            "Rheumatic Diseases",
            "Surveys and Questionnaires",
            "Male",
            "Female",
            "Rheumatology",
            "Pediatrics",
            "Clinical Competence",
            "Neoplasms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40665314/"
    },
    {
        "pmid": "40662744",
        "title": "Lessons learned from successful implementation of tetanus and diphtheria vaccination programs.",
        "abstract": "SUMMARYVaccines tetanus diphtheria known legacy vaccine developed 1920s long establishment modern immunology time Food  Drug Administration FDA still infancy Despite lacking technological advance today medical intervention represent two successful vaccine ever developed indicated incidence disease falling less one case tetanus per 10 million personyears approximately one case diphtheria per 1 billion personyears US population Here compare success tetanus diphtheria vaccination program common childhood vaccine review evidencebased approach adult booster vaccination schedules finding indicate completing childhood vaccination series decennial booster vaccination may longer needed maintain protective immunity general population Moreover updating current vaccination program remove adult decennial booster dos harmonize US recommendation guideline World Health Organization WHO may also improve riskbenefit ratio vaccination providing 1 billion annually healthcare savings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40662744/"
    },
    {
        "pmid": "40662276",
        "title": "Prevalence of hypertension in Africa in the last two decades: Systematic review and meta-analysis.",
        "abstract": "Despite common cardiovascular risk factor actual burden hypertension poorly characterized Africa metaanalyzed extensive pooled data determine overall prevalence hypertension Africa Following PRISMA guidelines systematically searched Google Scholar PubMed ScienceDirect Web Science database retrieve prevalence study hypertension among Africans published 2002 2023 Furthermore metaanalyzed crude ageadjusted prevalence hypertension using random effect model due expected high heterogeneity logit transformation original proportionsSeventyeight out initial 779 screened article complete data included total number hypertension case 71004 denominator population 286575 mostly communitybased study 23 countries pooled crude prevalence hypertension 28⸱5100 person 95 confidence interval CI 25⸱331⸱8 95 prediction interval 7⸱665⸱6 pooled prevalence increased age highest among aged ≥75 years 51⸱4 95CI 42⸱060⸱6 remained highest Southern Africa region overall 34⸱8 last decade 20132023 44⸱5 point estimate pooled crude prevalence higher among urban dwellers 32⸱9 95CI 26⸱839⸱5 rural residents 26⸱3 95CI 20⸱433⸱3 subset twentyone article reporting age stratification consistent standard population pooled agestandardized prevalence 27⸱2100 person 95CI 20⸱933⸱6 burden hypertension remains high especially urban area increasing age Frequent screening treatment recommended especially urban areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40662276/"
    },
    {
        "pmid": "40660196",
        "title": "Variation in measles seroprevalence among medical students based on place and year of birth: Ege University experience.",
        "abstract": "Measles despite vaccinepreventable disease remains significant global health concern crucial healthcare workers serve first line contact infected individuals properly immunized study aimed investigate change measles seroprevalence among Ege University Faculty Medicine student 2010 2024 Medical faculty student underwent antimeasles Immunoglobulin G screening Infectious Diseases Clinic Ege University Faculty Medicine Hospital İzmir Turkey January 1 2010 January 31 2024 included study demographic data participant recorded electronic patient files study included 1448 medical students 519 n  751 male mean age 2128 ± 148 years Measles seropositivity observed 461 participant n  668 Among born 1998 2004 seropositivity 238 whereas significantly higher 675 born 1986 1997 p  0001 Pearson correlation analysisof measles seroprevalence birth year revealed strong negative statistically significant relationship r0964 p  0001 analyzed place birth lowest measles seroprevalence observed Eastern Marmara region 345 study emphasizes substantial number young healthcare worker still vulnerable measles posing potential risk outbreaks Early screening vaccination medical student vaccinepreventable disease essential education proactive strategy protects individual also strengthens herd immunity",
        "mesh_terms": [
            "Humans",
            "Measles",
            "Seroepidemiologic Studies",
            "Male",
            "Turkey",
            "Female",
            "Students, Medical",
            "Young Adult",
            "Adult",
            "Universities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40660196/"
    },
    {
        "pmid": "40655295",
        "title": "Regional Disparities and Maternal Sociodemographic Determinants of Full Immunization Coverage Among Children Aged 12-23 Months in Nigeria: Insights from NDHS 2018.",
        "abstract": "Childhood immunization crucial reducing morbidity mortality vaccinepreventable diseases Despite global efforts Nigeria face persistently low immunization uptake significant regional socioeconomic disparities study investigated prevalence regional disparities sociodemographic determinant full immunization coverage among child aged 1223 month Nigeria secondary analysis utilized data 2018 Nigeria Demographic Health Survey NDHS focusing 2453 mother child aged 1223 months Full immunization coverage defined per World Health Organization WHO guidelines Descriptive statistics bivariate analysis multivariable logistic regression identified predictor coverage 26 child fully immunized nationwide Marked regional disparity observed North West 13 North East 18 exhibiting lowest rates South East 42 South South 41 highest Multivariable analysis revealed maternal education household wealth region residence significant predictors Children mother higher education likely fully immunized AOR 187 95 CI 110318 p  0022 richest household compared poorest AOR 320 95 CI 195525 p  0001 Children South East AOR 200 95 CI 116346 p  0013 South South AOR 173 95 CI 099302 p  0052 also showed significantly higher odds full immunization compared North West Full immunization coverage Nigeria remains critically low driven pronounced regional socioeconomic inequities Targeted intervention focusing improving maternal education expanding equitable healthcare access underserved regions providing financial support lowincome family essential Policy effort must prioritize vulnerable group enhance child health outcome achieve universal immunization coverage Nigeria",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655295/"
    },
    {
        "pmid": "40652272",
        "title": "Differential prognostic roles and clinical implications of mitochondrial and genomic tRNA-derived fragments in colorectal liver metastases.",
        "abstract": "Colorectal liver metastasis CRLM leading cause colorectal cancer CRCrelated mortality Transfer RNAderived fragment tRFs novel class small noncoding RNAs sncRNA regulate gene expression stress response immune function cancer increasingly implicated CRC progression prognostic significance CRLM remains unknown study investigates abundance prognostic value genomic ge mitochondrial mt tRFs CRLM Tumor sample CRLM patient underwent curative liver resection January 2012 December 2015 retrospectively analyzed Small RNA sequencing sRNAseq quantified ge mttRF expression tumor tissue Eventfree survival EFS primary outcome Associations tRF expression EFS evaluated using Cox regression spline modeling network analysis Among 588 screened samples 40 met eligibility criterion 18 female 45 median age 64 4279 total 432 tRFs identified getRFs 67 abundant mttRFs 33 Spline regression classified tRFs ten prognostic groups High getRF abundance predominantly associated unfavorable EFS FDR  02 94 mttRFs significantly p  0001 χsup2sup test often linked favorable EFS FDR  02 26 Network analysis tRF abundance correlation revealed higher intramitochondrial network density compared intragenomic tRF network significant structural difference observed prognostically significant vs nonsignificant favorable vs unfavorable tRFs Key tRF candidates including tRHalve3HisCAU tRNAleaderGlnUUG mttRFs well tRFmiscTyrGTA getRF remained independent prognostic marker adjusting clinical covariates study provides first comprehensive characterization tRF expression CRLM identifying distinct prognostic role ge mttRFs getRFs correlated poor prognosis several mttRFs linked favorable outcomes highlighting potential novel prognostic biomarkers therapeutic targets",
        "mesh_terms": [
            "Humans",
            "Colorectal Neoplasms",
            "Female",
            "Prognosis",
            "Male",
            "Liver Neoplasms",
            "Middle Aged",
            "RNA, Transfer",
            "Aged",
            "Mitochondria",
            "Adult",
            "Disease-Free Survival",
            "Genomics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40652272/"
    },
    {
        "pmid": "40652233",
        "title": "Assessment of nursing staff attitude regarding prevention of cervical cancer.",
        "abstract": "Cervical cancer third commonly diagnosed cancer among woman worldwide Egypt considered 14th major contributor female tumors assess nursing staff attitude regarding prevention cervical cancer descriptive crosssectional study framework executed Mansoura University Hospital six building psychiatry burns outpatient special medicine convalescence radiation building Mansoura city Egypt among 414 nursing staff chosen using convenience sampling technique structured interview questionnaire consisting two part used gather data June 2024 continued end November 2024 Univariate analysis descriptive data bivariate analysis chisquare test performed current research revealed 763 studied nursing staff positive attitude toward prevention cervical cancer 693 agreed cervical neoplasm highly preventable disease 717 agreed cervical neoplasm curable detected early Also statistically significant positive association educational level attitude p  0001 statistically significant positive association marital status attitude p  0031 Also statistically significant positive association vaccination HPV positive attitude p  0001 statistically significant positive association positive attitude cervical cancer screening p  0012 concluded threequarters nursing staff demonstrated positive attitude toward cervical cancer prevention underscoring need continued educational interventions study registered clinical trial involve interventional design",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40652233/"
    },
    {
        "pmid": "40647371",
        "title": "Screening for Cervical Cancer: A Comprehensive Review of Guidelines.",
        "abstract": "Cervical cancer remains one main cause female mortality especially middle lowincome countries despite effort towards implementation global vaccination human papillomavirus HPV aim study review compare recently published international guideline providing recommendation cervical cancer screening strategy among average highrisk women Thus comparative review guideline US Preventive Services Task Force USPSTF American Cancer Society ACS American Society Clinical Oncology ASCO World Health Organization WHO Canadian Task Force Preventive Health Care CTFPHC Cancer Council Australia CCA European Guidelines EG conducted overall agreement regarding suggestion made woman younger 21 older 65 guideline stating routine screening exception CTFPHC CCA expand age group 70 75 years respectively Continuation screening older woman also suggested history precancerous lesion inadequate screening guideline recommend routine screening 3065 years advises screening prioritized 3049 years HPV DNA testing method choice recommended guidelines followed cytology alternative except CTFPHC refers cytology only selfsampling acceptable method medical societies Agreements exist regarding recommendation specific groups woman history total hysterectomy benign reasons woman complete vaccination HPV individual lesbian gay bisexual transgender queer community woman multiple sexual partner early initiation sexual activity hand age group 2129 addressed differently reviewed guidelines differentiation also occur screening strategy case abnormal screening results woman immunodeficiency utero exposure diethylstilbestrole pregnant women development consistent practice protocol appropriate cervical cancer screening program seems major importance reduce mortality rate safely guide everyday clinical practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40647371/"
    },
    {
        "pmid": "40647258",
        "title": "Functional Foods in Modern Nutrition Science: Mechanisms, Evidence, and Public Health Implications.",
        "abstract": "recent years functional food garnered increasing scientific public health interest due potential confer physiological benefit beyond basic nutritional value International body EFSA FDA define functional food containing bioactive component may contribute prevention management chronic noncommunicable diseases including cardiovascular disease type 2 diabetes certain cancers evolving paradigm food medicine reflects broader shift nutritional science towards proactive healthoriented dietary strategies article provides comprehensive interdisciplinary overview functional food examining biological mechanisms clinical evidence public health significance regulatory frameworks future prospectsparticularly context advance personalized nutrition nutrigenomics thorough literature review conducted drawing recent peerreviewed study guideline key health authorities review highlight role specific compound probiotic prebiotics modulating gut microbiome flavonoid polyphenols antiinflammatory processes omega3 fatty acid cardiometabolic regulation vitamin mineral supporting immune function expanding body clinical trial metaanalyses support health benefit compoundsincluding reduction LDL cholesterol improved insulin sensitivity mitigation oxidative stressthe integration functional food everyday diet remains challenging Socioeconomic disparity limited health literacy often impede accessibility widespread adoption public health practice Functional food represent promising component preventionfocused modern healthcare maximize impact coordinated evidencebased approach essential involving collaboration among healthcare professionals nutrition scientists policymakers food industry Looking forward innovation artificial intelligence microbiome research genomic technology may unlock novel opportunity targeted effective application functional food population health",
        "mesh_terms": [
            "Humans",
            "Functional Food",
            "Public Health",
            "Nutritional Sciences",
            "Gastrointestinal Microbiome",
            "Nutrigenomics",
            "Nutritive Value",
            "Cardiovascular Diseases",
            "Prebiotics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40647258/"
    },
    {
        "pmid": "40645616",
        "title": "Basel Long COVID Cohort Study (BALCoS): protocol of a prospective cohort study.",
        "abstract": "recent pandemic caused SARSCoV2 profound global impact many individual recovered COVID19 developed longlasting symptom significantly disrupted daily life defines condition postCOVID19 condition PCC Common symptom include fatigue dyspnoea sleep disturbance cognitive difficulties Increasing evidence suggests PCC multifactorial condition shaped biomedical also psychological social factors article present protocol Basel Long COVID Cohort Study BALCoS aim improve understanding PCC capturing clinical functional psychosocial aspect repeated assessment course 1 year BALCoS prospective singlesite cohort study Inclusion criterion include either probable confirmed history SARSCoV2 infection persistent symptom consistent definition PCC sufficient German language skill age ≥18 years baseline collected detailed information previous SARSCoV2 infections symptom history reinfections COVID19 vaccination status preexisting medical conditions study includes standardised psychometric assessments physical performance tests ecological momentary assessment EMAs neurocognitive testing blood sample collection Assessments scheduled baseline 3month 6month 12month followup participant complete psychometric assessment time point Blood sample collected baseline Neurocognitive testing physical performance measure collected baseline 12month followup inperson participant only Participants unable attend person complete remote version study excluding inclinic assessments EMAs initiated day time point consist eight question 10 consecutive days study exploratory nature target sample size 120 participants BALCoS part Horizon Europe Long COVID project multinational interdisciplinary research consortium integrating mechanistic clinical interventional studies study approved Ethics Commission Northwest Central Switzerland BASECID 202300359 registered ClinicalTrialsgov ID NCT05781893 participant provide written informed consent Study finding disseminated peerreviewed publications NCT05781893",
        "mesh_terms": [
            "Female",
            "Humans",
            "Male",
            "COVID-19",
            "Post-Acute COVID-19 Syndrome",
            "Prospective Studies",
            "Psychometrics",
            "Research Design",
            "Switzerland",
            "Observational Studies as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40645616/"
    },
    {
        "pmid": "40643781",
        "title": "Association of HLA-DRA, HLA-DQA1, and IL-6 gene variations with susceptibility to multiple sclerosis.",
        "abstract": "Multiple sclerosis MS lead severe physical cognitive disability neurological deficits chronic autoimmune disease affecting central nervous system CNS etiology pathogenesis MS remain unclear nonetheless asserted cause complex genetic predisposition playing significant role study aim analyze relationship MS HLADRA rs3135388 rs3135391 HLADQA1 rs9272346 IL6 rs1800795 rs1900796 gene polymorphisms play important role inflammation immune response study included 100 healthy control 98 MS patients Realtime polymerase chain reaction RTPCR used analyze variation rs3135388 rs3135391 HLADRA gene rs9272346 HLADQA1 gene rs1800795 rs1900796 IL6 gene following DNA isolation peripheral blood Statistical technique applied assess outcomes result showed significant difference IL6 rs1800796 GC p  0024 patient control group genotype allele distribution analyzed HLADQA1 rs9272346 HLADRA rs3135388 rs3135391 variation substantially differ two groups Similarly significant difference found two group VitD B12 folic acid parameters relationship parameter genotypes evidence suggesting significant association IL6 rs1800796 polymorphism MS IL6 rs1800796 GC genotype may associated disease susceptibility risk taken account association intervention study MS",
        "mesh_terms": [
            "Humans",
            "HLA-DQ alpha-Chains",
            "Interleukin-6",
            "Genetic Predisposition to Disease",
            "Multiple Sclerosis",
            "Female",
            "Male",
            "Adult",
            "Polymorphism, Single Nucleotide",
            "Case-Control Studies",
            "HLA-DR alpha-Chains",
            "Middle Aged",
            "Gene Frequency",
            "Genotype",
            "Alleles",
            "Genetic Association Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40643781/"
    },
    {
        "pmid": "40640171",
        "title": "PLIN2 promotes colorectal cancer progression through CD36-mediated epithelial-mesenchymal transition.",
        "abstract": "Colorectal cancer CRC one common malignant tumor high incidence mortality challenge remains construct reliable prognostic prediction model elucidate key molecular mechanism tumor progression address this performed WGCNA based 120 immune cell expression profile GEO source obtain collection monocytesmacrophagesrelated genes prognostic model constructed univariate survival analysis LASSO regression analysis Then prognostic model validated Multivariate Cox regression KaplanMeier survival analysis ROC analysis prognostic model identified PLIN2 potential value CRC prognosis PLIN2 expression monocytesmacrophages verified scRNAseq datasets spatial transcriptome datasets PLIN2 found promote macrophage transformation M2 subtype Clinical specimen tissue microarrays confirmed differential expression prognostic value PLIN2 CRC patients Functional experiment demonstrated PLIN2 gene overexpression promoted proliferation migration invasion CRC cell significantly facilitated tumor growth vivo Mechanistically revealed CD36 potential downstream target gene PLIN2 CD36 inhibitor SulfoNsuccinimidyl Oleate significantly reversed PLIN2induced proliferation migration invasion EMT activity CRC cell vitro vivo Immunoprecipitation immunofluorescence experiment confirmed PLIN2 could interact CD36 PLIN2 stabilized CD36 protein expression inhibiting proteasomal degradation pathway thereby promoting CD36mediated EMT activity Overall study highlight PLIN2CD36 axis regulates EMT activity CRC progression suggesting intervention signaling pathway may offer promising therapeutic approach CRC progression Schematic diagram elucidating role PLIN2 CRC Figdraw FA transported cell via CD36mediated endocytosis CRC cells PLIN2 promotes stability CD36 interacts CD36 activate EMT process However CD36 inhibitor SSO inhibits binding FAs CD36 attenuates endocytosis thereby reversing PLIN2mediated EMT process Ultimately PLIN2induced enhancement CRC cell proliferation migration invasion attenuated CD36 inhibitor SSO",
        "mesh_terms": [
            "Humans",
            "Colorectal Neoplasms",
            "Epithelial-Mesenchymal Transition",
            "Disease Progression",
            "Animals",
            "CD36 Antigens",
            "Mice",
            "Cell Proliferation",
            "Perilipin-2",
            "Cell Line, Tumor",
            "Cell Movement",
            "Prognosis",
            "Gene Expression Regulation, Neoplastic",
            "Female",
            "Male",
            "Mice, Nude",
            "Mice, Inbred BALB C"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40640171/"
    },
    {
        "pmid": "40638114",
        "title": "Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.",
        "abstract": "trajectory core Alzheimer disease AD cerebrospinal fluid CSF biomarkers concurrent cognitive change across clinical spectrum remain unclear yet important clinical trial design map longitudinal CSF amyloid tau cognitive trajectory along clinical spectrum AD amyloidnegative controls longitudinal cohort study included participant minimum 2 CSF sample Alzheimer Centrum Amsterdam cohort across AD clinical spectrum ie abnormal amyloid level first visit different clinical stages cognitively normal control initially normal CSF marker November 2003 July 2019 maximum followup period 195 year median IQR 2 03 years Data analyzed March 2024 May 2025 AD biomarkers ßamyloid Aß142 Aß140 ratio total tau ttau phosphorylated tau ptau detected serially collected CSF CSF AD biomarkers measured Lumipulse G600II Cognition measured using MiniMental State Examination MMSE delayed memory recall component Rey Auditory Verbal Learning Test Analysis conducted using linear mixed models including random intercept slopes adjusting age education level sex model included interaction term time clinical stage study stagespecific slopes Biomarker conversion rate per clinical stage studied comparing biomarker status visits sample included 197 individual 103 male 523 including 83 control mean SD age 63 8 years 31 individual amyloid positivity cognitively unimpaired mean SD age 67 9 years 30 individual amyloidpositive mild cognitive impairment MCI mean SD age 67 7 years 53 individual amyloidpositive dementia mean SD age 65 8 years Aβ142140 ratio decreased control β SE  855 × 104 187 × 104 P  001 amyloidpositive cognitively unimpaired group β SE  105 × 103 314 × 104 P  001 remained low amyloidpositive MCI dementia groups 10 control 120 reached abnormal amyloid mean SD 48 34 years controls CSF ttau β SE  849 255 pgmL per year P  002 ptau β SE  136 041 pgmL per year P  001 level increased time level also increased amyloidpositive cognitively unimpaired ttau β SE  1724 458 pgmL per year P  001 ptau β SE  310 072 pgmL per year P  001 amyloidpositive MCI ttau β SE  3080 599 pgmL per year P  001 ptau β SE  440 093 pgmL per year P  001 groups ttau increasing dementia group β SE  2497 780 pgmL per year P  002 Longitudinal increase ptau ttau steeper amyloidpositive cognitively unimpaired MCI group controls 10 control 120 reaching abnormal ptau 12 control 145 reaching abnormal ttau levels Delayed recall declined amyloidpositive cognitively unimpaired group β SE  031 007 P  001 associated CSF amyloid level β SE  10229 4730 P  03 MMSE score declined individual amyloidpositive MCI β SE  125 012 P  001 dementia β SE  189 013 P  001 cohort study CSF amyloid decreased toward abnormal level controls declined amyloidpositive cognitively unimpaired group  concurrent decline delayed recall CSF amyloid stabilized amyloidpositive MCI dementia tau marker became increased ie abnormal amyloidpositive cognitively unimpaired amyloidpositive MCI groups suggesting increase CSF tau requires abnormal amyloid",
        "mesh_terms": [
            "Humans",
            "Alzheimer Disease",
            "tau Proteins",
            "Male",
            "Female",
            "Biomarkers",
            "Amyloid beta-Peptides",
            "Aged",
            "Longitudinal Studies",
            "Peptide Fragments",
            "Middle Aged",
            "Aged, 80 and over",
            "Cognitive Dysfunction",
            "Disease Progression"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40638114/"
    },
    {
        "pmid": "40637813",
        "title": "Evaluation of a Multiplex Electrochemiluminescence Assay for Detection of Anti-Pneumococcal Antibodies in the Diagnosis of Selective Polysaccharide Antibody Deficiency.",
        "abstract": "Streptococcus pneumoniae responsible severe infections especially patient primary antibody deficiency like selective antipolysaccharide antibody deficiency SPAD reference method recommaned World Health Organization assessment antipneumococcal capsular polysaccharide PCPs IgG antibody standardized serotypespecific ELISA WHOSSA manual method timeconsuming limit number evaluated PCPs aim evaluate performance value multiplex assay based electrochemiluminescence ECLplex panel 164 serum 82 patient sampled 48 week immunization 23valent pneumococcal polysaccharide vaccine PPV23 assessed reference WHOSSA 7 13 serotypes 18plex ECL assay 18 serotypes patient normal serum Igsubclasses level classified good n  43 poor responder n  39 ie SPAD patients according American Academy Asthma Allergy Immunologys AAAAI current guidelines observed excellent correlation two method antiPCPs titer 7 serotypes r  088 95 CI 087090 n  124 sera 13 serotypes r  087 087089 n  40 sera Using AAAAIs guideline interpretation test performance 18plex ECL assay SPAD diagnosis showed sensitivity 95 specificity 84 positive negative predictive value 84 95 respectively percentage agreement 89 SSA 18plex ECL assay 18plex ECL assay reliable rapid simple method evaluating antiPCPs response screening SPAD diagnosis",
        "mesh_terms": [
            "Humans",
            "Antibodies, Bacterial",
            "Streptococcus pneumoniae",
            "Luminescent Measurements",
            "Male",
            "Female",
            "Adult",
            "Pneumococcal Vaccines",
            "Middle Aged",
            "Adolescent",
            "Pneumococcal Infections",
            "Immunoglobulin G",
            "Child",
            "Young Adult",
            "Aged",
            "Polysaccharides, Bacterial",
            "Sensitivity and Specificity",
            "Immunologic Deficiency Syndromes",
            "Electrochemical Techniques",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40637813/"
    },
    {
        "pmid": "40636645",
        "title": "Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the Culprit.",
        "abstract": "Adrenal insufficiency known complication immune checkpoint inhibitor ICIs resection ablation adrenal glands modern era immunotherapy frequent assessment adrenal hormonal axis performed initiation ICIs order monitor complications interpretation laboratory tests elevated adrenocorticotropic hormone ACTH patient receive ICIs undergo adrenalectomy adrenal ablation provides additional set diagnostic challenge well described present case series four patient elevated ACTH without clinical symptoms biochemical decreased cortisol evidence adrenal insufficiency pattern suggesting compensatory increase ACTH highlight emerging phenomenon diagnostic challenge monitoring adrenal axis patient undergoing adrenalectomy ablation alongside ICI therapy emphasizing need close followup thorough investigation rule adrenal insufficiency patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40636645/"
    },
    {
        "pmid": "40635807",
        "title": "Perioperative challenges and management strategies for non-cardiac surgery in patients with rheumatic heart diseases: A narrative review.",
        "abstract": "Rheumatic heart disease RHDs impose substantial global burden primarily affecting individual 25 year age low mediumincome country LMICs poor marginalized group highincome countries123 underlying cause group betahemolytic streptococcus trigger immunemediated attack heart joints Although acute rheumatic fever ARF treatable occurrence complication remain high impoverished areas4 Variations social structure contribute difference incidence progression disease even affluent regions5 Administering anesthesia patient population present significant challenges particularly early management inadequate due limited medical care followup Literature show evidence anesthetic management different type RHDs mostly focusing mitral aortic valvulopathies67 review synthesizes literature database MEDLINE PubMed search year 2000 date focusing anesthesia management strategy challenge posed ARF RHD Specific topic covered include diagnosis management ARF acute complications perioperative care patient RHD unique consideration different valvular pathologiesWith review aim discus available evidence current World Health Organization WHO societal guideline context perioperative medical anesthetic management hemodynamic challenges postoperative courses emphasis basic pointofcare ultrasound POCUS training made review current era diagnostics therapeutic increasingly reliant echocardiography",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40635807/"
    },
    {
        "pmid": "40633814",
        "title": "Increasing the Rates of Postpartum Measles, Rubella, and Varicella Vaccination in Nonimmune Mothers: An Electronic Medical Record-Based Quality Improvement Intervention.",
        "abstract": "Postpartum measles mumps rubella MMR varicella vaccination critical nonimmune mother prevent severe maternal neonatal complications Despite recommendations vaccination rate remain suboptimal particularly completing twodose series study evaluates impact electronic medical record EMRbased intervention postpartum MMR varicella vaccination ratesA retrospective cohort study conducted two urban tertiary care centers Nonimmune postpartum patient public insurance delivered January 2021 June 2022 February 2023 October 2024 included pre postintervention groups respectively intervention implemented April 2023 modified mandated postpartum checklist EMR include measles immunity status emphasize necessity completing twodose series MMR varicella primary outcome completion rate twodose series secondary outcome assessing provider adherence patient acceptance Statistical analysis included chisquared ititests compare pre postintervention cohortsA total 468 patient included 220 preintervention 248 postintervention MMR series completion significantly increased 23 349 ipi  0001 Varicella series completion showed nonsignificant upward trend 270 365 ipi  0112 Provider adherence improved fewer missed opportunity offer second dose postpartum visit 496 vs 329 ipi  0004 MMR Patient declination rate remained stableIntegrating vaccination reminder EMR significantly improved postpartum MMR series completion varicella rate showed modest increase persistent provider followup patient education remain crucial Future effort focus addressing systemic barrier enhancing patient outreach optimize postpartum vaccination completion · EMR checklist improved MMR series completion rates · Varicella series completion showed modest improvement · Provider adherence vaccine guideline increased · Barriers postpartum vaccine completion still exist",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40633814/"
    },
    {
        "pmid": "40629311",
        "title": "Teachers' demographics, mindfulness skills, and anxiety predict COVID-19 vaccination status.",
        "abstract": "Given maintaining health teacher student utmost importance study explored potential predictor US teachers decision receive COVID19 vaccine evidencebased public health measure present study explored whether teachers demographic ie gender race age grade taught personal characteristic ie awareness nonjudgmental orientation component mindfulness anxiety state characteristic ie gubernatorial party associated decision receive COVID19 vaccine Five hundred sixteen Kindergarten12th grade teacher across US participated April 2022 Results stepwise generalized linear mixed effect model indicated teacher woman vs men White vs teacher color younger vs older less likely vaccinated Awareness skill associated greater odds vaccination whereas nonjudgmental orientation anxiety associated reduced odds vaccination study provides insight demographic personal statelevel influence associated teachers decision receive COVID19 vaccine Findings highlight importance targeted effort increase adherence public health guideline school reopen swiftly safely future public health crises",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "School Teachers",
            "Anxiety",
            "Mindfulness",
            "COVID-19",
            "Adult",
            "COVID-19 Vaccines",
            "United States",
            "Middle Aged",
            "Vaccination",
            "Demography"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40629311/"
    },
    {
        "pmid": "40628565",
        "title": "Factors Associated with Immune Effector Cell-Associated Neurotoxicity Syndrome in Adults with Hematological Malignancies Undergoing Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review.",
        "abstract": "systematically appraised study investigating factor associated ICANS development CART cell therapy adult hematological malignancy estimated ICANS prevalence conducted systematic review SR 4 database following PRISMA Preferred Reporting Items Systematic Reviews MetaAnalyses guideline study published 2010 December 2024 estimated ICANS prevalence exact binomial score testbased 95 confidence intervals applied FreemanTukey double arcsine transformation stabilize variance within randomeffects model using Metaprop command Stata Sixteen study 14 retrospective n  135 2 prospective n  300 included SR sample comprised adult various hematological malignancy received antiCD19 antiBCMA clinical factor seem associated ICANS incidence severity retrospective studies pooled prevalence 41 95 CI 3151 grade ICANS 20 95 CI 1328 grade ≥3 ICANS prospective studies pooled prevalence 51 95 CI 4556 Approximately half hematological patient undergoing CAR therapy develop ICANS Although factor may contribute development ICANS limited study samples retrospective nature majority studies discordance among result preclude certain risk factor conclusions Nurses play pivotal role posttreatment monitoring early detection management ICANS given direct continuous patient interaction Increasing nurses awareness potential risk factor ICANS enhance vigilance effectiveness managing condition",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40628565/"
    },
    {
        "pmid": "40624614",
        "title": "Superiority of pan-immune inflammation value, systemic inflammation index, and CALLY scores prognostic value for mortality of ischemic stroke patients followed in intensive care unit.",
        "abstract": "Inflammatory response play important role pathophysiology prognosis ischemic stroke Hyperinflammation progress aggravation brain damage deterioration clinical status study aimed demonstrate valuable easytoobtain inexpensive parameter prognostic assessment comparing Panimmune Inflammation Value PIV Systemic ImmuneInflammation Index SII CALLY score patient ischemic stroke retrospective singlecenter cohort study file patient followed diagnosis ischemic stroke tertiary intensive care units Multivariate regression analysis receiver operating characteristic curvesROC used detect association PIV SII CALLY inhospital mortality superiority predicting mortality ischemic stroke patients 1039 patients 453 died resulting overall survival rate 564 multivariate analysis high APACHE II score low albumin level remained independent risk factors ROC curve showed PIV SII CALLY exhibited good predictive values AUCs 0921 0887 0930 95 CI 09030936 08550896 09130945 p  0001 pairwise comparison data based AUC value indicated significant difference SII PIV CALLY p  0001 contrast significant difference found PIV CALLY p  0385 PIV SII CALLY index serve accessible reliable prognostic biomarkers enhance personalized treatment strategy improve clinical decisionmaking patient ischemic stroke",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Prognosis",
            "Ischemic Stroke",
            "Aged",
            "Intensive Care Units",
            "Middle Aged",
            "Retrospective Studies",
            "Inflammation",
            "ROC Curve",
            "Hospital Mortality",
            "Biomarkers",
            "Risk Factors",
            "Severity of Illness Index",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40624614/"
    },
    {
        "pmid": "40624367",
        "title": "EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.",
        "abstract": "Since publication 2021 European Hematology Association EHA Clinical Practice Guidelines treatment patient smouldering multiple myeloma SMM multiple myeloma MM developed collaboration European Society Medical Oncology novel international staging system R2ISS developed several prognostic factor entering clinical practice such minimal residual disease circulating plasma cell monoclonal protein assessed mass spectrometry and time writing 14 novel regimen approved EMA andor FDA treatment patient MM multidisciplinary group expert EHA European Myeloma Network based various institution mostly located Europe updated previous guideline produced algorithm everyday clinical practice incorporate level evidence grade recommendation based aforementioned new data EvidenceBased Guidelines provide key treatment recommendation patient newly diagnosed MM relapsed andor refractory MM including guidance use established drug well contemporary immunotherapies Novel approach management patient SMM focus might require early intervention Finally provide recommendation myelomarelated complication adverse events bone disease renal impairment infections well associated cellmobilizing therapies cytokinerelease syndrome immune effector cellassociated neurotoxicity syndrome",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40624367/"
    },
    {
        "pmid": "40623795",
        "title": "Real-world effectiveness study of guideline-directed COPD STANDARDized management in patients with chronic obstructive pulmonary disease: a cluster randomised trial design.",
        "abstract": "Chronic obstructive pulmonary disease COPD affect ageing population worldwide Exacerbations worsen health status increase health resource use Existing guideline recommend disease management fully implemented clinical setting Evidence regarding best practice realworld effectiveness limited nationwide multicentre clinical effectiveness trial performed 2023 2027 involving 99 secondary hospital urban rural area China openlabel adjudicator assessorblinded parallel group cluster randomised pragmatic trial Hospitals randomly allocated standardised management SM usual care total number 3456 stable patient COPD symptomatic individuals Global Initiative Chronic Obstructive Lung Disease GOLD Group B exacerbation risk individuals one moderate exacerbation history Group individual Group E using GOLD 2023 ABE classification enrolled SM group integrated intervention comprising five component delivered using physician nurse model are 1 longterm inhaled maintenance therapy 2 periodic inhaler technique assessment symptom monitoring 3 annual pulmonary function testing 4 COPD education session 5 health behaviour adoption smoking cessation vaccination pulmonary rehabilitation control group patient receive routine care primary goal assess realworld effectiveness guidelinedirected disease management exacerbation prevention moderatetosevere exacerbation primary outcome hospital admission mortality health status COPD selfmanagement secondary outcomes first pragmatic trial undertaken form developing country anticipated provide feasible effective COPD management model inform guideline rolled secondary primary care modification ensure standardised COPD care nationwide NCT04664491",
        "mesh_terms": [
            "Humans",
            "Male",
            "China",
            "Disease Progression",
            "Practice Guidelines as Topic",
            "Pragmatic Clinical Trials as Topic",
            "Pulmonary Disease, Chronic Obstructive"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40623795/"
    },
    {
        "pmid": "40620437",
        "title": "Unraveling cutaneous histiocytosis: insights into histology, pathogenesis, diagnosis, and treatment pitfalls.",
        "abstract": "Histiocytoses represent group diverse rare disorder characterized abnormal accumulation cell derived mononuclear phagocyte system various tissue organs mononuclear phagocyte system includes monocytes macrophages dendritic cells specialized tissueresident phagocytes cell essential innate adaptive immunity preserving tissue homeostasis Several classification histiocytoses Histiocyte Society 1987 1997 2016 2018 2022 International Consensus Classification 2022 generally acknowledged 2022 classification clarifies heterogeneous disorder dividing three major groups Cutaneous involvement histiocytosis often polymorphous making clinical decision challenging Cutaneous histiocytoses occur either primary case manifestation multisystemic disease support standard pathology report immunohistochemical staining warranted exact etiopathogenesis histiocytoses remains poorly understood various association malignancies including visceral hematologic cancers well autoimmune disease infection Borrelia burgdorferi still review One recent advancement field discovery somatic mutation RAFMEKERK signaling pathway particularly BRAF mutations Oncogeneinduced senescenceassociated BRAF mutation described Langerhans cell histiocytosis ErdheimChester disease Targeted therapy BRAF inhibitor dabrafenib vemurafenib shown promising results MEK inhibitors like trametinib cobimetinib demonstrated efficiency regardless BRAF mutation status Local treatment cutaneous histiocytosis include topical steroids calcineurin inhibitors alkylating agents phototherapy steroid injections laser therapies Despite current advance pathogenesis treatments cutaneous histiocytosis stand challenging heterogeneous group disorders treatment guideline warranted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40620437/"
    },
    {
        "pmid": "40619406",
        "title": "Meta-analysis of TB & HIV co-infection mortality rate in sub-Saharan African children, youth, and adolescents.",
        "abstract": "Despite effectiveness antiretroviral treatment ART reducing morbidity mortality child adolescent coinfections face elevated risk death due young age compromised immune systems risk factor tuberculosis TB adverse TB outcome HIVinfected adult welldocumented mortality estimation understanding mortality risk among HIVinfected child adolescents especially era test treatment universal ART HIVinfected persons remains limited study aimed estimate mortality rate among TB HIVcoinfected child SubSaharan African country using SRM systematically searched relevant study seven international electronic databases Articles searched using Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines Article searching included six electronic database including PubMedMEDLINE N  1287 Scopus N  447 Web Science N  174 Science Direct N  749 Cochran N  57 Google Scholar research repository base searching N  42 quality primary study evaluated using Joanna Briggs Institute JBI checklist pooled mortality rate estimated using weighted inverse variance randomeffect metaanalysis Heterogeneity among study assessed using Cochrans Q test estimated using I2 statistic document registered Prospero CRD420251012913 SRM 16 individual study included coinfected mortality screening 5098 participants 657 death reported cotreatment started pooled mortality burden estimated 1296 95 CI 894 1698 I2  926 P  0001 majority TB coinfected case newly diagnosed ART started final weighted inverse variance randomeffect regression indicated stage III IV pooled HR  434 poor fair ART adherence pooled HR  311 missed Isoniazid preventive therapy IPT pooled HR  307 hemoglobin level ≤ 10 mgdL pooled HR  284 bedridden functional status pooled HR  319 threshold CD4 count pooled HR  180 missed cotrimoxazole preventive therapy CPT pooled AOR  158 predictor premature death coinfection review overall pooled burden mortality HIVinfected child SSA country high compared End TB Strategy target estimation Significant predictor mortality included clinical stage III IV poor fair ART adherence missed Isoniazid preventive therapy IPT hemoglobin level ≤ 10 mgdL Therefore counseling antiretroviral therapy adherence strengthened early screening treating anemia screening scaling IPT critical ART drug nutritional counseling done regular visit caregiver prevent premature death among children youths adolescent coinfection SSA",
        "mesh_terms": [
            "Humans",
            "Africa South of the Sahara",
            "Adolescent",
            "HIV Infections",
            "Child",
            "Coinfection",
            "Tuberculosis",
            "Male",
            "Female",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619406/"
    },
    {
        "pmid": "40615433",
        "title": "An international multi-cohort investigation of self-reported sleep and future depressive symptoms in older adults.",
        "abstract": "Poor subjective sleep associated future depression older adults limited consensus sleep feature strongest associations Moreover composite score incorporating multiple feature may better represent sleep burden individual sleep items analyzed older adult age ≥ 60 without clinically relevant depressive symptom multicohort United States sample US N  4826 Netherlands Rotterdam Study RS N  3663 goal identifying individual composite sleep feature associated future clinically relevant depressive symptom 36 year later Sleeprelated daytime symptom Risk Ratio 95 CI 210 158 280 US 210 140 314 RS difficulty falling asleep 187 149 235 US RS  190 150 243 RS strongest individual sleep features Moreover combination feature impactful 332 233 473 US 319 264 386 RS providing largest effect size fewest number items Future study assess whether screening tool incorporating features paired targeted sleep treatment could reduce rate incident depression older adults Examining mechanism underlying association could improve effectiveness sleeprelated treatment older adults",
        "mesh_terms": [
            "Humans",
            "Aged",
            "Male",
            "Female",
            "Depression",
            "Self Report",
            "Sleep",
            "Middle Aged",
            "Cohort Studies",
            "United States",
            "Netherlands",
            "Sleep Wake Disorders",
            "Aged, 80 and over",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40615433/"
    },
    {
        "pmid": "40613758",
        "title": "Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.",
        "abstract": "Studies multiple myeloma MM second common hematologic malignancy shown inconclusive result regarding role exercise treatment study evaluated relationship physical exercise MM treatment outcomes 5TMM mouse model tumorbearing mouse underwent treatment included bortezomib dexamethasone alongside 6 week low moderateintensity treadmill aerobic training Tumor burden survival data recorded Additionally retrospective analysis conducted 65 MM patient undergoing maintenance therapy West China Hospital 2013 2024 Patients categorized based adherence World Health Organization WHO physical activity guidelines progressionfree survival progressionfree survival maintenance therapy analyzed mouse model combination dualdrug therapy exercise improved outcomes extending survival 10 days Aerobic exercise reduced regulatory cell increased NK cell peripheral blood mice exercise group mice myokines IL15 irisin upregulated implying myokines could contribute regulation antiMM immunity patient study patient met physical activity recommendation demonstrated significantly better progressionfree survival PFS progressionfree survival maintenance treatment PFSm Overall appropriate aerobic exercise may benefit MM patients suggesting potential exercise adjunct MM treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40613758/"
    },
    {
        "pmid": "40610982",
        "title": "Effects of postoperative antifungal therapy on the recurrence of Aspergillus infection after pulmonary aspergilloma resection: a prospective, randomized, controlled, single-center, 24-month, open-label, parallel group trial.",
        "abstract": "Surgical resection considered effective therapeutic method pulmonary aspergilloma PA necessity postoperative antifungal therapy remains controversial Previous study several shortcoming retrospective design inadequate followup durations study aim address evidence gap evaluating effect postoperative antifungal therapy Aspergillus infection recurrence drugrelated side effects conducted prospective randomized controlled singlecenter clinical trial Eligible patient PA underwent surgical resection institute enrolled randomly assigned receive either 3month course voriconazole VRZ tablet postoperatively symptomatic treatment alone Participants evaluated Aspergillus infection recurrence drugrelated side effect every 3 month 2 years Ultimately 36 patient VRZ group 14 patient control group included analysis balanced baseline characteristic groups median followup 27 months recurrence Aspergillus infection observed either group Symptomatic improvement eg hemoptysis white sputum comparable groups Although serum IgG level significantly increased 222 gL VRZ treatment p  0001 parameter indicating immune activity CD4supsup CD8supsup CD4supsupCD8supsup ratio IgA IgM Aspergillusspecific IgG pulmonary function showed significant intergroup difference final followup Regarding safety VRZ intervention associated significant increase aspartate aminotransferase level 209 ± 62 UL 265 ± 78 UL p  0023 Hypokalemia incidence numerically higher VRZ group 214 vs 0 p  0530 though statistically significant finding demonstrated postoperative antifungal therapy reduce Aspergillus recurrence rate posed potential safety risks immunocompetent patient undergoing complete resection without intraoperative fungal spillage routine postoperative antifungal agent recommended Chinese Clinical Trial Registry Number ChiCTR1800019990 registration date December 11th 2018",
        "mesh_terms": [
            "Humans",
            "Male",
            "Antifungal Agents",
            "Female",
            "Middle Aged",
            "Prospective Studies",
            "Pulmonary Aspergillosis",
            "Voriconazole",
            "Aged",
            "Recurrence",
            "Adult",
            "Aspergillus",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40610982/"
    }
]